
<html lang="en"     class="pb-page"  data-request-id="be3b947a-7048-4d0f-93d6-4acac49f269e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-11;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00457;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists" /></meta><meta name="dc.Creator" content="Ramakrishna  Nirogi" /></meta><meta name="dc.Creator" content="Abdul Rasheed  Mohammed" /></meta><meta name="dc.Creator" content="Anil K.  Shinde" /></meta><meta name="dc.Creator" content="Shankar Reddy  Gagginapally" /></meta><meta name="dc.Creator" content="Durga Malleshwari  Kancharla" /></meta><meta name="dc.Creator" content="Vanaja Reddy  Middekadi" /></meta><meta name="dc.Creator" content="Narsimha  Bogaraju" /></meta><meta name="dc.Creator" content="Srinivasa Rao  Ravella" /></meta><meta name="dc.Creator" content="Pooja  Singh" /></meta><meta name="dc.Creator" content="Sumit Raosaheb  Birangal" /></meta><meta name="dc.Creator" content="Ramkumar  Subramanian" /></meta><meta name="dc.Creator" content="Raghava Choudary  Palacharla" /></meta><meta name="dc.Creator" content="Vijay  Benade" /></meta><meta name="dc.Creator" content="Nageswararao  Muddana" /></meta><meta name="dc.Creator" content="Pradeep  Jayarajan" /></meta><meta name="dc.Description" content="Alzheimer’s disease (AD) is a neurodegenerative disorder that has a higher prevalence and incidence in people older than 60 years. The need for improved AD therapies is unmet as the current therapi..." /></meta><meta name="Description" content="Alzheimer’s disease (AD) is a neurodegenerative disorder that has a higher prevalence and incidence in people older than 60 years. The need for improved AD therapies is unmet as the current therapi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 15, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00457" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00457" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00457" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00457" /></link>
        
    
    

<title>Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00457" /></meta><meta property="og:title" content="Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0020.jpeg" /></meta><meta property="og:description" content="Alzheimer’s disease (AD) is a neurodegenerative disorder that has a higher prevalence and incidence in people older than 60 years. The need for improved AD therapies is unmet as the current therapies are symptomatic with modest efficacy. Partial agonists of the 5-HT4 receptor (5-HT4R) offer both symptomatic and disease-modifying treatments as they shift amyloid-precursor-protein (APP) processing from the amyloidogenic pathway to the nonamyloidogenic pathway by activating the α-secretase enzyme. In addition, they also offer symptomatic treatment by increasing levels of the neurotransmitter acetylcholine in the brain. Because of this fascinating dual mechanism of action, several chemical scaffolds having 5-HT4R pharmacophores were designed and evaluated. Most of the synthesized compounds showed potent in vitro affinities and in vivo efficacies. Upon analysis of focused structure–activity relationships, compound 4o was identified as a potent 5-HT4R partial agonist with favorable ADME properties and good in vivo efficacy. GR-125487, a selective 5-HT4R antagonist, attenuated the activity of compound 4o in the novel-object-recognition-test cognition model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00457"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00457">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00457&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00457&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00457&amp;href=/doi/10.1021/acs.jmedchem.8b00457" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4993-5008</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00421" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00460" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT<sub>4</sub> Receptor Partial Agonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ramakrishna Nirogi</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ramakrishna Nirogi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#76180005041d3605030013185815191b"><span class="__cf_email__" data-cfemail="abc5ddd8d9c0ebd8deddcec585c8c4c6">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ramakrishna++Nirogi">Ramakrishna Nirogi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2045-0784" title="Orcid link">http://orcid.org/0000-0002-2045-0784</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Abdul Rasheed Mohammed</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Abdul Rasheed Mohammed</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Abdul+Rasheed++Mohammed">Abdul Rasheed Mohammed</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anil K. Shinde</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anil K. Shinde</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anil+K.++Shinde">Anil K. Shinde</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shankar Reddy Gagginapally</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shankar Reddy Gagginapally</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shankar+Reddy++Gagginapally">Shankar Reddy Gagginapally</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Durga Malleshwari Kancharla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Durga Malleshwari Kancharla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Durga+Malleshwari++Kancharla">Durga Malleshwari Kancharla</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vanaja Reddy Middekadi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vanaja Reddy Middekadi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vanaja+Reddy++Middekadi">Vanaja Reddy Middekadi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Narsimha Bogaraju</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Narsimha Bogaraju</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Narsimha++Bogaraju">Narsimha Bogaraju</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Srinivasa Rao Ravella</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Srinivasa Rao Ravella</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Srinivasa+Rao++Ravella">Srinivasa Rao Ravella</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pooja Singh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pooja Singh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pooja++Singh">Pooja Singh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sumit Raosaheb Birangal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sumit Raosaheb Birangal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sumit+Raosaheb++Birangal">Sumit Raosaheb Birangal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ramkumar Subramanian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ramkumar Subramanian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ramkumar++Subramanian">Ramkumar Subramanian</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Raghava Choudary Palacharla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raghava Choudary Palacharla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raghava+Choudary++Palacharla">Raghava Choudary Palacharla</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vijay Benade</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vijay Benade</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vijay++Benade">Vijay Benade</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nageswararao Muddana</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nageswararao Muddana</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nageswararao++Muddana">Nageswararao Muddana</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Pradeep Jayarajan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pradeep Jayarajan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Research, Suven Life Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pradeep++Jayarajan">Pradeep Jayarajan</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00457&amp;href=/doi/10.1021%2Facs.jmedchem.8b00457" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4993–5008</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 15, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 March 2018</li><li><span class="item_label"><b>Published</b> online</span>15 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00457" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00457</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4993%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRamakrishna%2BNirogi%252C%2BAbdul%2BRasheed%2BMohammed%252C%2BAnil%2BK.%2BShinde%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D11%26contentID%3Dacs.jmedchem.8b00457%26title%3DSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationships%252C%2Band%2BPreclinical%2BEvaluation%2Bof%2BHeteroaromatic%2BAmides%2Band%2B1%252C3%252C4-Oxadiazole%2BDerivatives%2Bas%2B5-HT4%2BReceptor%2BPartial%2BAgonists%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5008%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00457"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1553</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00457" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ramakrishna&quot;,&quot;last_name&quot;:&quot;Nirogi&quot;},{&quot;first_name&quot;:&quot;Abdul&quot;,&quot;last_name&quot;:&quot;Rasheed Mohammed&quot;},{&quot;first_name&quot;:&quot;Anil&quot;,&quot;last_name&quot;:&quot;K. Shinde&quot;},{&quot;first_name&quot;:&quot;Shankar&quot;,&quot;last_name&quot;:&quot;Reddy Gagginapally&quot;},{&quot;first_name&quot;:&quot;Durga&quot;,&quot;last_name&quot;:&quot;Malleshwari Kancharla&quot;},{&quot;first_name&quot;:&quot;Vanaja&quot;,&quot;last_name&quot;:&quot;Reddy Middekadi&quot;},{&quot;first_name&quot;:&quot;Narsimha&quot;,&quot;last_name&quot;:&quot;Bogaraju&quot;},{&quot;first_name&quot;:&quot;Srinivasa&quot;,&quot;last_name&quot;:&quot;Rao Ravella&quot;},{&quot;first_name&quot;:&quot;Pooja&quot;,&quot;last_name&quot;:&quot;Singh&quot;},{&quot;first_name&quot;:&quot;Sumit&quot;,&quot;last_name&quot;:&quot;Raosaheb Birangal&quot;},{&quot;first_name&quot;:&quot;Ramkumar&quot;,&quot;last_name&quot;:&quot;Subramanian&quot;},{&quot;first_name&quot;:&quot;Raghava&quot;,&quot;last_name&quot;:&quot;Choudary Palacharla&quot;},{&quot;first_name&quot;:&quot;Vijay&quot;,&quot;last_name&quot;:&quot;Benade&quot;},{&quot;first_name&quot;:&quot;Nageswararao&quot;,&quot;last_name&quot;:&quot;Muddana&quot;},{&quot;first_name&quot;:&quot;Pradeep&quot;,&quot;last_name&quot;:&quot;Jayarajan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;4993-5008&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00457&quot;},&quot;abstract&quot;:&quot;Alzheimer’s disease (AD) is a neurodegenerative disorder that has a higher prevalence and incidence in people older than 60 years. The need for improved AD therapies is unmet as the current therapies are symptomatic with modest efficacy. Partial agonists of the 5-HT4 receptor (5-HT4R) offer both symptomatic and disease-modifying treatments as they shift amyloid-precursor-protein (APP) processing from the amyloidogenic pathway to the nonamyloidogenic pathway by activating the α-secretase enzyme. In addition, they also offer symptomatic treatment by increasing levels of the neurotransmitter acetylcholine in the brain. Because of this fascinating dual mechanism of action, several chemical scaffolds having 5-HT4R pharmacophores were designed and evaluated. Most of the synthesized compounds showed potent in vitro affinities and in vivo efficacies. Upon analysis of focused structure–activity relationships, compound 4o was identified as a potent 5-HT4R partial agonist with favorable ADME properties and good in vivo &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00457&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00457" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00457&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00457" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00457&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00457" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00457&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00457&amp;href=/doi/10.1021/acs.jmedchem.8b00457" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00457" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00457" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00457%26sid%3Dliteratum%253Aachs%26pmid%3D29763304%26genre%3Darticle%26aulast%3DNirogi%26date%3D2018%26atitle%3DSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationships%252C%2Band%2BPreclinical%2BEvaluation%2Bof%2BHeteroaromatic%2BAmides%2Band%2B1%252C3%252C4-Oxadiazole%2BDerivatives%2Bas%2B5-HT4%2BReceptor%2BPartial%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D11%26spage%3D4993%26epage%3D5008%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/jmcmar.2018.61.issue-11/20180614/jmcmar.2018.61.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Alzheimer’s disease (AD) is a neurodegenerative disorder that has a higher prevalence and incidence in people older than 60 years. The need for improved AD therapies is unmet as the current therapies are symptomatic with modest efficacy. Partial agonists of the 5-HT<sub>4</sub> receptor (5-HT<sub>4</sub>R) offer both symptomatic and disease-modifying treatments as they shift amyloid-precursor-protein (APP) processing from the amyloidogenic pathway to the nonamyloidogenic pathway by activating the α-secretase enzyme. In addition, they also offer symptomatic treatment by increasing levels of the neurotransmitter acetylcholine in the brain. Because of this fascinating dual mechanism of action, several chemical scaffolds having 5-HT<sub>4</sub>R pharmacophores were designed and evaluated. Most of the synthesized compounds showed potent in vitro affinities and in vivo efficacies. Upon analysis of focused structure–activity relationships, compound <b>4o</b> was identified as a potent 5-HT<sub>4</sub>R partial agonist with favorable ADME properties and good in vivo efficacy. GR-125487, a selective 5-HT<sub>4</sub>R antagonist, attenuated the activity of compound <b>4o</b> in the novel-object-recognition-test cognition model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a progressively debilitating neurodegenerative disorder mostly affecting the aging population. Although the underlying causative factors are yet to be identified, symptoms include confusion, memory loss, and dementia, ultimately leading to death. The current pharmacotherapy provides only symptomatic relief through the augmentation of cholinergic function and has undesired side effects, such as nausea, vomiting, and bradycardia. Moreover, no disease-modifying therapy is available to the patients to date. Thus, there is a need for new therapeutic targets for the treatment of this disorder. The 5-HT<sub>4</sub> receptor has attracted a lot of attention. 5-HT<sub>4</sub>R belongs to a superfamily of seven transmembrane G-protein-coupled receptors (GPCRs) and is coupled to a G protein containing a Gαs subunit.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> 5-HT<sub>4</sub>R is reported to have a potential role in many central nervous system (CNS) disorders, such as AD,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and peripherally mediated disorders, such as irritable-bowel syndrome<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and gastroparesis.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The 5-HT<sub>4</sub> receptors are highly expressed in brain regions like the hippocampus, amygdala, and cerebral cortex, suggesting the involvement of the receptor in cognitive processes.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> 5-HT<sub>4</sub>R agonists modulate amyloid-precursor-protein (APP)-derived peptides, amyloid β (Aβ), and soluble amyloid-precursor protein α (sAPPα).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">sAPPα is nonamyloidogenic protein that is reported to have a potent neuroprotective role against the neurotoxic effects of glutamate and β-amyloid.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Human 5-HT<sub>4</sub>R isoforms are positively coupled to adenylyl cyclase production. Thus, the activation of this G-protein-coupled receptor activates adenylyl cyclase, consequently increasing the production of cAMP. The increased cAMP in turn increases sAPPα release. The stimulatory effect of 5-HT<sub>4</sub>R on sAPPα release is mimicked by forskolin, a direct activator of adenylyl cyclase, and 8-bromo-cAMP, a membrane-permeant cAMP analogue, suggesting the involvement of adenylyl cyclase and cAMP in modulating sAPPα by 5-HT<sub>4</sub>R.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> 5-HT<sub>4</sub>R also increases neuronal acetylcholine (ACh) levels in the brain.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Thus, 5-HT<sub>4</sub>R partial agonists may be of use for both disease-modifying and symptomatic treatments of cognitive disorders. Owing to its dual mechanism of action in treating AD and other cognition-related diseases, 5-HT<sub>4</sub>R became an attractive target for drug discovery. Several structurally diverse heteroaromatic derivatives,<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9−13)</a> as 5-HT<sub>4</sub>R agonists or partial agonists, have been explored for both CNS and peripheral indications. The 5-HT<sub>4</sub>R partial agonist PRX-03140 showed significant improvement of ADAS-cog scores in a Phase 2a study for AD.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Apart from this compound, several other compounds were in development, such as BIMU-1,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> RS-67333,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> prucalopride,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and PF-04995274,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> among others (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). In our continued efforts at discovering novel small molecules with diverse mechanism of action to treat AD,<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> we shifted our attention to 5-HT<sub>4</sub>R agonists partly because of their dual mechanism of action and partly because of the availability of the proof of concept in the form of the PRX-03140 Phase 2 positive results. Our internally discovered clinical candidate SUVN-D4010, a 5-HT<sub>4</sub>R partial agonist, has completed Phase 1 clinical trials in healthy subjects<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and also Phase 2 clinical trials, enabling long-term safety studies. The structure of this compound has not been disclosed so far.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported 5-HT<sub>4</sub>R ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most of the reported 5-HT<sub>4</sub>R ligands that have been explored for both CNS and peripheral indications have either benzamide or imidazole carboxamide scaffolds. Previous work<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> from our group disclosed a series of 3-isopropylimidazo[1,5-<i>a</i>]pyridine carboxamide derivatives (<b>5a</b>, series 1) as 5-HT<sub>4</sub>R partial agonists that displayed cognition-enhancing properties in animal models. However, the brain penetration of these compounds was poor (<i>C</i><sub>brain</sub>/<i>C</i><sub>plasma</sub> ≤ 0.3). As we are targeting the CNS receptor, low brain penetration in rats makes this scaffold unsuitable for further development. Our goal was to identify a potent 5-HT<sub>4</sub>R agonist with adequate brain penetration, acceptable ADME, and preclinical efficacy as a possible drug candidate for the treatment of AD. The series 1 compounds<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> were modified by keeping the basic pharmacophore and the isopropyl substituent unchanged (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) to obtain several diverse chemical scaffolds. The 5-HT<sub>4</sub>R pharmacophore consists of an aromatic moiety, a coplanar carbonyl group or its bioisostere, and a voluminous substituent in the basic amino framework of the molecule.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Genesis of ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Successive modifications in the position of the nitrogen atom, the position of the isopropyl group, and the position of the carboxamide group in the heteroaromatic ring resulted in novel 1-isopropylimidazo[1,5-<i>a</i>]pyridine carboxamide derivatives (series 2), 2-isopropylimidazo[1,2-<i>a</i>]pyridine carboxamide derivatives (series 3), and 2-isopropylpyrazolo[1,5-<i>a</i>]pyridine carboxamide derivatives (series 4). The replacement of the carboxamide group in each of the series with an amide bioisostere resulted in 1,3,4-oxadiazole derivatives. The results of these modifications, in terms of their in vitro binding affinity, pharmacokinetic, hERG-affinity, receptor-occupancy, and in vivo efficacy profiles, constitute the subject matter of this manuscript.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The synthesis of heteroaromatic carboxylic acid <b>A</b><sub><b>1</b></sub> commenced from commercially available 2-bromopyridine, <b>1</b>, which was treated with <i>n</i>-BuLi followed by isobutyraldehyde to obtain compound <b>2</b>. The hydroxyl group in compound <b>2</b> was converted into a leaving group by mesylation and then was displaced with sodium azide to obtain azido compound <b>3</b>. The azide group in compound <b>3</b> was reduced with a triphenylphosphine/H<sub>2</sub>O combination (a Staudinger reaction),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> which afforded amino compound <b>4</b>. Amino compound <b>4</b> was treated with ethyl chlorooxoacetate to obtain intermediate <b>5</b>, which upon cyclization with POCl<sub>3</sub> in 1,2-dichloroethane afforded imidazo[1,5-<i>a</i>]pyridine ethyl ester, <b>6</b>. Ester <b>6</b> was hydrolyzed with NaOH and upon acidification yielded 1-isopropyl-imidazo[1,5-<i>a</i>]pyridine-3-carboxylic acid, <b>A</b><sub><b>1</b></sub> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The 2-isopropylimidazo[1,2-<i>a</i>]pyridine carboxylic acid, <b>A</b><sub><b>2</b></sub>, was synthesized from commercially available ethyl 2-aminonicotinate, <b>7</b>, which upon being refluxed with 1-chloro-3-methyl-butan-2-one in ethanol yielded imidazo[1,2-<i>a</i>]pyridine ester derivative <b>8</b>, which after hydrolysis afforded the corresponding acid, <b>A</b><sub><b>2</b></sub> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Synthesis of 2-isopropylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxylic acid, <b>A</b><sub><b>3</b></sub>, started from a reaction of 2-picoline, <b>9</b>, with isobutyryl chloride, which afforded intermediate <b>10</b>. Intermediate <b>10</b> upon cyclization with <i>O</i>-mesitylenesulfonylhydroxylamine afforded 2-isopropylpyrazolo[1,5-<i>a</i>]pyridine, <b>11</b>, which after a reaction with <i>n</i>-BuLi followed by carboxylation with carbon dioxide (dry ice) and acidification yielded acid <b>A</b><sub><b>3</b></sub> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Heteroaromatic Acid <b>A</b><sub><b>1</b></sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) <i>n</i>-BuLi, isobutyraldehyde, THF, −78 °C, 1 h, 56%. (b) (i) MsCl, Et<sub>3</sub>N, DCM, 0 °C, 90%; (ii) NaN<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h, 68%. (c) Ph<sub>3</sub>P, THF, H<sub>2</sub>O, rt, 86%. (d) Ethyl chlorooxoacetate, Et<sub>3</sub>N, DCM, 0 °C, 1 h, 90%. (e) POCl<sub>3</sub>, DCE, reflux, 16 h, 27%. (f) NaOH, EtOH, H<sub>2</sub>O, 95 °C, 75%. (g) Concd HCl.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Heteroaromatic Acid <b>A</b><sub><b>2</b></sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) 1-Chloro-3-methylbutan-2-one, EtOH, 90° C, 16 h, 32%. (b) NaOH, THF, H<sub>2</sub>O, 95 °C, 90%. (c) 1 N HCl.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Heteroaromatic Acid <b>A</b><sub><b>3</b></sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) <i>n</i>-BuLi, THF, isobutyryl chloride, −78 °C, 50%. (b) <i>O</i>-Mesitylenesulfonylhydroxylamine, CHCl<sub>3</sub>, rt, 60%. (c) <i>n</i>-BuLi, dry ice (CO<sub>2</sub> source), −78 °C, 1 N HCl, 50%.</p></p></figure><div class="NLM_p">Ethyl isonipecotate <b>12</b> was alkylated, either by reactions with alkyl halides or by reductive amination with aldehydes to obtain compounds <b>13a</b>–<b>13c</b>. Upon ester hydrolysis with lithium hydroxide, compounds <b>13a</b>–<b>13c</b> afforded lithium carboxylates <b>14a</b>–<b>14c</b>, respectively (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Acid hydrazides <b>15</b>, <b>16</b>, and <b>18</b> were synthesized from the corresponding esters, <b>6</b>, <b>8</b>, and <b>17</b>. Ester <b>17</b> was obtained from acid <b>A</b><sub><b>3</b></sub> upon treatment with dry HCl in methanol (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the N-Substituted Lithium Isonipecotates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Cs<sub>2</sub>CO<sub>3</sub>, R–X, AcN, rt or R–CHO, NaBH(OAc)<sub>3</sub>, DCM, 0 °C to rt. (b) LiOH, THF, 0 °C to rt.</p></p></figure><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Heteroaromatic Hydrazides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Hydrazine hydrate, EtOH, reflux. (b) SOCl<sub>2</sub>, MeOH, 0 °C to rt.</p></p></figure><div class="NLM_p">Acids <b>A</b><sub><b>1</b></sub>–<b>A</b><sub><b>3</b></sub> were reacted with the earlier reported<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> N-Boc-substituted piperidine, <b>B</b><sub><b>1</b></sub>, or the 3-aza-bicyclo[3.1.0]hexane amine, <b>B</b><sub><b>2</b></sub>, in the presence of TBTU or HATU to obtain the Boc-protected carboxamide derivatives, <b>19a</b>, <b>19b</b>, <b>21a</b>, <b>21b</b>, <b>23a</b>, and <b>23b</b>, which upon Boc deprotection with dry HCl in isopropanol afforded compounds <b>20a</b>, <b>20b</b>, <b>22a</b>, <b>22b</b>, <b>24a</b>, and <b>24b</b>, respectively. Upon N-alkylation, either by reactions with alkyl halides or reductive amination with aldehydes, these compounds afforded 1-isopropylimidazo[1,5-<i>a</i>]pyridine carboxamides (<b>2a</b>–<b>2g</b>), 2-isopropylimidazo[1,2-<i>a</i>]pyridine carboxamides (<b>3a</b>–<b>3q</b>), and 2-isopropylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxamides (<b>4a</b>–<b>4l</b>), respectively (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). The 1,3,4-oxadiazole derivatives <b>2h</b>–<b>2j</b>, <b>3r</b>, <b>3s</b>, and <b>4m</b>–<b>4o</b> were synthesized by reactions between hydrazides <b>15</b>, <b>16</b>, and <b>18</b> and substituted lithium carboxylates <b>14a</b>–<b>14c</b> in the presence of POCl<sub>3</sub> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>).</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of the Heteroaromatic Carboxamide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) TBTU, EtiPr<sub>2</sub>N, DCM, 50%. (b) IPA/HCl, 0 °C to rt, 16 h. (c) K<sub>2</sub>CO<sub>3</sub>, R–X, AcN, rt or R–CHO, NaBH(OAc)<sub>3</sub>, DCM, 0 °C to rt.</p></p></figure><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of the 1,3,4-Oxadiazoles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) POCl<sub>3</sub>, 120 °C, 4–10 h.</p></p></figure><div class="NLM_p">Isopropylimidazo[1,5-<i>a</i>]pyridine carboxamide derivatives <b>2a</b>–<b>2e</b>, with different substitutions on the piperidine (<b>B</b><sub><b>1</b></sub>) nitrogen, showed in vitro potency (EC<sub>50</sub> < 100 nM) toward 5-HT<sub>4</sub>R with partial-agonist activity (<i>E</i><sub>max</sub> < 100%, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compounds with bulkier substitutions, such as methylpiperidine (<b>2c</b>) and methylpyran (<b>2d</b>), on the piperidine nitrogen showed increased potency (EC<sub>50</sub> < 10 nM) as compared with simple substitutions bearing compounds such as isopropyl (<b>2a</b>) and methoxypropyl (<b>2b</b>). Similarly, compounds with N-substituted 3-aza-bicyclo[3.1.0]hexane rings (<b>B</b><sub><b>2</b></sub>) showed increased potency toward 5-HT<sub>4</sub>R as compared with the simple piperidine (<b>B</b><sub><b>1</b></sub>) counterparts. Compounds with a methoxypropyl substitution (<b>2f</b>) and a pyran substitution (<b>2g</b>) on the nitrogen of 3-aza-bicyclo[3.1.0]hexane showed increased potency as compared with the piperidine counterparts (<b>2b</b> and <b>2e</b>, respectively).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Functional Activity, In Vitro Metabolism, In Vivo Pharmacokinetics, and Brain Penetration of the 5-HT<sub>4</sub>R-Agonist Compounds <b>2a</b>–<b>2j</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0014.gif" alt="" id="GRAPHIC-d182e1070-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0015.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The functional activities were determined in CHO cells stably expressing the human 5-HT<sub>4E</sub> isoform and a reporter gene. Each EC<sub>50</sub> value was expressed as the geometric mean of two independent experiments performed in triplicate. RLM, rat liver microsomes; HLM, human liver microsomes; CL, intravenous clearance; <i>C</i><sub>max</sub>, maximum systemic concentration; <i>C</i><sub>b</sub>, concentration in the brain; <i>C</i><sub>p</sub>, concentration in the plasma; AUC, area under the curve; <i>C</i><sub>b</sub>/<i>C</i><sub>p</sub>, brain-to-plasma-concentration ratio; % F, oral bioavailability; <b>B</b><sub><b>1</b></sub>, N-substituted piperidine ring; <b>B<sub>2</sub></b>, N-substituted 3-aza-bicyclo[3.1.0]hexane ring; ND, not determined. The reported in vitro potencies of PRX-03140 (17–52 nM/30–61%), PF-04995274 (0.26 nM/7%), and prucalopride (26 nM/52%) are comparable to the in-house data (see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div></div><div></div></div><div class="NLM_p">The development and application of bioisosteres have been adopted as a fundamental tactical approach useful for addressing a number of aspects, such as improving potency, enhancing selectivity, altering physical properties, reducing or redirecting metabolism, eliminating or modifying toxicophores, and acquiring novel intellectual property associated with drug candidates.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The 1,3,4-oxadiazoles derivatives,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><b>2h</b>–<b>2j</b>, as carboxamide bioisosteres, were synthesized and evaluated. However, these compounds showed weak in vitro potency toward 5-HT<sub>4</sub>R. In brief, the carboxamide derivatives showed moderate in vitro potency, and the 1,3,4-oxadiazole derivatives showed weak potency toward 5-HT<sub>4</sub>R.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Compounds from this series were evaluated for their metabolic stability in rat and human microsomes. These compounds showed moderate to good microsomal metabolic stability. The piperidine analogues with methoxypropyl (<b>2b</b>) and tetrahydropyran (<b>2e</b>) groups and the 3-aza-bicyclo[3.1.0]hexane analogues with methoxypropyl (<b>2f</b>) and pyran (<b>2g</b>) groups showed higher metabolic stability. Compounds <b>2b</b> and <b>2g</b>, which showed good metabolic stability, were evaluated in rat pharmacokinetic (PK) studies. Both of the compounds showed poor oral bioavailability, suggesting a lack of correlation between microsomal stability and oral exposure. The brain penetration (<i>C</i><sub>b</sub>/<i>C</i><sub>p</sub>), however, had substantially improved (1.8 to 2) as compared with that of the earlier-reported series 1 compound <b>5a</b> (0.31).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The 1,3,4-oxadiazole derivatives were not evaluated in PK experiments owing to their poor in vitro potency.</div><div class="NLM_p">Given the improvement in brain penetration in the series 2 compounds, the scope of the SAR was further expanded by synthesizing and evaluating a series of isopropylimidazo[1,2-<i>a</i>]pyridine derivatives (series 3, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Most of the piperidine ring (<b>B</b><sub><b>1</b></sub>) compounds (<b>3a</b>–<b>3h</b>) showed potent in vitro activity toward 5-HT<sub>4</sub>R (EC<sub>50</sub> < 10 nM). Compounds with N-substituted 3-aza-bicyclo[3.1.0]hexane rings (<b>3i</b>–<b>3m</b>) however were 2–10-fold less potent (compounds <b>3a</b> vs <b>3i</b> and <b>3b</b> vs <b>3j</b>). During the course of this research, a publication<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> from Pfizer reported the formation of a cyclized oxazolidine metabolite of PF-04995274, which was reported as unique to humans and was not observed in animal studies. Given the partial structural similarity to PF-04995274 (i.e., the <i>tert</i>-hydroxyl groups on the piperidine N-substituents of compounds <b>3f</b>, <b>3g</b>, <b>3h</b>), these compounds may theoretically have the potential to form such unique metabolites. Though these compounds showed potent in vitro activity at 5-HT<sub>4</sub>R, no additional explorations were carried out. The rat pharmacokinetic studies of compounds <b>3b</b> and <b>3c</b> showed high clearance, poor exposure, and poor bioavailability, observations akin to those of the series 2 compounds. On the basis of its high in vitro potency and high brain penetration, compound <b>3c</b> was evaluated in the long-term memory deficit assay the novel-object-recognition test (NORT) to see if the in vitro activity translated into in vivo efficacy. The NORT<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> has been regarded as a spontaneous delayed-nonmatching-to-sample (DNMS) test. The test is based on a spontaneous behavior. The main assumption at the base of this test is that access to novelty (object or environment) can elicit approach behaviors in animals. NORT does not involve reference-memory components; thus, it can be considered a “pure” recognition-memory test and a valid task to assess working memory. Also, the test does not involve positive or negative reinforcement (food or electric shocks), and this makes NORT comparable to the memory tests currently used with humans. These advantages make NORT quick and easily implemented, and therefore it has been widely used for assessing mild cognitive impairment in preclinical research. This apparent “unconditioned preference” for novelty has been used in the NORT in order to study memory functions by assessing the ability of an animal to recognize a novel object in a familiar environment. Although this model has face and predictive validity for memory deficits, the percentage of translational success from rats to humans is poor to date. In this experiment, the rats treated with <b>3c</b> at 0.3 and 1 mg/kg, po, spent significantly more time exploring the novel object than the familiar object in the test phase; that is, the rats remembered the familiar object even after a 24 h time gap. However, the vehicle-treated rats spent almost equal time exploring the novel object as well as the familiar object, forgetting the familiar object after the 24 h time gap (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Encouraged by these results, further modification of the chemical scaffold was done with the aim of obtaining compounds with good oral bioavailability. Chloro substitution was brought at the 3-position of imidazo[1,2-<i>a</i>]pyridine to obtain compounds <b>3n</b> and <b>3o</b>, and the carbon atom (C-3) was replaced with a nitrogen atom to obtain triazolo compounds <b>3p</b> and <b>3q</b>. However, these modifications resulted in very weak potency (<b>3q</b>) or a complete loss of potency (<b>3n</b>–<b>3p</b>). However, the microsomal metabolic stability of these compounds had increased substantially. We hypothesized that this improvement in the microsomal metabolic stability was probably due to blocking of the high-electron-density 3-position of imidazo[1,2-<i>a</i>]pyridine. However, the 1,3,4-oxadiazole derivatives, <b>3r</b> and <b>3s</b>, showed weak affinity toward 5-HT<sub>4</sub>R with favorable metabolic stability.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Functional Activity, In Vitro Metabolism, In Vivo Pharmacokinetics, and Brain Penetration of the 5-HT<sub>4</sub>R-Agonist Compounds <b>3a</b>–<b>3s</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0016.gif" alt="" id="GRAPHIC-d182e1320-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0017.gif" alt="" id="gr16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The functional activities were determined in CHO cells stably expressing the human 5-HT<sub>4E</sub> isoform and a reporter gene. Each EC<sub>50</sub> value was expressed as the geometric mean of two independent experiments performed in triplicate. RLM, rat liver microsomes; HLM, human liver microsomes; CL, intravenous clearance; <i>C</i><sub>max</sub>, maximum systemic concentration; <i>C</i><sub>b</sub>, concentration in the brain; <i>C</i><sub>p</sub>, concentration in the plasma; AUC, area under the curve; <i>C</i><sub>b</sub>/<i>C</i><sub>p</sub>, brain-to-plasma-concentration ratio; % F, oral bioavailability; <b>B</b><sub><b>1</b></sub>, N-substituted piperidine ring; <b>B<sub>2</sub></b>, N-substituted 3-aza-bicyclo[3.1.0]hexane ring; ND, not determined.</p></div></div><div></div></div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0021.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Attenuation of long-term memory deficits in NORT by compounds <b>3c</b>, <b>4n</b>, and <b>4o</b>. Data represent exploration-time means ± SEM compared with those of the vehicle group (<i>n</i> = 7–8 per group). **<i>p</i> < 0.01 vs the vehicle group (Student’s paired <i>t</i>-test). Two independent studies were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As attempts to improve the metabolic stability by structural modifications resulted in less potent or inactive compounds, further SAR studies were carried out through the synthesis of pyrazolo[1,5-<i>a</i>]pyridine derivatives (series 4, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). As it was evident from the results shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, the compounds that had piperidines (<b>B</b><sub><b>1</b></sub>) with N-substitutions of methoxypropyl (<b>4a</b>) or pyranylmethyl (<b>4b</b>) groups were more potent than the compound with an isopropyl group (<b>4c</b>). The corresponding N-substituted 3-aza-bicyclo[3.1.0]hexane derivatives (<b>4d</b>–<b>4f</b>) were less potent, similar to the series 2 and series 3 compounds. Most of the evaluated compounds were extensively metabolized in both rat and human liver microsomes. On the basis of the availability of resources, compounds <b>4b</b> and <b>4c</b> have been explored in pharmacokinetic (PK) studies. Both of the compounds showed poor oral bioavailability, and <b>4c</b> showed poor brain penetration as well. In an attempt to increase the microsomal metabolic stability, 3-chloro-pyrazolopyridine derivatives (<b>4g</b>–<b>4i</b>) and triazolopyridine derivatives (<b>4j</b>–<b>4l</b>) were synthesized. However, these compounds did not show any activity toward 5-HT<sub>4</sub>R. In line with earlier observations, the metabolic stability of 3-chloro-pyrazolopyridine derivatives <b>4g</b>–<b>4i</b> was moderately improved, whereas the metabolic stability of triazolopyridine derivatives <b>4k</b>–<b>4l</b> was increased substantially. The 1,3,4-oxadiazole derivatives (<b>4m</b>–<b>4o</b>), however, showed potent in vitro activity and also showed improved metabolic stability. Compounds <b>4m</b>, <b>4n</b>, and <b>4o</b> showed good oral bioavailability; compounds <b>4n</b> and <b>4o</b> showed improved brain penetration. However, the N-isopropyl-substituted derivative, <b>4m</b>, showed poor brain penetration (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compounds <b>4n</b> and <b>4o</b> were evaluated in efficacy models of cognition. In NORT, compound <b>4o</b> showed robust efficacy at 3 and 10 mg, po, whereas compound <b>4n</b> showed efficacy at 1 and 10 mg, po (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The reference compound, RS-67333, a 5-HT<sub>4</sub>R partial agonist,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> showed efficacy at 0.3 and 1.0 mg/kg, ip. In a separate experiment, the observed activity of <b>4o</b> in NORT was blocked by the administration of the selective 5-HT<sub>4</sub>R antagonist GR-125487,<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> giving ample evidence that the efficacy observed may be arising from its agonistic activity at 5-HT<sub>4</sub>R (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Functional Activity, In Vitro Metabolism, In Vivo Pharmacokinetics, and Brain Penetration of the 5-HT<sub>4</sub>R-Agonist Compounds <b>4a</b>–<b>4o</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0018.gif" alt="" id="GRAPHIC-d182e1556-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0019.gif" alt="" id="gr17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The functional activities were determined in CHO cells stably expressing the human 5-HT<sub>4E</sub> isoform and a reporter gene. Each EC<sub>50</sub> value was expressed as the geometric mean of two independent experiments performed in triplicate. RLM, rat liver microsomes; HLM, human liver microsomes; CL, intravenous clearance; <i>C</i><sub>max</sub>, maximum systemic concentration; <i>C</i><sub>b</sub>, concentration in the brain; <i>C</i><sub>p</sub>, concentration in the plasma; AUC, area under the curve; <i>C</i><sub>b</sub>/<i>C</i><sub>p</sub>, brain-to-plasma-concentration ratio; % F, oral bioavailability; <b>B</b><sub><b>1</b></sub>, N-substituted piperidine ring; <b>B<sub>2</sub></b>, N-substituted 3-aza-bicyclo[3.1.0]hexane ring; ND, not determined.</p></div></div><div></div></div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Attenuation of long-term memory deficits in NORT by compound <b>4o</b> and blockade of its activity by the selective 5-HT<sub>4</sub>R antagonist GR-125487. Data shown are means ± SEM (<i>n</i> = 4 animals).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to further substantiate the finding that the observed efficacy was arising from 5-HT<sub>4</sub>R agonism, compounds <b>4n</b> and <b>4o</b> were evaluated for their receptor occupancy (RO).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Both of the compounds showed significant RO, with absolute ED<sub>50</sub> values of 8.47 and 6.15 mg/kg, po, respectively (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), suggesting that the in vivo efficacy observed for these compounds may be mediated through 5-HT<sub>4</sub>R. The partial agonist from Pfizer, PF-04995274, showed a dose-dependent RO with an ED<sub>50</sub> value of 0.017 mg/kg, sc, which is comparable to the reported value (0.008 mg/kg, sc).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. 5-HT<sub>4</sub>R occupancy of compounds <b>4n</b> and <b>4o</b>. Data represent means ± SEM of percent changes in acetylcholine levels (<i>n</i> = 5–8 per group). *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs the vehicle group (Bonferroni post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The protein-binding experiment was done in rat, dog, and human liver microsomes to ascertain the free fraction available for <b>4n</b> and <b>4o</b>. Compound <b>4n</b> showed free fractions of 26% in rat plasma and 14% in brain homogenate, whereas compound <b>4o</b> showed free fractions of 17% in rat plasma and 24% in brain homogenate. The percent free fractions for both compounds in plasma were similar in other species, like dog and human. Both <b>4n</b> and <b>4o</b> showed minimal inhibition of cytochrome P450 3A4 and 2D6 enzymes and had absolute IC<sub>50</sub> values of >10 μM. On the basis of its favorable in vitro affinity, higher oral exposures, dose-dependent RO, robust efficacy in NORT, and significant free fraction in the brain, compound <b>4o</b> was selected for further evaluation in microdialysis studies. It is known in the literature that 5-HT<sub>4</sub>R agonists improve memory formation by enhancing the synaptic release of acetylcholine (the neurotransmitter responsible for cognition processes) in the brain, which in turn enhances the cholinergic transmission.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The microdialysis experiments showed that compound <b>4o</b> increased acetylcholine levels dose-dependently in the frontal cortex upon oral dosing at 3 and 10 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The 5-HT<sub>4</sub>R partial agonist PRX-03140 was used as a positive control. At 1 mg/kg, ip, PRX-03140 produced an about 254% increase from the predose levels. The increase in acetylcholine levels by PRX-03140 was in agreement with the literature reports.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Increase in acetylcholine release in the frontal cortex by compound <b>4o</b>. Data represent mean percent increases ± SEM relative to those of the vehicle group (<i>n</i> = 7–8 per group). *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs the vehicle group (Dunnett’s post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">5-HT<sub>4</sub>R agonists have the ability to shift the equilibrium of amyloid-precursor-protein (APP) processing from the amyloidogenic form to the nonamyloidogenic form, thereby showing a disease-modifying potential.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The APP processing shifts the equilibrium from the amyloidogenic form to the nonamyloidogenic form by generating sAPPα, which is reported to provide neuroprotective effects.<a onclick="showRef(event, 'ref7 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref7 ref37 ref38">(7,37,38)</a> In this experiment, the 5-HT<sub>4</sub>R agonist prucalopride was used as a positive control. Treatment with prucalopride (10 mg/kg, sc) produced a 65% increase above the control levels. These results are in agreement with the literature.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The increase in sAPPα levels produced by compound <b>4o</b> (1–10 mg/kg, sc) was higher than the effects produced by prucalopride (10 mg/kg, sc). The increase in cortical sAPPα levels in mice demonstrated that compound <b>4o</b> may have a disease-modifying potential (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose-dependent increases in sAPPα levels after subcutaneous (sc) treatments with compound <b>4o</b>. Data represent means ± SD (<i>n</i> = 4−6 per group). *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs the vehicle group (Dunnett’s post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compounds <b>4n</b> and <b>4o</b> showed comparable potencies toward 5-HT<sub>4</sub>R isoforms (5-HT<sub>4D</sub>, 5-HT<sub>4E</sub>, and 5-HT<sub>4L</sub>) with EC<sub>50</sub> values ranging from 6 to 62 nM. Compounds <b>4n</b> and <b>4o</b> showed a weak propensity to inhibit hERG channels in electrophysiology patch-clamp assays, and the IC<sub>50</sub> values were found to be 2.3 μM with a 76% <i>I</i><sub>max</sub> and 1.9 μM with a 100% <i>I</i><sub>max</sub>, respectively, at 10 μM concentrations. Compounds <b>4n</b> and <b>4o</b> showed excellent selectivity against 5-HT receptors (5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>6</sub>, and 5-HT<sub>7</sub>), adrenergic receptors (Adα<sub>1B</sub>, Adα<sub>2C</sub>), adenosine receptor A<sub>2A</sub>, cannabinoid receptors (CB<sub>1</sub> and CB<sub>2</sub>), dopamine receptors (D<sub>1</sub>, D<sub>2S</sub>, D<sub>3</sub>, and D<sub>5</sub>), histamine receptors (H<sub>1</sub> and H<sub>3</sub>), muscarinic receptors (M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, M<sub>4</sub>, and M<sub>5</sub>), and serotonin transporters at the highest tested concentration of 10 μM (see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_001.pdf" class="ext-link">Supporting Information</a>). Compound <b>4o</b> showed partial-agonist activity toward the 5-HT<sub>2</sub>B receptor when evaluated in a rat-fundus assay (see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> On the basis of the panel of the selectivity assessment involving the majority of GPCRs that are responsible for cognition, we hypothesize that compound <b>4o</b> selectively modulates 5-HT<sub>4</sub>R. Further evaluation of compound <b>4o</b> in additional efficacy-model, receptor-mapping, and extended safety studies will be done in due course.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, starting from the poorly brain-penetrant <b>5a</b>, effecting successive modifications in the position of the nitrogen atom, the position of the isopropyl group, and the position of the carboxamide group in the heteroaromatic ring resulted in the identification of a series of pyrazolo[1,5-<i>a</i>]pyridine derivatives represented by compound <b>4o</b>. Lead compound <b>4o</b> is a potent and selective 5-HT<sub>4</sub>R partial agonist with high oral exposures and good brain penetration. In vivo RO studies demonstrated a clear relationship among the in vitro affinity, free brain exposure, in vivo efficacy, and RO . We have also demonstrated in this report that the compounds <b>3c</b>, <b>4n</b>, and <b>4o</b> improved long-term memory deficits in NORT, a finding that is consistent with previous reports. The attenuation of the efficacy of compound <b>4o</b> in NORT by the selective 5-HT<sub>4</sub>R antagonist GR-125487 and the dose-dependent 5-HT<sub>4</sub> RO provides ample evidence that the cognitive effects of compound <b>4o</b> were mediated through 5-HT<sub>4</sub>R. Compound <b>4o</b> increased neurotransmitter ACh release in the prefrontal cortex, a finding that is consistent with previous reports. Compound <b>4o</b> increased neuroprotective sAPPα levels, thus offering a disease-modifying therapy. A safety assessment of this compound is in progress to ascertain the therapeutic margins between efficacious concentrations and safety findings.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless stated otherwise, all reagents and solvents were purchased from common commercial suppliers and were used without further purification. <sup>1</sup>H NMR spectra were recorded at 400 MHz, and <sup>13</sup>C NMR were recorded at 100 MHz on a Bruker NMR spectrometer instrument. All <sup>1</sup>H NMR shifts are reported in δ units (ppm) relative to the signals for chloroform (7.27 ppm), DMSO (2.50 ppm), and MeOH (3.31 ppm). All coupling constants (<i>J</i> values) are reported in hertz (Hz). NMR abbreviations are as follows: bs, broadened singlet; s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and dd, doublet of doublets. Thin-layer chromatography (TLC) was performed on Merck silica-gel 60 F<sub>254</sub> plates. Electrospray-ionization mass spectra were recorded on an API 4000 triple quadrupole instrument (MDS-SCIEX). Infrared spectra were recorded on KBr discs and in solid state using a PerkinElmer model 1600 FT-IR spectrophotometer (PerkinElmer). Elemental analyses were carried out in an Elementar Vario microcube instrument, and the analyses indicated by the symbols of the elements were within ±0.4% of the theoretical values. Column chromatography was performed using a 100–200 mesh silica gel. The HPLC purities of the final compounds were measured using Agilent systems (Model-1100 series). DSC was recorded on a Waters DSC Q100 instrument. The melting points of the synthesized compounds were determined using an Electro Derman open-capillary apparatus and were not corrected. The reference standards PRX-03140, RS-67333, PF-04995274, GR-125487, prucalopride, and others were synthesized and characterized in-house using their respective reported procedures. All final compounds were determined to have purities of >95% by one of the aforementioned methods unless stated otherwise.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Synthesis of 2-Methyl-1-(pyridin-2-yl)-1-propanol, <b>2</b></h3><div class="NLM_p last">To a stirred solution of 2-bromopyridine, <b>1</b> (13 g, 82.3 mmol), in dry THF (150 mL) cooled to −78 °C, <i>n</i>-BuLi (45.0 mL, 1.6 M in hexane) was added dropwise over a period of 30 min. Isobutyraldehyde (15.0 mL, 153.0 mmol) was added over a period of 15 min, and after the reaction mixture was stirred for 15 min at this temperature, it was gradually warmed to rt and stirred for 2 h. The reaction mixture was then cooled to 0 °C and quenched by the addition of ice water followed by the addition of EtOAc. The two layers were separated, and the aqueous layer was extracted again with EtOAc. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure to afford a crude product, which was purified by silica-gel column chromatography to obtain 6.1 g of the title compound, <b>2</b>, in a 47% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.55 (d, <i>J</i> = 4.7 Hz, 1H), 7.69 (t, <i>J</i> = 7.8 Hz, 1H), 7.19 (d, <i>J</i> = 2.2 Hz, 2H), 4.19 (d, <i>J</i> = 5.8 Hz, 1H), 2.15–2.05 (m, 1H), 1.02 (d, <i>J</i> = 6.8 Hz, 3H), 0.81 (d, <i>J</i> = 6.4 Hz, 3H); mass (<i>m</i>/<i>z</i>): 152.1 (M+H)<sup>+</sup>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of 2-Methyl-1-(pyridin-2-yl)-1-azidopropane, <b>3</b></h3><div class="NLM_p last">To a stirred solution of compound <b>2</b> (5.5 g, 36.3 mmol) and triethylamine (10.0 mL, 72.6 mmol) in dry DCM (150.0 mL) cooled to 0 °C was added methanesulfonyl chloride (3.0 mL, 36.3 mmol) over a period of 15 min. After the reaction mixture was stirred for another 30 min, it was diluted with water (50.0 mL) and DCM (50 mL), and the two layers were separated. The aqueous layer was further extracted with DCM (2 × 50 mL). The combined organic layers were washed with water (150 mL) and brine (150 mL) and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>; the solvent was removed under reduced pressure to obtain the mesylated intermediate, which was dissolved in DMF (66.0 mL), and K<sub>2</sub>CO<sub>3</sub> (10.0 g, 72.6 mmol) followed by NaN<sub>3</sub> (3.5 g, 57.3 mmol) was added. The reaction temperature was gradually raised to 80 °C, and the reaction mass was maintained at this temperature for 2 h before it was brought to rt. The reaction mixture was diluted with water (100 mL) and EtOAc (150 mL), and the two layers were separated. The organic layer was further washed with water followed by a brine solution and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure to obtain the title azido, 2-methyl-1-(pyridin-2-yl)-1-azidopropane, <b>3</b> (6.0 g), in a 99% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.60 (d, <i>J</i> = 4.4 Hz, 1H), 7.73 (t, <i>J</i> = 7.8 Hz, 1H), 7.30 (d, <i>J</i> = 7.8 Hz, 1H), 7.24 (dd, <i>J</i> = 4.4, 7.8 Hz, 1H), 4.26 (d, <i>J</i> = 7.3 Hz, 1H), 2.30–2.10 (m, 1H), 1.0 (d, <i>J</i> = 6.6 Hz, 3H), 0.88 (d, <i>J</i> = 6.7 Hz, 3H); mass (<i>m</i>/<i>z</i>): 177.2 (M+H)<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis of 2-Methyl-1-(pyridin-2-yl)-1-aminopropane, <b>4</b></h3><div class="NLM_p last">To a stirred solution of compound <b>3</b> (6.0 g, 36.3 mmol) in THF (68.0 mL) at rt, triphenylphosphine (11.0 g, 44.6 mmol) followed by water (3.1 mL, 185.0 mmol) was added. After 16 h of stirring at rt, the volatiles were removed under reduced pressure, and the crude reaction mixture was purified by silica-gel column chromatography to obtain compound <b>4</b> (3.83 g) in a 70% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.55 (d, <i>J</i> = 2.4 Hz, 1H), 7.64 (t, <i>J</i> = 7.6 Hz, 1H), 7.26 (d, <i>J</i> = 1.8 Hz, 2H), 7.13 (t, <i>J</i> = 6.0 Hz, 1H), 3.69 (d, <i>J</i> = 1.2 Hz, 1H), 2.07–2.01 (m, 1H), 0.95 (d, <i>J</i> = 1.6 Hz, 3H), 0.79 (d, <i>J</i> = 3.5 Hz, 3H); mass (<i>m</i>/<i>z</i>): 151.1 (M+H)<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis of Ethyl <i>N</i>-[2-Methyl-1-(pyridin-2-yl)-propyl]-oxalamate, <b>5</b></h3><div class="NLM_p last">To a stirred solution of compound <b>4</b> (3.8 g, 25.3 mmol) and triethylamine (10.0 mL, 50.6 mmol) in solvent DCM (50 mL) cooled to 0 °C, ethyl chlorooxoacetate (3.0 mL, 25.3 mmol) was added over a period of 10 min. After the reaction mixture was stirred at this temperature for 1h, it was diluted with DCM (50 mL), washed with water (50 mL), and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure to obtain compound <b>5</b> (5.52 g) in an 87% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.57 (d, <i>J</i> = 3.9 Hz, 1H), 8.28 (d, <i>J</i> = 7.2 Hz, 1H), 7.68 (t, <i>J</i> = 12.2 Hz, 1H), 7.19 (d, <i>J</i> = 7.4 Hz, 2H), 4.88 (t, <i>J</i> = 7.2 Hz, 1H), 4.35 (q, 2H), 2.23–2.15 (m, 1H), 1.37 (t, 3H), 0.95 (d, <i>J</i> = 6.8 Hz, 3H), 0.82 (d, <i>J</i> = 6.6 Hz, 3H); mass (<i>m</i>/<i>z</i>): 251.1 (M+H)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of Ethyl 1-Isopropyl-imidazo[1,5-<i>a</i>]pyridine-3-carboxylate, <b>6</b></h3><div class="NLM_p last">To a stirred solution of compound <b>5</b> (5.5 g, 22.0 mmol) in 1,2-dichloroethane (50.0 mL) at rt, POCl<sub>3</sub> (20.0 mL) was added dropwise over a period of 15 min. The reaction mixture was then heated to 130 °C for 72 h. The volatiles were removed under reduced pressure to obtain a crude mass, which was neutralized with a NaHCO<sub>3</sub> solution and extracted with EtOAc. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The crude product was purified by silica-gel column chromatography to obtain compound <b>6</b> (3.58 g) in a 70% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.32 (d, <i>J</i> = 7.1 Hz, 1H), 7.65 (d, <i>J</i> = 9.0 Hz, 1H), 7.00 (t, <i>J</i> = 6.6 Hz, 1H), 6.88 (t, <i>J</i> = 6.7 Hz, 1H), 4.58–4.50 (m, 2H), 3.47–3.39 (m, 1H), 1.43 (d, <i>J</i> = 6.6 Hz, 6H), 1.32 (t, 3H); mass (<i>m</i>/<i>z</i>): 233.1 (M+H)<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis of Ethyl 2-Isopropyl-imidazo[1,2-<i>a</i>]pyridine-8-carboxylate, <b>8</b></h3><div class="NLM_p last">To a stirred solution of ethyl 2-aminonicotinate, <b>7</b> (0.8 g, 3.44 mmol), in ethanol (4.72 mL) at rt, 1-chloro-3-methylbutan-2-one (6.9 g, 41.2 mmol) was added. The reaction mixture was stirred at 95 °C for 4 h. The solvent was removed under reduced pressure, and the crude reaction mixture was purified by silica-gel column chromatography to obtain compound <b>8</b> (0.45 g) in a 58% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.22 (d, <i>J</i> = 6.6 Hz, 1H), 7.87 (d, <i>J</i> = 7.1 Hz, 1H), 7.40 (s, 1H), 6.79 (t, <i>J</i> = 6.9 Hz, 1H), 4.50–4.45 (q, 2H), 3.26–3.19 (m, 1H), 1.39 (d, <i>J</i> = 6.8 Hz, 6H); mass (<i>m</i>/<i>z</i>): 233.2 (M+H)<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of 3-Methyl-1-pyridin-2-yl-2-butanone, <b>10</b></h3><div class="NLM_p last">To a stirred solution of 2-picoline, <b>9</b> (20.0 g, 214.7 mmol), in dry THF (860.0 mL) cooled to −78 °C, <i>n</i>-BuLi (1.6 M in hexanes, 134.2 mL, 214.7 mmol) was added over a period of 15 min. After the reaction mixture was stirred for 1 h at this temperature, isobutyryl chloride (25.2 g, 236.2 mmol) was added at once, and the reaction mass was stirred for another 30 min. The reaction mass was quenched by the addition of a saturated ammonium chloride solution. The two layers were separated, and the aqueous layer was extracted with EtOAc. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the volatiles were removed under reduced pressure to obtain a crude mass, which was purified by silica-gel column chromatography to obtain the title compound, <b>10</b> (5.4 g), in a 13% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.54 (d, <i>J</i> = 4.3 Hz, 1H), 7.65 (t, <i>J</i> = 7.7 Hz, 1H), 7.23 (t, <i>J</i> = 7.7 Hz, 1H), 7.16 (d, <i>J</i> = 6.7 Hz, 1H), 3.96 (s, 2H), 2.86–2.77 (m, 1H), 1.13 (d, <i>J</i> = 6.4 Hz, 6H); mass (<i>m</i>/<i>z</i>): 164.33 (M+H)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthesis of 2-Isopropyl Pyrazolo[1,5-<i>a</i>]pyridine, <b>11</b></h3><div class="NLM_p last">To a stirred solution of compound <b>10</b> (3.3 g, 3.44 mmol) in CHCl<sub>3</sub> (67.0 mL) cooled to 0 °C, <i>O</i>-mesitylenesulfonylhydroxylamine (4.35 g, 20.2 mmol) was added. The reaction mass was stirred at rt for 1 h, after which TLC revealed the completion of the reaction; the volatiles were then removed, and the crude mass was purified by silica-gel column chromatography to obtain the title compound, <b>11</b> (1.0 g), in a 31% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.38 (d, <i>J</i> = 8.8 Hz, 1H), 7.4 (d, <i>J</i> = 8.8 Hz, 1H), 7.04 (t, <i>J</i> = 8.2 Hz, 1H), 6.66 (t, <i>J</i> = 6.4 Hz, 1H), 6.3 (s, 1H), 3.21 (m, 1H), 1.37 (d, <i>J</i> = 6.8 Hz, 6H); mass (<i>m</i>/<i>z</i>): 161.1 (M+H)<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis of Compounds <b>13a</b>–<b>13c</b> by N-Alkylation with Alkyl Halides</h3><div class="NLM_p last">We followed the procedure as reported in our own patent publication<a onclick="showRef(event, 'patent1'); return false;" href="javascript:void(0);" class="ref patent1">(40)</a> with minor modifications. To a stirred solution of ethyl isonipecotate, <b>12</b> (1.0 mmol), in acetonitrile (2.0 mL) at rt were added Cs<sub>2</sub>CO<sub>3</sub> (2.2 mmol) and alkyl halide (1.1 mmol). The reaction mass was gradually heated to the reflux temperature and stirred at this temperature for 4–12 h until all the starting material were consumed. The reaction mixture was cooled to rt and filtered through a small pad of Celite. The filtrate was evaporated under reduced pressure, which afforded the N-alkylated ethyl isonipecotates <b>13a</b>–<b>13c</b> in quantitative yields.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Synthesis of Compounds <b>14a</b>–<b>14c</b></h3><div class="NLM_p last">We followed the procedure as reported in our own patent publication<a onclick="showRef(event, 'patent1'); return false;" href="javascript:void(0);" class="ref patent1">(40)</a> with minor modifications. To a stirred solution of an N-alkylated ethyl isonipecotate (<b>13a</b>, <b>13b</b>, or <b>13c</b>, 1.0 mmol) in THF (2.0 mL) and water (2.0 mL) cooled to 0 °C was added LiOH·H<sub>2</sub>O (1.1 mmol). After being stirred for 30 min at this temperature, the reaction mass was brought to rt and stirred for 6–12 h until all the ester was hydrolyzed. Upon completion of the reaction, the reaction mass was diluted with EtOAc, and the two layers were separated. The aqueous layer was further extracted with EtOAc, and the resultant aqueous layer was evaporated under reduced pressure, affording N-alkylated lithium carboxylates <b>14a</b>–<b>14c</b> in quantitative yields, which were used in the next step without further purification.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis of 1-Isopropyl-imidazo[1,5-<i>a</i>]pyridine-3-carboxylic Acid Hydrazide, <b>15</b></h3><div class="NLM_p last">To a stirred solution of <b>6</b> (0.23 g, 1.0 mmol) in EtOH (10.0 mL) at rt, hydrazine hydrate (2.0 mL) was added. The reaction mixture was heated to reflux for 8 h until all the ester was consumed. The volatiles were removed under reduced pressure to obtain a crude mass, which was triturated with hexane followed by ether, affording hydrazide <b>15</b> as a brown-colored solid (0.21 g) in a 90% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.36 (s, 1H), 9.28 (d, <i>J</i> = 7.0 Hz, 1H), 7.78 (d, <i>J</i> = 8.9 Hz, 1H), 6.99–6.94 (m, 2H), 4.47 (s, 2H), 3.39–3.30 (m, 1H), 1.32 (d, <i>J</i> = 6.9 Hz, 6H); mass (<i>m</i>/<i>z</i>): 219.2 (M+H)<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Synthesis of 2-Isopropyl-imidazo[1,2-<i>a</i>]pyridine-8-carboxylic Acid Hydrazide, <b>16</b></h3><div class="NLM_p last">Following the procedure used for preparing compound <b>15</b>, compound <b>16</b> was obtained as a dark-brown-colored solid in an 85% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 11.39 (bs, 1H), 8.17 (d, <i>J</i> = 6.6 Hz, 1H), 8.13 (d, <i>J</i> = 7.0 Hz, 1H), 7.38 (s, 1H), 6.90 (t, <i>J</i> = 6.9 Hz, 1H), 4.29 (d, <i>J</i> = 3.7 Hz, 2H), 3.14 (m, 1H), 1.38 (d, <i>J</i> = 6.8 Hz, 6H); mass (<i>m</i>/<i>z</i>): 219.2 (M+H)<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of Methyl 2-Isopropylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxylate, <b>17</b></h3><div class="NLM_p last">To a stirred solution of acid <b>A</b><sub><b>3</b></sub> (0.23 g, 1.1 mmol) in MeOH (5.0 mL) cooled to 0 °C, thionyl chloride (0.2 mL) was added dropwise. The reaction temperature was gradually raised to 65 °C, and the reaction mixture was stirred at this temperature for 4 h. The volatiles were removed under reduced pressure, and the crude mass was diluted with DCM and an aqueous NaHCO<sub>3</sub> solution. The two layers were separated, the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure to obtain ester <b>17</b> (0.25 g) in a 100% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63 (d, J = 8.7 Hz, 1H), 7.40 (d, <i>J</i> = 6.8 Hz, 1H), 7.07 (t, <i>J</i> = 7.3 Hz, 1H), 6.46 (s, 1H), 4.0 (s, 3H), 3.34 (m, 1H), 1.38 (d, <i>J</i> = 6.7 Hz, 6H); mass (<i>m</i>/<i>z</i>): 219.2 (M+H)<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Synthesis of 2-Isopropylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxylic Acid Hydrazide, <b>18</b></h3><div class="NLM_p last">Following the procedure used for preparing compound <b>15</b>, compound <b>18</b> was obtained as a dark-brown-colored solid in a 95% yield. <sup>1</sup>H NMR (400 MHz, DMSO): δ 11.4 (bs, 1H), 7.86 (d, <i>J</i> = 8.6 Hz, 1H), 7.69 (d, <i>J</i> = 6.9 Hz, 1H), 7.37 (t, <i>J</i> = 7.8 Hz, 1H), 6.68 (s, 1H), 4.95 (bs, 2H), 3.28–3.20 (m, 1H), 1.35 (d, <i>J</i> = 6.8 Hz, 6H); mass (<i>m</i>/<i>z</i>): 219.2 (M+H)<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Synthesis of <i>N</i>-[<i>N</i>-<i>tert</i>-Butyloxycarbonyl-3-azabicyclo[3.1.0]hexane-6-yl-methyl]1-isopropyl Imidazo[1,5-<i>a</i>]pyridine-3-carboxamide, <b>19b</b></h3><div class="NLM_p last">To a stirred solution of acid <b>A</b><sub><b>1</b></sub> (600.0 mg, 2.94 mmol) in DCM (11.8 mL) cooled to 0 °C, diisopropylethyl amine (0.77 mL, 4.41 mmol), <i>tert</i>-butyl 6-aminomethyl-3-aza-bicyclo[3.1.0]hexane-3-carboxylate (<b>B</b><sub><b>2</b></sub>, 624.0 mg, 2.94 mmol), and TBTU (944.0 mg, 2.94 mmol) were sequentially added. The reaction temperature was gradually brought to rt, and the reaction mixture was stirred for 16 h before being diluted with DCM and water. The two layers were separated, the aqueous layer was extracted once with DCM, and the combined organic layers were washed with a brine solution. The resultant organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated under reduced pressure. The crude mass was purified by silica-gel column chromatography to obtain the title compound, <b>19b</b> (1.03 g), in an 85% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.38 (d, <i>J</i> = 7.1 Hz, 1H), 7.56 (d, <i>J</i> = 9.9 Hz, 1H), 7.44 (t, <i>J</i> = 5.2 Hz, 1H), 6.86 (t, <i>J</i> = 9.9 Hz, 1H), 6.75 (t, <i>J</i> = 6.8 Hz, 1H), 3.67 (d, <i>J</i> = 6.7 Hz, 2H), 3.39–3.36 (m, 4H), 3.09–3.07 (m, 1H), 1.42 (s, 9H), 1.39–1.37 (m, 8H), 1.03–0.97 (m, 1H); mass (<i>m</i>/<i>z</i>): 399.3 (M+H)<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis of <i>N</i>-[<i>N</i>-3-Azabicyclo[3.1.0]hexane-6-yl-methyl]1-isopropyl Imidazo[1,5-<i>a</i>]pyridine-3-carboxamide Hydrochloride, <b>20b</b></h3><div class="NLM_p last">To a stirred solution of Boc-protected amide derivative <b>19b</b> (1.0 g, 2.51 mmol) in isopropanol (5.0 mL) cooled to 0 °C, a solution of dry HCl in IPA (5.0 mL) was added. The contents were stirred for 16 h at rt before the volatiles were removed under reduced pressure. The HCl salt thus obtained was triturated with several portions of ether to obtain the title compound, <b>20b</b> (630.0 mg), as a white solid in a 98% yield. mp 172–174 °C. <sup>1</sup>H NMR (400 MHz, DMSO): δ 9.55 (bs, 1H), 9.35 (d, <i>J</i> = 7.0 Hz, 1H), 8.95 (bs, 1H), 8.59 (t, <i>J</i> = 5.6 Hz, 1H), 7.83 (d, <i>J</i> = 9.0 Hz, 1H), 7.01 (t, J = 8.4 Hz, 1H), 6.95 (t, <i>J</i> = 6.8 Hz, 1H), 3.43–3.41 (m, 1H), 3.27–3.19 (m, 6H), 1.77 (s, 2H), 1.35 (d, <i>J</i> = 6.9 Hz, 7H); mass (<i>m</i>/<i>z</i>): 299.2 (M+H)<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Synthesis of 1-Isopropyl-imidazo[1,5-<i>a</i>]pyridine-3-carboxylic Acid, <b>A<sub>1</sub></b></h3><div class="NLM_p last">To a stirred solution of compound <b>6</b> (1.56 g, 6.7 mmol) in a mixture of ethanol and water (1:1, 20 mL), NaOH (0.3 g, 7.38 mmol) was added, and the reaction mixture was heated to reflux for 2 h. The volatiles were removed under reduced pressure to one-third the solution’s volume, and the solution was diluted with water and extracted with solvent ether. The aqueous layer was acidified with concd HCl to pH 4–5, and the acidified aqueous layer was extracted with a mixture of methanol and DCM (1:9). The combined organic layers were dried on anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure to obtain acid <b>A</b><sub><b>1</b></sub> (1.33 g) in a 97% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.20 (d, <i>J</i> = 7.0 Hz, 1H), 7.86 (d, <i>J</i> = 8.9 Hz, 1H), 7.09 (t, <i>J</i> = 6.6 Hz, 1H), 7.02 (t, <i>J</i> = 6.7 Hz, 1H), 3.45–3.36 (m, 1H), 1.30 (d, <i>J</i> = 6.5 Hz, 6H); mass (<i>m</i>/<i>z</i>): 205.2 (M+H)<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Synthesis of 2-Isopropyl-imidazo[1,2-<i>a</i>]pyridine-8-carboxylic Acid, <b>A</b><sub><b>2</b></sub></h3><div class="NLM_p last">To a stirred solution of compound <b>8</b> (0.44 g, 2.0 mmol) in a mixture of THF and water (1:1, 7.2 mL) cooled to 0 °C, NaOH (83.4 mg, 2.2 mmol) was added. The reaction-mixture temperature was slowly raised to rt, and after 3 h of stirring, TLC revealed the complete consumption of the ester. The reaction mass was diluted with ether, and the two layers were separated. The aqueous layer was acidified with 1 N HCl to pH 4–5 and extracted with DCM. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure to obtain acid <b>A</b><sub><b>2</b></sub> (380.0 mg) in a 98% yield. <sup>1</sup>H NMR (400 MHz, DMSO): δ 8.76 (d, <i>J</i> = 6.5 Hz, 1H), 7.96 (d, <i>J</i> = 6.8 Hz, 1H), 7.94 (s, 1H), 7.13 (t, <i>J</i> = 6.2 Hz, 1H), 2.95–2.93 (m, 1H), 1.28 (d, <i>J</i> = 6.4 Hz, 6H); mass (<i>m</i>/<i>z</i>): 205.3 (M+H)<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Synthesis of 2-Isopropylpyrazolo[1,5-<i>a</i>]pyridine-7-carboxylic Acid, <b>A</b><sub><b>3</b></sub></h3><div class="NLM_p last">To a stirred solution of compound <b>11</b> (0.5 g, 3.1 mmol) in dry THF (12.0 mL) cooled to −78 °C, <i>n</i>-BuLi (1.6 M in hexanes, 2.0 mL, 3.2 mmol) was added. The reaction mass was stirred at the same temperature for another hour before being quenched by dry ice (solid CO<sub>2</sub>). The reaction mixture was diluted with water and EtOAc, and the two layers were separated. The aqueous layer was acidified with 1 N HCl to pH 2–3 and extracted with chloroform. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure to obtain acid <b>A</b><sub><b>3</b></sub> (35.0 mg) in a 55% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 15.2 (s, 1H), 7.88 (d, <i>J</i> = 7.0 Hz, 1H), 7.73 (d, J = 8.7 Hz, 1H), 7.31 (t, <i>J</i> = 7.4 Hz, 1H), 6.51 (s, 1H), 3.29–3.22 (m, 1H), 1.40 (d, <i>J</i> = 6.8 Hz, 6H); mass (<i>m</i>/<i>z</i>): 205.2 (M+H)<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Synthesis of <i>N</i>-[<i>N</i>-3-Methoxypropyl-3-azabicyclo[3.1.0]hexane-6-yl-methyl]1-isopropyl Imidazo[1,5-<i>a</i>]pyridine-3-carboxamide, <b>2f</b></h3><div class="NLM_p last">To a stirred solution of deprotected amide derivative <b>20b</b> (630.0 mg, 1.88 mmol) in acetonitrile (7.5 mL), K<sub>2</sub>CO<sub>3</sub> (390.0 mg, 2.82 mmol) and 1-bromo-3-methoxypropane (380.0 mg, 2.5 mmol) were added. The reaction mass was heated to reflux for 7 h. The volatiles were removed under reduced pressure. The crude product was purified by silica-gel column chromatography to obtain the desired compound, <b>2f</b> (620.0 mg), as an off-white-colored gummy liquid in a 67% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.40 (d, <i>J</i> = 7.2 Hz, 1H), 7.53 (d, <i>J</i> = 8.8 Hz, 1H), 7.37 (bs, 1H), 6.83 (t, <i>J</i> = 8.0 Hz, 1H), 6.72 (t, <i>J</i> = 4.0 Hz, 1H), 3.39 (t, <i>J</i> = 8.0 Hz, 2H), 3.25 (m, 1H), 3.27 (s, 3H), 3.30 (t, <i>J</i> = 4.0 Hz, 2H), 3.06 (d, <i>J</i> = 8.0 Hz, 2H), 2.45 (t, <i>J</i> = 8.0 Hz, 2H), 2.30 (d, <i>J</i> = 8.0 Hz, 2H), 1.97–1.90 (m, 1H), 1.72–1.65 (m, 2H), 1.49–1.43 (m, 1H), 1.47–1.43 (m, 1H), 1.39 (d, <i>J</i> = 8.0 Hz, 6H); mass (<i>m</i>/<i>z</i>); 371.3 (M+H)<sup>+</sup>. <sup>13</sup>C NMR: δ 160.2, 139.2, 129.1, 127.2, 124.6, 120.3, 117.4, 114.7, 69.1, 57.5, 55.8, 54.4, 42.3, 39.7, 26.6, 25.7, 21.7, 11.7. HPLC: 99.32%. C, H, N for C<sub>21</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub>, calcd: C, 68.08, H, 8.16, N, 15.12; found: C, 68.32, H, 8.51, N, 15.32.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Synthesis of <i>N</i>-[<i>N</i>-(Tetrahydropyran-4-yl-methyl)-piperidin-4-yl-methyl]-2-isopropyl-imidazo[1,2-<i>a</i>]pyridine-8-carboxamide, <b>3c</b></h3><div class="NLM_p last">Compound <b>3c</b> was synthesized following the procedures used in the synthesis of compound <b>2f</b>, in a 49% overall yield. <sup>1</sup>H NMR (400 MHz, DMSO): δ 10.428 (t, <i>J</i> = 5.5 Hz, 1H), 8.67 (d, <i>J</i> = 6.5 Hz, 1H), 7.95 (d, <i>J</i> = 7.0 Hz, 1H), 7.85 (s, 1H), 7.04 (t, <i>J</i> = 7.0 Hz, 1H), 3.87–3.79 (m, 2H), 3.39 (s, 4H), 3.34–3.29 (m, 1H), 2.8 (s, 4H), 1.99 (s, 1H), 1.87–1.80 (m, 2H), 1.67–1.58 (m, 4H), 1.30 (d, <i>J</i> = 6.6 Hz, 6H); mass (<i>m</i>/<i>z</i>): 399.5 (M+H)<sup>+</sup>. HPLC: 98.12%. C, H, N for C<sub>25</sub>H<sub>36</sub>N<sub>4</sub>O<sub>6</sub>, calcd: C, 61.46, H, 7.43, N, 11.47; found: C, 61.55, H, 7.89, N, 11.62.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Synthesis of 2-Isopropyl-7-{5-[1-(3-methoxypropyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-pyrazolo[1,5-<i>a</i>]pyridine, <b>4n</b></h3><div class="NLM_p last">To a stirred solution of lithium 1-(3-methoxypropyl)-piperidine-4-carboxylate, <b>14b</b> (250.0 mg, 1.2 mmol), in POCl<sub>3</sub> (2.0 mL) at rt, hydrazide <b>18</b> (220.0 mg, 1.0 mmol) was added. The reaction-mixture temperature was raised to 80–85 °C, and the mixture was stirred for 10 h. The reaction mixture was cooled to ice-bath temperature and quenched by the addition of a 1 N NaOH solution. The reaction mass was extracted with CHCl<sub>3</sub>. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the volatiles were removed under reduced pressure to obtain a crude mass, which was purified by silica-gel column chromatography to obtain compound <b>4n</b> (138.0 mg) in a 36% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.64 (d, <i>J</i> = 7.2 Hz, 1H), 7.46 (d, <i>J</i> = 8.0 Hz, 1H), 7.14 (t, <i>J</i> = 7.2 Hz, 1H), 6.49 (s, 1H) 3.44 (t, <i>J</i> = 6.4 Hz, 2H), 3.34 (s, 3H), 3.29–3.24 (m, 1H), 3.16–3.11 (m, 1H), 3.02 (t, 2H), 2.49 (t, 2H), 2.20 (t, 2H), 2.12 (t, <i>J</i> = 12.0 Hz, 2H), 1.83–1.80 (m, 2H), 1.64–1.54 (m, 2H), 1.39 (d, <i>J</i> = 8.0 Hz, 6H); mass (<i>m</i>/<i>z</i>); 384.2 (M+H)<sup>+</sup>. C, H, N for C<sub>21</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub>, calcd: C, 65.77, H, 7.62, N, 18.26; found: C, 65.49, H, 7.37, N, 17.98.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Oxalate Salt Formation</h3><div class="NLM_p last">To a stirred solution of the above-obtained 1,3,4-oxadiazole <b>4n</b> (96.0 mg, 0.25 mmol) in isopropanol (4.0 mL) cooled to 0 °C, oxalic acid (23.0 mg, 0.25 mmol) was added, and the reaction mass was stirred for 1 h. The volatiles were removed under reduced pressure, and the crude salt thus obtained was triturated with several portions of solvent ether to obtain the oxalate salt of <b>4n</b> in a quantitative yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.90 (d, <i>J</i> = 8.8 Hz, 1H), 7.52 (d, <i>J</i> = 6.8 Hz, 1H), 7.34 (dd, <i>J</i> = 7.5, 8.4 Hz, 1H), 6.68 (s, 1H) 3.50–3.36 (m, 5H), 3.24 (s, 3H), 3.20–3.10 (m, 1H), 3.10–2.95 (m, 4H), 2.40–2.30 (m, 2H), 2.20–2.05 (m, 2H), 1.95–1.85 (m, 2H), 1.32 (t, <i>J</i> = 6.8 Hz, 6H); mass (<i>m</i>/<i>z</i>); 384.3 (M+H)<sup>+</sup>. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.3, 164.4, 161.6, 159.2, 150.8, 141.3, 123.4, 122.4, 121.0, 115.3, 95.0, 69.0, 57.8, 53.6, 50.2, 30.0, 27.6, 25.9, 23.8, 22.6, 22.5. MR 143.8–149.9 °C. HPLC: 99.08%.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Synthesis of 2-Isopropyl-7-{5-[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-yl]-[1,3,4]oxadiazol-2-yl}-pyrazolo[1,5-<i>a</i>]pyridine, <b>4o</b></h3><div class="NLM_p last">Following the procedure used in the synthesis of compound <b>4n</b> as depicted above, compound <b>4o</b> was prepared (180.0 mg) in a 44% yield using lithium 1-(tetrahydropyran-4-ylmethyl)-piperidine-4-carboxylate, <b>14c</b> (280.0 mg, 1.2 mmol), and hydrazide <b>18</b> (220.0 mg, 1.0 mmol). <sup>1</sup>H NMR (400 MHz, CDCl3): δ 8.10 (s, 1H), 8.0 (d, <i>J</i> = 7.0 Hz, 1H), 7.86 (d, <i>J</i> = 8.32 Hz, 1H), 7.19 (t, <i>J</i> = 7.5 Hz, 1H), 5.03–4.98 (m, 1H), 3.99 (d, <i>J</i> = 3.0 Hz, 1H), 3.96 (d, <i>J</i> = 3.2 Hz, 1H), 3.42 (t, <i>J</i> = 11.2 Hz, 2H), 3.14–3.06 (m, 1H), 2.95 (d, <i>J</i> = 10.1 Hz, 2H), 2.22 (d, <i>J</i> = 6.9 Hz, 2H), 2.13–1.99 (m, 6H), 1.77 (m, 1H), 1.69 (d, <i>J</i> = 6.6 Hz, 6H), 1.32–1.22 (m, 2H); mass (<i>m</i>/<i>z</i>); 410.3 (M+H)<sup>+</sup>. C, H, N for C<sub>23</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub>, calcd: C, 67.46, H, 7.63, N, 17.10; found: C, 67.23, H, 7.54, N, 17.47.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Fumarate Salt Formation</h3><div class="NLM_p last">To a stirred solution of the above-obtained 1,3,4-oxadiazole <b>4o</b> (103.0 mg, 0.25 mmol) in isopropanol (4.0 mL) cooled to 0 °C, fumaric acid (30.0 mg, 0.25 mmol) was added, and the reaction mass was stirred for 1 h. The volatiles were removed under reduced pressure, and the crude salt thus obtained was triturated with several portions of solvent ether to obtain the fumarate salt of <b>4o</b> in a quantitative yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub> + D<sub>2</sub>O): δ 8.58 (s, 1H), 8.01 (d, <i>J</i> = 8.2, Hz, 1H), 7.96 (d, <i>J</i> = 6.9 Hz, 1H), 7.22 (t, <i>J</i> = 7.6 Hz, 1H), 6.46 (s, 2H), 4.94–4.88 (m, 1H), 3.84–3.80 (m, 2H), 3.50–3.25 (m, 5H), 3.0–2.90 (m, 2H), 2.88–2.80 (m, 2H), 2.35–2.25 (m, 2H), 2.10–1.97 (m, 3H), 1.65–1.60 (m, 2H), 1.58 (d, <i>J</i> = 6.6 Hz, 6H), 1.20–1.10 (m, 2H); mass (<i>m</i>/<i>z</i>); 410.0 (M+H)<sup>+</sup>. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.5, 166.3, 161.6, 159.0, 141.3, 134.2, 123.5, 122.4, 120.9, 115.2, 95.0, 66.8, 63.6, 52.1, 32.1, 31.6, 28.4, 27.5, 22.6. MR 205.2–209.6 °C. HPLC: 98.38%.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Animals and Ethics</h3><div class="NLM_p last">All animal care and experiments were carried out according to protocols approved by the Institutional Animal Ethics Committee (IAEC) of Suven Life Science Ltd., constituted according to the directions of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), India.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Determination of EC<sub>50</sub> Values for 5-HT<sub>4</sub>R</h3><div class="NLM_p">The compounds were screened in a cell-based reporter-gene assay and an end-point luminescence assay that measures the levels of cAMP inside cells upon the activation or inhibition of the receptor using the luciferase reporter. Serotonin (5-HT) and luciferin was purchased from Sigma-Aldrich. T4 DNA Ligase and high-fidelity Taq polymerase were procured from Roche. Superscript Reverse Transcriptase and mammalian expression vector pcDNA3.1 were purchased from Invitrogen. The CRE-Luc reporter-gene construct was supplied by Stratagene. Cell-culture media and sera were procured from Invitrogen. All other DNA-restriction and -modification enzymes were from New England Biolabs. All other reagents and common chemicals were purchased from Sigma-Aldrich. The human 5-HT<sub>4</sub>R cDNA clone was purchased from Origene. The coding sequence was amplified by PCR using gene-specific primers. The amplified DNA was cloned into the mammalian expression vector pcDNA 3.1. The authenticity of the cloned genes was determined by restriction analysis and nucleotide sequencing. The CHO cell line was purchased from the American Type Culture Collection. The cells were routinely cultured in Hams F12 medium supplemented with 10% fetal bovine serum at 37 °C in 5% CO<sub>2</sub>. The cells were transfected with the 5-HT<sub>4</sub> isoforms along with 3-fold excess of the CRE-Luc reporter gene using Lipofectamine, as recommended by the supplier. The cells were further cultured in the same medium supplemented with 800 μg/mL G418. Individual colonies were picked after 2 weeks of selection and screened for serotonin-induced luciferase activity. Colonies exhibiting maximum serotonin-induced luciferase activity were selected and amplified for further investigation. The recombinant CHO cells were plated in 96 well clear-bottom white plates (Corning) and cultured overnight as described above. Cells were grown overnight in serum-free medium before the incubation with the compounds to prevent receptor desensitization due to the presence of endogenous ligands in the serum.</div><div class="NLM_p">The reference endogenous agonist serotonin and test compounds, in Opti-MEM medium at 11 different test concentrations from 10 μM to 0.1 nM in 3-fold serial dilutions, were separately incubated with the cells in individual wells for 4 h at 37 °C in 5% CO<sub>2</sub>. Compounds whose potencies were less than 1 nM were tested in a dose–response study whose test concentrations were from 1 μM to 0.01 nM. After the incubation, the medium was removed, and the cells were washed with phosphate-buffered saline and lysed in lysis buffer (10 mM Tris, pH 8.0; 50 mM NaCl; 1 mM DTT; 1× protease-inhibitor cocktail; and 0.1% NP40). The luciferase activity was measured in the individual wells using a luciferin substrate in a Victor Light Luminometer (PerkinElmer).</div><div class="NLM_p last">The maximum response produced by each drug was normalized to the 5-HT-induced maximum response. The data were analyzed using GraphPad Prism software to derive the EC<sub>50</sub> values that corresponded to the concentrations of agonists required to obtain half-maximal stimulation of adenylyl cyclase. Each values was expressed as the geometric mean of two independent experiments performed in triplicate. Reference compound PF-04995274, a reported partial agonist,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> showed partial-agonist activity in our 5-HT<sub>4E</sub> cell-based reporter-gene assay with an EC<sub>50</sub> value of 1.3 nM and an <i>E</i><sub>max</sub> of 18%, which is well in agreement with the published data (EC<sub>50</sub> = 0.26 nM, <i>E</i><sub>max</sub> = 7%). The EC<sub>50</sub> values of some other reported compounds were also determined using our assay and compared with the published data. The EC<sub>50</sub> values obtained versus the reported values are tabulated in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_001.pdf" class="ext-link">Supporting Information</a> of this manuscript.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Microsomal Metabolic Stability</h3><div class="NLM_p last">The compounds were incubated with microsomes at 0.5 mg/mL protein in 100 mM phosphate buffer (pH 7.4) at 37 °C. The reactions were initiated by the addition of NADPH. All incubations were carried out for 30 min. At 30 min, an aliquot of the sample was removed and transferred into 300 μL of acetonitrile. The samples were stored at −20 °C until analysis. The samples were analyzed using LC-MS/MS. The results were expressed as the percent metabolized at 30 min postincubation.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> CYP 3A4 and 2D6 Inhibition</h3><div class="NLM_p last">The CYP 3A4 and 2D6 inhibitory potentials of the test compounds were studied using human liver microsomes. Inhibitory activity was evaluated by incubating the test compound (0.1–45 μM) in duplicate for 2 (3A4) and 12 min (2D6) with human liver microsomes in the presence of an isoform-specific substrate (midazolam for 3A4 or dextromethorphan for 2D6) and an NADPH-regeneration system. Incubations were terminated by the addition of ice-cold acetonitrile containing an internal standard, and the metabolites were quantified using LC-MS/MS. Peak-area ratios of the analytes versus the internal standards were used for calculating IC<sub>50</sub> values.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Pharmacokinetic Study in Rats</h3><div class="NLM_p last">Male Wistar rats (225 ± 25 g) were used as experimental animals. Three animals were housed in each cage. Two days prior to the dosing day, the male Wistar rats were anesthetized with isoflurane for the surgical placement of jugular-vein catheters. Animals were fasted overnight before oral dosing (po), and food pellets were allowed 2 h postdosing, whereas during intravenous dosing, food and water were provided ad libitum. Three rats were dosed with the compounds orally (3 mg/kg) and intravenously (1 mg/kg). Dose formulation was prepared by using water as a vehicle (10 mL/kg for oral dosing and 2 mL/kg for intravenous dosing). At each time point, blood was collected through the jugular vein and immediately replenished with an equivalent volume of normal saline from freely moving rats. The collected blood was transferred to a labeled Eppendorf tube containing 10 μL of heparin as an anticoagulant. The time points for the blood-sample collection were predose and 0.08 (iv only), 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h postdose (<i>n</i> = 3). The collected blood was centrifuged at 4000 rpm for 10 min. The plasma was prepared and stored at −70 °C until analysis. The test-compound concentrations were extracted from the plasma samples by protein precipitation using four volumes of acetonitrile (v/v) containing a predetermined internal standard. The precipitates were centrifuged at 11 292<i>g</i> and 10 °C for 10 min, and the supernatants were transferred and injected in an LC-MS/MS. The analytes of interest were quantified using the suitable multiple-reaction-monitoring mode in the range of 2–2000 ng/mL or ng/g against a set of calibration standards and quality-control samples. The study samples were analyzed using the calibration samples within each batch and the quality-control samples across the batches. The pharmacokinetic parameters were determined by standard noncompartmental analysis (Phoenix WinNonLin software, version 6.2 or higher) using a linear trapezoidal with linear interpolation method.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Rodent-Brain-Penetration Study</h3><div class="NLM_p last">Male Wistar rats (225 ± 25 g) were used as experimental animals. Three animals were housed in each cage. The animals were given water and food ad libitum throughout the experiment and maintained on a 12 h light–dark cycle. Brain penetration was determined in a discrete manner in the rats. The compounds were formulated in water and administered orally at 10 mg/kg (free-base equivalent). Blood samples were removed via cardiac punctures after isoflurane anesthesia at 1 h postdose. The animals were sacrificed to collect the brain tissue. The plasma was separated, and the brain samples were homogenized and stored at −70 °C until analysis. The concentrations of the compounds in the plasma and brain were determined using an LC-MS/MS method. The test-compound concentrations were extracted from the brain homogenates by protein precipitation using four volumes of acetonitrile (v/v) containing a predetermined internal standard. The precipitates were centrifuged at 11 292<i>g</i> and 10 °C for 10 min, and the supernatants were transferred and injected in an LC-MS/MS. The compounds were quantified in the calibration range of 1–2000 ng/mL in the plasma and brain homogenates. The study samples were analyzed using calibration samples within each batch and quality-control samples across the batches. Extent of the brain-to-plasma ratio was calculated (<i>C</i><sub>b</sub>/<i>C</i><sub>p</sub>).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Novel-Object-Recognition Task</h3><div class="NLM_p last">Male Wistar rats 10–12 weeks of age were used. The arena was an open field made of acrylic (50 × 50 × 50 cm). Twenty-four hours prior to testing, the rats were habituated to individual test arenas for 20 min in the absence of any objects. Twenty-four hours after the habituation, the rats (7–8 animals per group) were administered their respective treatments. After a post-treatment interval of 30 min, the rats were subjected to a familiarization phase (T1). The rats were placed individually in the open field containing two identical objects (a1 and a2) for 3 min. The choice trial (T2) was carried out 24 h after the T1 trial. The rats were administered their respective treatments. After a post-treatment interval of 30 min, the rats were subjected to the choice trial (T2). The rats were allowed to explore the open field for 3 min in the presence of one familiar object (a3) and one novel object (b). Exploration times were noted.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Novel-Object-Recognition Task with the 5-HT<sub>4</sub>R Selective Antagonist, GR-125487</h3><div class="NLM_p last">On day 1, the Wistar rats (<i>n</i> = 7–8 per group) were habituated to the arena for 20 min. On day 2 or 3, 30 min before trial 1, the animals were administered the vehicle (water for injection, WFI) or compound <b>4o</b> (3 mg/kg, po). On day 2 or 3, GR-125487 (1 mg/kg, sc) was administered 40 min before the trial. Trial 1 was a familiarization task in the arena, with 2 yellow bottles of same dimensions for a period of 3 min. Trial 2 was a recognition task in the arena, with one yellow and one black bottle for a period of 3 min. The vehicle-treated rats spent almost equal time exploring the novel object and the familiar object in the test (i.e., they did not remember the familiar object). The rats treated with compound <b>4o</b> at 3 mg/kg, po, spent significantly more time exploring the novel object than the familiar object in the test phase. The rats treated with GR-125487 at 1 mg/kg, sc, spent almost equal time exploring the novel object and the familiar object in the test phase. Groups treated with the <b>4o</b> (3 mg/kg, po) and GR 125487 (1 mg/kg, sc) combination spent almost equal time exploring the novel object and the familiar object in the test phase. GR-125487 antagonized or blocked the action of compound <b>4o</b>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Determination of In Vivo Receptor Occupancy (RO)</h3><div class="NLM_p last">Male Wistar rats (<i>n</i> = 4 per group) were administered the vehicle or test compounds (0.3, 1, 3, 10, and 30 mg/kg, po). After 1 h of treatment with the test compounds or the vehicle, the rats were restrained and administered a tracer (SB207145, 1 μg/kg) intravenously. Thirty minutes after the tracer administration, the rats were sacrificed, and each brain was separated for the isolation of the cerebellum (nonspecific region) and striatum (specific region). The isolated brain tissues were transferred to prelabeled vials and stored on dry ice until the quantification of the tracer (SB207145) using LC-MS/MS. Percent receptor occupancy was calculated using the concentration of the tracer in the striatum compared with the concentration in the cerebellum (receptor null region).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> In Vivo Brain Microdialysis</h3><div class="NLM_p last">Animals were placed in a stereotaxic frame with an incisor bar set at 3.2 mm under the horizontal plane, passing through the interaural line. A microdialysis guide cannula (CMA/11, CMA Microdialysis) was implanted into the frontal cortex (AP = +3.2 mm, ML = −3.2 mm, DV = −1.5 mm). The coordinates were taken according to Paxinos and Watson<a onclick="showRef(event, 'add'); return false;" href="javascript:void(0);" class="ref add">(41)</a> with reference points taken from the bregma and vertical from the skull. On the day of the experiment, a pre-equilibrated microdialysis probe (CMA/11, 2 mm, CMA Microdialysis) was inserted into the guide cannula, directing the dialysis membrane into the frontal cortex. The probe was perfused with aCSF at 1.5 μL/min set by a microinfusion pump (Picoplus). After a stabilization period of 2 h, sample collection was initiated with a sampling interval of 20 min; five basal samples were collected prior to the administration of compound <b>4o</b> (3 or 10 mg/kg, po) and dialysate samples were collected for an additional period of 4 h. Samples were stored at −70 °C until the quantification of acetylcholine by LC-MS/MS.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(42)</a></div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Estimation of Mouse-Brain Cortical sAPPα Levels</h3><div class="NLM_p last">Male C57BL/6J mice (20–30 g) were randomly divided (<i>n</i> = 7 per group) into different treatment groups. In the control group, the mice were subcutaneously (sc) administered sterile water by injection. The mice from treatment groups each received a single sc injection of a test compound (dose volume of 10 mL/kg) or prucalopride (10 mg/kg) dissolved in sterile water. The mice were sacrificed by cervical dislocation at 60 or 90 min after the administration of the test compound or prucalopride, respectively. The brains were quickly isolated, and the cortexes were dissected at −20 °C. Each cortex was immediately kept on a dry ice and weighed before being stored at −80 °C until the quantification of sAPPα using an enzyme-linked immunosorbent assay (ELISA) via commercially available kits from IBL (currently known as Tecan).<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(43−45)</a> Statistical analyses were performed using GraphPad Prism (version 4). The data are means ± SD of sAPPα levels expressed as percentages of the control values (from the mice that received water by injection). Values were compared between the different groups by an unpaired test. The significance level was set at *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00457" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00457" class="ext-link">10.1021/acs.jmedchem.8b00457</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures, characterization data of the final compounds, comparative in vitro affinities of the 5-HT<sub>4</sub>R reference standards, data from the functional assays, protein-binding results, selectivity profile, and elemental analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular-formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_001.pdf">jm8b00457_si_001.pdf (444.06 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_002.csv">jm8b00457_si_002.csv (2.42 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00457" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramakrishna Nirogi</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2045-0784" title="Orcid link">http://orcid.org/0000-0002-2045-0784</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b6d8c0c5c4ddf6c5c3c0d3d898d5d9db"><span class="__cf_email__" data-cfemail="6d031b1e1f062d1e181b0803430e0200">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abdul Rasheed Mohammed</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anil K. Shinde</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shankar Reddy Gagginapally</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Durga Malleshwari Kancharla</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vanaja Reddy Middekadi</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Narsimha Bogaraju</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srinivasa Rao Ravella</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pooja Singh</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sumit Raosaheb Birangal</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramkumar Subramanian</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raghava Choudary Palacharla</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vijay Benade</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nageswararao Muddana</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pradeep Jayarajan</span> - <span class="hlFld-Affiliation affiliation">Discovery Research, Suven Life
Sciences Limited, Serene Chambers, Road-5, Avenue-7, Banjara Hills, Hyderabad 500 034, India</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through the contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The support of scientists from the Analytical Chemistry, In Vitro and In Vivo Pharmacology, Drug Metabolism, and Pharmacokinetics Departments and moral and financial support from Venkateswarlu Jasti, CEO, Suven Life Sciences Ltd., Hyderabad, are greatly acknowledged.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">5-HT<sub>4</sub>R</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine 4 receptor</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">oral dosing</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous dosing</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minutes</p></td></tr><tr><td class="NLM_term">mm</td><td class="NLM_def"><p class="first last">millimeter</p></td></tr><tr><td class="NLM_term">rpm</td><td class="NLM_def"><p class="first last">rounds per minute</p></td></tr><tr><td class="NLM_term">cps</td><td class="NLM_def"><p class="first last">counts per second</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human Ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">sAPPα</td><td class="NLM_def"><p class="first last">soluble amyloid precursor protein α</p></td></tr><tr><td class="NLM_term">RO</td><td class="NLM_def"><p class="first last">receptor occupancy</p></td></tr><tr><td class="NLM_term">LC-MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration giving a 50% response</p></td></tr><tr><td class="NLM_term">ED<sub>50</sub></td><td class="NLM_def"><p class="first last">median effective dose</p></td></tr><tr><td class="NLM_term"><i>E</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximal effect</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">tetrahydropyran</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term"><i>n</i>-BuLi</td><td class="NLM_def"><p class="first last"><i>n</i>-butyllithium</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">isopropanol</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerald, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adham, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laz, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaysse, P. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartig, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branchek, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinshank, R. L.</span></span> <span> </span><span class="NLM_article-title">The 5-HT<sub>4</sub> receptor: Molecular cloning and pharmacological characterization of two splice variants</span>. <i>EMBO Journal</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2815</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=2806-2815&author=C.+Geraldauthor=N.+Adhamauthor=H.+T.+Kaoauthor=M.+A.+Olsenauthor=T.+M.+Lazauthor=L.+E.+Schechterauthor=J.+A.+Bardauthor=P.+J.+J.+Vaysseauthor=P.+R.+Hartigauthor=T.+A.+Branchekauthor=R.+L.+Weinshank&title=The+5-HT4+receptor%3A+Molecular+cloning+and+pharmacological+characterization+of+two+splice+variants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerald%26aufirst%3DC.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DKao%26aufirst%3DH.%2BT.%26aulast%3DOlsen%26aufirst%3DM.%2BA.%26aulast%3DLaz%26aufirst%3DT.%2BM.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DBard%26aufirst%3DJ.%2BA.%26aulast%3DVaysse%26aufirst%3DP.%2BJ.%2BJ.%26aulast%3DHartig%26aufirst%3DP.%2BR.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DWeinshank%26aufirst%3DR.%2BL.%26atitle%3DThe%25205-HT4%2520receptor%253A%2520Molecular%2520cloning%2520and%2520pharmacological%2520characterization%2520of%2520two%2520splice%2520variants%26jtitle%3DEMBO%2520Journal%26date%3D1995%26volume%3D14%26spage%3D2806%26epage%3D2815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maillet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span> <span> </span><span class="NLM_article-title">New insights into serotonin 5-HT<sub>4</sub> receptors: A novel therapeutic target for Alzheimer’s disease?</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.2174/1567205043332252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.2174%2F1567205043332252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=15975071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvF2jt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=79-85&author=M.+Mailletauthor=S.+J.+Robertauthor=F.+Lezoualc%E2%80%99h&title=New+insights+into+serotonin+5-HT4+receptors%3A+A+novel+therapeutic+target+for+Alzheimer%E2%80%99s+disease%3F&doi=10.2174%2F1567205043332252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into serotonin 5-HT4 receptors: A novel therapeutic target for Alzheimer's disease?</span></div><div class="casAuthors">Maillet, Marjorie; Robert, Sylvain J.; Lezoualc'h, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">79-85</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin 5-HT4 receptor mediates many physiol. effects in the central nervous system.  The recent mol. identification of 5-HT4 receptors and the development of selective 5-HT4 receptor ligands have led to many important new insights into the signalling pathways and the physiol. roles of these G protein-coupled-receptors in neurons.  With respect to neurodegenerative disorders, it is suggested that 5-HT4 agonists may represent a new avenue for the treatment of Alzheimer's disease.  This mini-review will focus on recent in vitro and in vivo pharmacol. and biochem. studies showing the involvement of 5-HT4 receptors in cognitive processes and the amyloid precursor protein processing.  The potential use of 5-HT4 agonists for the treatment of AD will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEiivpw5diLVg90H21EOLACvtfcHk0liY-ewKZT2bOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvF2jt70%253D&md5=6e42fa1b968fffe34f6ee96ed37bc957</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F1567205043332252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205043332252%26sid%3Dliteratum%253Aachs%26aulast%3DMaillet%26aufirst%3DM.%26aulast%3DRobert%26aufirst%3DS.%2BJ.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26atitle%3DNew%2520insights%2520into%2520serotonin%25205-HT4%2520receptors%253A%2520A%2520novel%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2004%26volume%3D1%26spage%3D79%26epage%3D85%26doi%3D10.2174%2F1567205043332252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, F.</span></span> <span> </span><span class="NLM_article-title">Drugs acting on serotonin receptors for the treatment of functional GI disorders</span>. <i>Dig. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1159/000090309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1159%2F000090309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=16699264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A280%3ADC%252BD283msl2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=59-69&author=M.+Toniniauthor=F.+Pace&title=Drugs+acting+on+serotonin+receptors+for+the+treatment+of+functional+GI+disorders&doi=10.1159%2F000090309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs acting on serotonin receptors for the treatment of functional GI disorders</span></div><div class="casAuthors">Tonini Marcello; Pace Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Digestive diseases (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">59-69</span>
        ISSN:<span class="NLM_cas:issn">0257-2753</span>.
    </div><div class="casAbstract">In the gut, serotonin (5-hydroxytryptamine: 5-HT) exerts a variety of effects on intrinsic enteric neurons, extrinsic afferents, enterocytes and smooth muscle cells, which are related to the expression of multiple 5-HT receptor types and subtypes regulating motility, vascular tone, secretion and perception.  Agonists and antagonists at 5-HT receptors have gained access to the market for the two major variants of the irritable bowel syndrome (IBS), a functional disorder characterized by abdominal pain associated with diarrhea and/or constipation in the absence of any organic abnormality.  Indeed, the 5-HT3 receptor antagonist alosetron is available in the US market for the treatment of women with severe, diarrhea-predominant IBS (D-IBS) refractory to conventional therapy, whereas tegaserod, a partial 5-HT4 receptor agonist, has been approved by the FDA and other regulatory agencies for the treatment of women with constipation-predominant IBS (C-IBS) or functional constipation.  This review is mainly intended to discuss the role of non-neuronal (paracrine) and neuronal 5-HT in the pathophysiology of functional gastrointestinal disorders (FGIDs), such as IBS and functional dyspepsia, and the mechanisms through which drugs acting on 5-HT receptors regulate visceral motility, perception and secretion in these two conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq9uzlmfvkOmx8TEN9K18QfW6udTcc2eY6pDeYL-2b8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283msl2msA%253D%253D&md5=dda3f4f7c10a3e874dbeec3da1d316eb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1159%2F000090309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000090309%26sid%3Dliteratum%253Aachs%26aulast%3DTonini%26aufirst%3DM.%26aulast%3DPace%26aufirst%3DF.%26atitle%3DDrugs%2520acting%2520on%2520serotonin%2520receptors%2520for%2520the%2520treatment%2520of%2520functional%2520GI%2520disorders%26jtitle%3DDig.%2520Dis.%26date%3D2006%26volume%3D24%26spage%3D59%26epage%3D69%26doi%3D10.1159%2F000090309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouras, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camilleri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mckinzie, S.</span></span> <span> </span><span class="NLM_article-title">Selective stimulation of colonic transit by the benzofuran 5-HT<sub>4</sub> agonist prucalopride, in healthy humans</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1136/gut.44.5.682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1136%2Fgut.44.5.682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10205205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK1MXjtF2ktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1999&pages=682-686&author=E.+P.+Bourasauthor=M.+Camilleriauthor=D.+D.+Burtonauthor=S.+Mckinzie&title=Selective+stimulation+of+colonic+transit+by+the+benzofuran+5-HT4+agonist+prucalopride%2C+in+healthy+humans&doi=10.1136%2Fgut.44.5.682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans</span></div><div class="casAuthors">Bouras, E. P.; Camilleri, M.; Burton, D. D.; McKinzie, S.</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">682-686</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Prucalopride (R093877) is a selective and specific 5HT4 agonist, the first of a new chem. class of benzo-furans, with gastrointestinal prokinetic activities in vitro.  To evaluate the effects of prucalo-pride on gastrointestinal and colonic transit.  A validated scintigraphic technique was used to measure gastrointestinal and colonic transit over 48 h in 50 healthy volunteers.  For seven days, each subject received a daily dose of 0.5, 1, 2, or 4 mg prucalopride, or placebo in a double blind, randomized fashion.  The transit test was performed over the last 48 h.  There were significant accelerations of overall colonic transit at 4, 8, 24, and 48 h (p<0.05) and proximal colonic emptying t1/2 (p<0.05).  The 0.5, 2, and 4 mg doses of prucalopride were almost equally effective and accelerated colonic transit compared with placebo.  Prucalopride did not significantly alter gastric emptying (p>0.5) or small bowel transit (overall p=0.12).  The medication appeared to be well tolerated during the seven day treatment of healthy subjects.  Prucalopride accelerates colonic transit, partly by stimulating proximal colonic emptying, but does not alter gastric or small bowel transit in healthy human subjects.  Prucalopride deserves further study in patients with constipation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0h8xd_-Aq1bVg90H21EOLACvtfcHk0lhhwugRAbbRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtF2ktrg%253D&md5=a2d3dd4271c784729e9fb49d4d6f74ab</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1136%2Fgut.44.5.682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.44.5.682%26sid%3Dliteratum%253Aachs%26aulast%3DBouras%26aufirst%3DE.%2BP.%26aulast%3DCamilleri%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DD.%2BD.%26aulast%3DMckinzie%26aufirst%3DS.%26atitle%3DSelective%2520stimulation%2520of%2520colonic%2520transit%2520by%2520the%2520benzofuran%25205-HT4%2520agonist%2520prucalopride%252C%2520in%2520healthy%2520humans%26jtitle%3DGut%26date%3D1999%26volume%3D44%26spage%3D682%26epage%3D686%26doi%3D10.1136%2Fgut.44.5.682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors, a place in the sun: act two</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2011.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.coph.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=21342787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=87-93&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors%2C+a+place+in+the+sun%3A+act+two&doi=10.1016%2Fj.coph.2011.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors, a place in the sun: act two</span></div><div class="casAuthors">Bockaert, Joel; Claeysen, Sylvie; Compan, Valerie; Dumuis, Aline</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-93</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  5-HT4 receptors control brain physiol. functions such as learning and memory, feeding and mood behavior as well as gastro-intestinal transit. 5-HT4 receptors are one of the 5-HT receptors for which the available drugs and signalling knowledge are the most advanced.  Several therapeutic 5-HT4 receptor drugs have been commercialized.  Therefore, the hope that 5-HT4 receptors could also be the target for brain diseases is reasonable.  Several major devastating illnesses could benefit from 5-HT4 receptors-directed therapy such as Alzheimer's disease, feeding-assocd. diseases such as anorexia and major depressive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-9UQID9lqbVg90H21EOLACvtfcHk0ljGR8Kb8jB2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs7Y%253D&md5=6f136864149bddba0ec1f0ed3b153968</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%252C%2520a%2520place%2520in%2520the%2520sun%253A%2520act%2520two%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26spage%3D87%26epage%3D93%26doi%3D10.1016%2Fj.coph.2011.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S. J.</span></span> <span> </span><span class="NLM_article-title">The serotonin 5-HT<sub>4</sub> receptor and the amyloid precursor protein processing</span>. <i>Exp. Gerontol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/S0531-5565(02)00157-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2FS0531-5565%2802%2900157-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=12543273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=159-166&author=F.+Lezoualc%E2%80%99hauthor=S.+J.+Robert&title=The+serotonin+5-HT4+receptor+and+the+amyloid+precursor+protein+processing&doi=10.1016%2FS0531-5565%2802%2900157-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin 5-HT4 receptor and the amyloid precursor protein processing</span></div><div class="casAuthors">Lezoualc'h, Frank; Robert, Sylvain J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">159-166</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A large body of evidence supports a major role for the serotonin 5-HT4 receptor in learning and memory and it is suggested that 5-HT4 agonists may be beneficial for memory disorders such as Alzheimer's disease (AD).  The 5-HT4 receptors are members of the G protein-coupled receptor superfamily and are pos. coupled to adenylyl cyclase.  In this communication the authors show that a neuronal isoform of the human 5-HT4 receptor, h5-HT4(g) regulates the metab. of the amyloid precursor protein (APP695).  This process is obsd. in Chinese hamster ovary (CHO) cells stably coexpressing the neuronal h5-HT4(g) receptor isoform as well as the human APP695.  The 5-HT4 agonists strongly stimulate the release of the non-amyloidogenic sol. amyloid precursor protein sAPPα as detected by immunoblot.  Prucalopride was more potent than serotonin (5-HT) with regard to enhanced of sAPPα secretion.  This process was blocked by a selective 5-HT4 antagonist, GR113808.  Furthermore, 5-HT4 ligands enhance sAPPα secretion via cAMP-dependent and PKA-independent signaling pathways indicating there are alternative pathways by which the h5-HT4 receptor via cAMP regulates APP metab.  Because the α-cleavage event may preclude the formation of amyloidogenic peptides, and secreted sAPPα has putative neuroprotective and enhancing-memory properties, our present data suggest the 5-HT4 receptor as a novel target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobwRXVEkZwfLVg90H21EOLACvtfcHk0ljGR8Kb8jB2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFWmsw%253D%253D&md5=b4e047f7299a56f139389894c3a3060c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0531-5565%2802%2900157-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0531-5565%252802%252900157-2%26sid%3Dliteratum%253Aachs%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DRobert%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520serotonin%25205-HT4%2520receptor%2520and%2520the%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DExp.%2520Gerontol.%26date%3D2003%26volume%3D38%26spage%3D159%26epage%3D166%26doi%3D10.1016%2FS0531-5565%2802%2900157-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zugaza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmeister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardier, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span> <span> </span><span class="NLM_article-title">The human serotonin 5-HT<sub>4</sub> receptor regulates secretion of non-amyloidogenic precursor protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">44881</span>– <span class="NLM_lpage">44888</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109008200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1074%2Fjbc.M109008200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=11584021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFegurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=44881-44888&author=S.+J.+Robertauthor=J.+L.+Zugazaauthor=R.+Fischmeisterauthor=A.+M.+Gardierauthor=F.+Lezoualc%E2%80%99h&title=The+human+serotonin+5-HT4+receptor+regulates+secretion+of+non-amyloidogenic+precursor+protein&doi=10.1074%2Fjbc.M109008200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein</span></div><div class="casAuthors">Robert, Sylvain J.; Zugaza, Jose L.; Fischmeister, Rodolphe; Gardier, Alain M.; Lezoualc'h, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">44881-44888</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The serotonin 5-HT4 receptor has recently gained a lot of attention for its functional roles in central processes such as memory and cognition.  In this study, we show that activation of the human 5-HT4 (h5-HT4) receptor stimulates the secretion of the non-amyloidogenic sol. form of the amyloid precursor protein (sAPPα).  5-HT enhanced the level of secreted sAPPα in a time- and dose-dependent manner in Chinese hamster ovary cells stably expressing the h5-HT4(e) receptor isoform.  The increase was inhibited by the selective 5-HT4 receptor antagonist, GR 113808.  The 5-HT4 selective agonists, prucalopride and renzapride, also increased secreted sAPPα in IMR32 human neuroblastoma cells.  The stimulatory effect of 5-HT was mimicked by forskolin, a direct activator of adenylyl cyclase, and 8-bromo-cAMP, a membrane-permeant cAMP analog.  On the contrary, inhibition of protein kinase A (PKA) by H 89 potentiated the 5-HT-induced increase in both secreted and cellular sAPPα.  This phenomenon involves a novel PKA-independent stimulatory process that overcomes a PKA-dependent inhibitory one.  Finally, activation of the h5-HT4(e) receptor did not modify extracellular amyloid β-protein in Chinese hamster ovary cells transfected with the human APP695.  Given the neuroprotective and enhancing memory effects of sAPPα, our results may open a new avenue for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZXW1Ib2lqw7Vg90H21EOLACvtfcHk0ljGR8Kb8jB2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFegurk%253D&md5=bf4cbeb9c1c76976cde9ce9579a7ffc5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109008200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109008200%26sid%3Dliteratum%253Aachs%26aulast%3DRobert%26aufirst%3DS.%2BJ.%26aulast%3DZugaza%26aufirst%3DJ.%2BL.%26aulast%3DFischmeister%26aufirst%3DR.%26aulast%3DGardier%26aufirst%3DA.%2BM.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26atitle%3DThe%2520human%2520serotonin%25205-HT4%2520receptor%2520regulates%2520secretion%2520of%2520non-amyloidogenic%2520precursor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D44881%26epage%3D44888%26doi%3D10.1074%2Fjbc.M109008200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors</span>. <i>Curr. Drug Targets: CNS Neurol. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.2174/1568007043482615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.2174%2F1568007043482615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=14965243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=39-51&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors&doi=10.2174%2F1568007043482615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors</span></div><div class="casAuthors">Bockaert, J.; Claeysen, S.; Compan, V.; Dumuis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-51</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin 4 receptors (5-HT4Rs) were discovered 15 yr ago.  They are coded by a very complex gene (700Kb, 38 exons) which generates 8 C-terminal variants (a, b, c, d, e, f, g, and n).  Their sequences differ after position L358.  Another variant is characterized by a 14 residue insertion within the extracellular loop 2.  Highly selective potent 5-HT4 receptor antagonists and partial agonists which cross the blood-brain barrier have been synthesized, but a specific full agonist for brain studies is still missing.  Based on physiol. and behavioral expts., 5-HT4Rs may be targets to treat cognitive deficits, abdominal pain, and feeding disorders.  One 5-HT4R-directed drug (SL65.0155) is already in phase II to treat patients suffering from memory deficits or dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemFXFD0xNLrVg90H21EOLACvtfcHk0ljGR8Kb8jB2TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D&md5=b9139c95c9d832dd89b51d45fc3bde96</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1568007043482615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482615%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D39%26epage%3D51%26doi%3D10.2174%2F1568007043482615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waizumi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papanikolaou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutzman-Engwall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubitski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span> <span> </span><span class="NLM_article-title">Identification of multiple 5-HT<sub>4</sub> partial agonist clinical candidates for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9240</span>– <span class="NLM_lpage">9254</span>, <span class="refDoi"> DOI: 10.1021/jm300953p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300953p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGhsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9240-9254&author=M.+A.+Brodneyauthor=D.+E.+Johnsonauthor=A.+Sawant-Basakauthor=K.+J.+Coffmanauthor=E.+M.+Drummondauthor=E.+L.+Hudsonauthor=K.+E.+Fisherauthor=H.+Noguchiauthor=N.+Waizumiauthor=L.+L.+McDowellauthor=A.+Papanikolaouauthor=B.+A.+Pettersenauthor=A.+W.+Schmidtauthor=E.+Tsengauthor=K.+Stutzman-Engwallauthor=D.+M.+Rubitskiauthor=M.+A.+Vanase-Frawleyauthor=S.+Grimwood&title=Identification+of+multiple+5-HT4+partial+agonist+clinical+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm300953p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Multiple 5-HT4 Partial Agonist Clinical Candidates for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Brodney, Michael A.; Johnson, David E.; Sawant-Basak, Aarti; Coffman, Karen J.; Drummond, Elena M.; Hudson, Emily L.; Fisher, Katherine E.; Noguchi, Hirohide; Waizumi, Nobuaki; McDowell, Laura L.; Papanikolaou, Alexandros; Pettersen, Betty A.; Schmidt, Anne W.; Tseng, Elaine; Stutzman-Engwall, Kim; Rubitski, David M.; Vanase-Frawley, Michelle A.; Grimwood, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9240-9254</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cognitive impairments obsd. in Alzheimer's disease (AD) are in part a consequence of reduced acetylcholine (ACh) levels resulting from a loss of cholinergic neurons.  Preclinically, serotonin 4 receptor (5-HT4) agonists are reported to modulate cholinergic function and therefore may provide a new mechanistic approach for treating cognitive deficits assocd. with AD.  Herein the authors communicate the design and synthesis of potent, selective, and brain penetrant 5-HT4 agonists.  The overall goal of the medicinal chem. strategy was identification of structurally diverse clin. candidates with varying intrinsic activities.  The exposure-response relationships between binding affinity, intrinsic activity, receptor occupancy, drug exposure, and pharmacodynamic activity in relevant preclin. models of AD were utilized as key selection criteria for advancing compds.  On the basis of their excellent balance of pharmacokinetic attributes and safety, two lead 5-HT4 partial agonist candidates PF-04995274 and PF-03382792 were chosen for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqT9o-N9H9KbVg90H21EOLACvtfcHk0liiO4GI_x3-tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGhsLzJ&md5=269b3b0ff783eafbaa8f45a90f320a46</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm300953p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300953p%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DDrummond%26aufirst%3DE.%2BM.%26aulast%3DHudson%26aufirst%3DE.%2BL.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DNoguchi%26aufirst%3DH.%26aulast%3DWaizumi%26aufirst%3DN.%26aulast%3DMcDowell%26aufirst%3DL.%2BL.%26aulast%3DPapanikolaou%26aufirst%3DA.%26aulast%3DPettersen%26aufirst%3DB.%2BA.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DStutzman-Engwall%26aufirst%3DK.%26aulast%3DRubitski%26aufirst%3DD.%2BM.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520multiple%25205-HT4%2520partial%2520agonist%2520clinical%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9240%26epage%3D9254%26doi%3D10.1021%2Fjm300953p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptor agonists for the treatment of Alzheimer’s disease</span>. <i>Neurosci. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.4236/nm.2011.22013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.4236%2Fnm.2011.22013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKht77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=87-92&author=I.+Ahmadauthor=R.+Nirogi&title=5-HT4+receptor+agonists+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.4236%2Fnm.2011.22013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptor agonists for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ahmad, Ishtiyaque; Nirogi, Ramakrishna</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">NMEEBO</span>;
        ISSN:<span class="NLM_cas:issn">2158-2912</span>.
    
            (<span class="NLM_cas:orgname">Scientific Research Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurol. disorder primarily affecting new memory formation as well as retrieval of previously acquired memories.  According to World Health Organization, current global population suffering from cognitive impairment is estd. to 37 million.  The no. is projected to double in next one and half decade.  Half of the population afflicted with dementia is represented by AD patients.  Current therapies, which provide marginal symptomatic relief to AD patients, are effective only in half of the patient population.  In depth understanding of the mol. mechanism of the disease is urgently required to develop more effective therapies.  Therapies in clin. development may either offer symptomatic relief to patients or provide pure disease modifications, thus limiting benefit to patients.  5-HT4 receptor agonists offer an attractive option for the treatment of AD patients.  Activation of 5-HT4 receptor under preclin. conditions is demonstrated to improve neurotransmission and enhance the release of acetylcholine resulting in the memory formation.  In various cell based and animal models, partial 5-HT4 receptor agonists are demonstrated to promote the release of sol. amyloid precursor protein alpha and block the release of amyloid beta peptide offering suitable candidates as disease modification agents.  Remarkably, 5-HT4 receptor agonists are also reported to induce neurogenesis in hippocampus as well as enteric system through the activation of cAMP response element binding protein in rodents.  Taken together, 5-HT4 agonists address all major facets of Alzheimer's disease and may provide therapeutic potential for other neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuyo7_gJ-VqrVg90H21EOLACvtfcHk0liiO4GI_x3-tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKht77M&md5=641e27dc6f84024df4874cbf50bb4598</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4236%2Fnm.2011.22013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fnm.2011.22013%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DNirogi%26aufirst%3DR.%26atitle%3D5-HT4%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurosci.%2520Med.%26date%3D2011%26volume%3D2%26spage%3D87%26epage%3D92%26doi%3D10.4236%2Fnm.2011.22013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmeister, R.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptor ligands: applications and new prospects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1021/jm020099f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020099f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1ejsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=319-344&author=M.+Langloisauthor=R.+Fischmeister&title=5-HT4+receptor+ligands%3A+applications+and+new+prospects&doi=10.1021%2Fjm020099f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 Receptor Ligands: Applications and New Prospects</span></div><div class="casAuthors">Langlois, Michel; Fischmeister, Rodolphe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The present paper describes the recent advances made in medicinal chem. and in the mechanisms proposed to explain the physiol. role of 5-HT4 receptors in the different tissues where they are present and the putative clin. applications of the agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0XyIrWuAGRLVg90H21EOLACvtfcHk0lgWdE9SszKzGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1ejsg%253D%253D&md5=a812f9e611bcea02f0e819783fa2f1c9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm020099f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020099f%26sid%3Dliteratum%253Aachs%26aulast%3DLanglois%26aufirst%3DM.%26aulast%3DFischmeister%26aufirst%3DR.%26atitle%3D5-HT4%2520receptor%2520ligands%253A%2520applications%2520and%2520new%2520prospects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D319%26epage%3D344%26doi%3D10.1021%2Fjm020099f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Modica, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittala, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siracusa, M. A.</span></span> <span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>3</sub> and 5-HT<sub>4</sub> ligands: An update of medicinal chemistry research in the past few years</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.2174/092986710790192730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.2174%2F092986710790192730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=20015043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=334-362&author=M.+N.+Modicaauthor=V.+Pittalaauthor=G.+Romeoauthor=L.+Salernoauthor=M.+A.+Siracusa&title=Serotonin+5-HT3+and+5-HT4+ligands%3A+An+update+of+medicinal+chemistry+research+in+the+past+few+years&doi=10.2174%2F092986710790192730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years</span></div><div class="casAuthors">Modica, M. N.; Pittala, V.; Romeo, G.; Salerno, L.; Siracusa, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">334-362</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The biogenic amine serotonin (5-hydroxytryptamine, 5-HT) is one of the most studied neurotransmitters in the central nervous system.  It acts through the activation of at least fourteen 5-HT receptor subtypes.  Over the last two decades, high attention was devoted to the 5-HT3 and 5-HT4 receptors due to their colocalization in the gastrointestinal tract and because their ligands are useful in the treatment of intestinal serotonergic system dysfunctions.  The focus of this review is to discuss the literature concerning recent advances on 5-HT3R and 5-HT4R ligands and their structure-activity relationships from a medicinal chem. perspective.  During the last few years, new and significant progresses have been made in the field of novel potent and selective ligands, mixed ligands, agonists, partial agonists, and antagonists, and a no. of patents have been filed.  Furthermore several ligands targeting the 5-HT3R and 5-HT4R have been proposed for novel therapeutic indications such as the treatment of various psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdNfYoWkWpJbVg90H21EOLACvtfcHk0lgWdE9SszKzGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSlsr0%253D&md5=7031f777b035675f1c562ec72c054f85</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986710790192730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710790192730%26sid%3Dliteratum%253Aachs%26aulast%3DModica%26aufirst%3DM.%2BN.%26aulast%3DPittala%26aufirst%3DV.%26aulast%3DRomeo%26aufirst%3DG.%26aulast%3DSalerno%26aufirst%3DL.%26aulast%3DSiracusa%26aufirst%3DM.%2BA.%26atitle%3DSerotonin%25205-HT3%2520and%25205-HT4%2520ligands%253A%2520An%2520update%2520of%2520medicinal%2520chemistry%2520research%2520in%2520the%2520past%2520few%2520years%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D334%26epage%3D362%26doi%3D10.2174%2F092986710790192730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castriconi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennuni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rienzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menziani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbraccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappelli, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship studies in serotonin 5-HT<sub>4</sub> receptor ligands based on a benzo[<i>de</i>][2,6]naphthridine scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.ejmech.2014.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=24871995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=36-46&author=F.+Castriconiauthor=M.+Paolinoauthor=G.+Giulianiauthor=M.+Anziniauthor=G.+Campianiauthor=L.+Mennuniauthor=C.+Sabatiniauthor=M.+Lanzaauthor=G.+Caselliauthor=F.+De+Rienzoauthor=M.+C.+Menzianiauthor=M.+Sbracciaauthor=P.+Molinariauthor=T.+Costaauthor=A.+Cappelli&title=Synthesis+and+structure-activity+relationship+studies+in+serotonin+5-HT4+receptor+ligands+based+on+a+benzo%5Bde%5D%5B2%2C6%5Dnaphthridine+scaffold&doi=10.1016%2Fj.ejmech.2014.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthyridine scaffold</span></div><div class="casAuthors">Castriconi, Federica; Paolino, Marco; Giuliani, Germano; Anzini, Maurizio; Campiani, Giuseppe; Mennuni, Laura; Sabatini, Chiara; Lanza, Marco; Caselli, Gianfranco; De Rienzo, Francesca; Menziani, Maria Cristina; Sbraccia, Maria; Molinari, Paola; Costa, Tommaso; Cappelli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-46</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A small series of serotonin 5-HT4 receptor ligands has been designed from flexible 2-methoxyquinoline compds. by applying the conformational constraint approach.  2-Methoxyquinoline compds., e.g., I, and the corresponding conformationally constrained analogs, e.g., II, were synthesized and their interactions with the 5-HT4 receptor were examd. by measuring both binding affinity and the ability to promote or inhibit receptor-G protein coupling.  Ester deriv. I and conformationally constrained compd. II were demonstrated to be the most interesting compds. showing a nanomolar 5-HT4R affinity similar to that shown by ref. ligands cisapride (III) and RS-23,597-190 (IV).  The result was rationalized by docking studies in term of high similarity in the binding modalities of flexible I and conformationally constrained II.  The intrinsic efficacy of some selected ligands was detd. by evaluating the receptor-G protein coupling and the results obtained demonstrated that the nature and the position of substituents play a crit. role in the interaction of these ligands with their receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkr3OLUrCRSLVg90H21EOLACvtfcHk0lgWdE9SszKzGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqurfF&md5=f638b3b57a0130f99d4bd9095e53ce9e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DCastriconi%26aufirst%3DF.%26aulast%3DPaolino%26aufirst%3DM.%26aulast%3DGiuliani%26aufirst%3DG.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DSabatini%26aufirst%3DC.%26aulast%3DLanza%26aufirst%3DM.%26aulast%3DCaselli%26aufirst%3DG.%26aulast%3DDe%2BRienzo%26aufirst%3DF.%26aulast%3DMenziani%26aufirst%3DM.%2BC.%26aulast%3DSbraccia%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DCappelli%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520studies%2520in%2520serotonin%25205-HT4%2520receptor%2520ligands%2520based%2520on%2520a%2520benzo%255Bde%255D%255B2%252C6%255Dnaphthridine%2520scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D36%26epage%3D46%26doi%3D10.1016%2Fj.ejmech.2014.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">EPIX Pharmaceuticals</span>. Lead product
candidate-PRX-03140. <a href="http://library.corporate-ir.net/library/91/917/91717/items/297502/EPIX-FactSheet-Alz-071708a.pdf" class="extLink">http://library.corporate-ir.net/library/91/917/91717/items/297502/EPIX-FactSheet-Alz-071708a.pdf</a> (accessed April 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EPIX+Pharmaceuticals.+Lead+product%0Acandidate-PRX-03140.+http%3A%2F%2Flibrary.corporate-ir.net%2Flibrary%2F91%2F917%2F91717%2Fitems%2F297502%2FEPIX-FactSheet-Alz-071708a.pdf+%28accessed+April+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span> </span><span class="NLM_article-title">EPIX Pharmaceuticals Reports Compelling Clinical Results for PRX-03140
in Alzheimer’s Disease; Statistically Significant Improvement
in Cognitive Function Achieved Within Two Weeks</span>.  <i>Business Wire</i>, Dec 18, 2007. Available at <a href="https://www.businesswire.com/news/home/20071218005206/en/EPIX-Pharmaceuticals-Reports-Compelling-Clinical-Results-PRX-03140" class="extLink">https://www.businesswire.com/news/home/20071218005206/en/EPIX-Pharmaceuticals-Reports-Compelling-Clinical-Results-PRX-03140</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EPIX+Pharmaceuticals+Reports+Compelling+Clinical+Results+for+PRX-03140%0Ain+Alzheimer%E2%80%99s+Disease%3B+Statistically+Significant+Improvement%0Ain+Cognitive+Function+Achieved+Within+Two+Weeks.+Business+Wire%2C+Dec+18%2C+2007.+Available+at+https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20071218005206%2Fen%2FEPIX-Pharmaceuticals-Reports-Compelling-Clinical-Results-PRX-03140."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DEPIX%2520Pharmaceuticals%2520Reports%2520Compelling%2520Clinical%2520Results%2520for%2520PRX-03140%250Ain%2520Alzheimer%25E2%2580%2599s%2520Disease%253B%2520Statistically%2520Significant%2520Improvement%250Ain%2520Cognitive%2520Function%2520Achieved%2520Within%2520Two%2520Weeks%26jtitle%3DBusiness%2520Wire" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti-Gauthier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumireu-Mourat, B.</span></span> <span> </span><span class="NLM_article-title">BIMU1 increases associative memory in rats by activating 5-HT<sub>4</sub> receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(97)00058-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2FS0028-3908%2897%2900058-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=9225296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK2sXktlSrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=697-706&author=E.+Marchetti-Gauthierauthor=F.+S.+Romanauthor=A.+Dumuisauthor=J.+Bockaertauthor=B.+Soumireu-Mourat&title=BIMU1+increases+associative+memory+in+rats+by+activating+5-HT4+receptors&doi=10.1016%2FS0028-3908%2897%2900058-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">BIMU1 increases associative memory in rats by activating 5-HT4 receptors</span></div><div class="casAuthors">Marchetti-Gauthier, E.; Roman, F. S.; Dumuis, A.; Bockaert, J.; Soumireu-Mourat, B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4/5</span>),
    <span class="NLM_cas:pages">697-706</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Olfactory assocn. learning was used to investigate the involvement of 5-HT4 receptors in learning and long-term memory.  The behavioral role of the 5-HT4 receptors was studied by using BIMU1 (3-ethyl-2,3-dihydro-N-[endo-8-methyl-8-azabicyclo(3.2.1)oct-3-yl]-2-oxo-1H-benzimidazole-1-carboxamide, hydrochloride (Boehringer Ingelheim, Italy)); a mixed 5-HT4 agonist/5-HT3 antagonist, and GR125487 (1-[2-[(Me sulfonyl)-amino]ethyl]-4-piperidinyl-Me 5-fluoro-2-methoxy-1H-indole-3-carboxylate; Glaxo Group Research, Hertfordshire, U.K.), a specific 5-HT4 antagonist.  The i.p. injections of BIMU1 at 1, 5, and 10 mg/kg were followed by an substantial improvement (>15% in percentage of correct responses at the dose of 10 mg/kg) in associative memory.  Difficulty rapidly reversing behavioral responses to previously learned assocn., 1 mo later indicated that the BIMU1 effect at 10 mg/kg was not transient, but correlated to long-term memory.  The effects of BIMU1 are most likely to be mediated by 5-HT4 receptors since they were blocked by GR125487 at 10 mg/kg.  These data suggest that activation of 5-HT4 receptors may modulate cognitive processes like learning and memory.  Also, 5-HT4 receptor agonists could be useful for treating mnesic deficits as displayed in patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzX-RtVuCgcbVg90H21EOLACvtfcHk0ljt4ZowknC4GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlSrtLc%253D&md5=c117d4166934db82f0295bc336555a12</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2897%2900058-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252897%252900058-0%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti-Gauthier%26aufirst%3DE.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DSoumireu-Mourat%26aufirst%3DB.%26atitle%3DBIMU1%2520increases%2520associative%2520memory%2520in%2520rats%2520by%2520activating%25205-HT4%2520receptors%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D697%26epage%3D706%26doi%3D10.1016%2FS0028-3908%2897%2900058-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannoni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaven, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bundel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti-Gauthier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valjent, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span> <span> </span><span class="NLM_article-title">Early administration of RS 67333, a specific 5-HT<sub>4</sub> receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">96</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2013.00096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.3389%2Ffnagi.2013.00096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=24399967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslamsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=96&author=P.+Giannoniauthor=F.+Gavenauthor=D.+de+Bundelauthor=K.+Barangerauthor=E.+Marchetti-Gauthierauthor=F.+S.+Romanauthor=E.+Valjentauthor=P.+Marinauthor=J.+Bockaertauthor=S.+Riveraauthor=S.+Claeysen&title=Early+administration+of+RS+67333%2C+a+specific+5-HT4+receptor+agonist%2C+prevents+amyloidogenesis+and+behavioral+deficits+in+the+5XFAD+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffnagi.2013.00096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Early administration of RS67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease</span></div><div class="casAuthors">Giannoni, Patrizia; Gaven, Florence; Bundel, Dimitride; Baranger, Kevin; Marchetti-Gauthier, Evelyne; Roman, Francois S.; Valjent, Emmanuel; Marin, Philippe; Bockaert, Joeel; Rivera, Santiago; Claeysen, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">96/1-96/12</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Amyloid β (Aβ) accumulation is considered the main culprit in the pathogenesis of Alzheimer's disease (AD).  Recent studies suggest that decreasing Aβ prodn. at very early stages of AD could be a promising strategy to slow down disease progression.  Serotonin 5-HT4 receptor activation stimulates α-cleavage of the amyloid precursor protein (APP), leading to the release of the sol. and neurotrophic sAPPα fragment and thus precluding Aβ formation.  Using the 5XFAD mouse model of AD that shows accelerated Aβ deposition, we investigated the effect of chronic treatments (treatment onset at different ages and different durations) with the 5-HT4 receptor agonist RS 67333 during the asymptomatic phase of the disease.  Chronic administration of RS 67333 decreased concomitantly the no. of amyloid plaques and the level of Aβ species.  Redn. of Aβ levels was accompanied by a striking decrease in hippocampal astrogliosis and microgliosis.  RS 67333 also transiently increased sAPPα concn. in the cerebrospinal fiuid and brain.  Moreover, a specific 5-HT4 receptor antagonist (RS 39604) prevented the RS 67333-mediated redn. of the amyloid pathol.  Finally, the novel object recognition test deficits of 5XFAD mice were reversed by chronic treatment with RS 67333.  Collectively, these results strongly highlight this 5-HT4 receptor agonist as a promising disease modifying-agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIgv-fla4yPLVg90H21EOLACvtfcHk0ljt4ZowknC4GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslamsbzJ&md5=3370afc60266e72919e21e8df93f17b4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2013.00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2013.00096%26sid%3Dliteratum%253Aachs%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3Dde%2BBundel%26aufirst%3DD.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DMarchetti-Gauthier%26aufirst%3DE.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DValjent%26aufirst%3DE.%26aulast%3DMarin%26aufirst%3DP.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DClaeysen%26aufirst%3DS.%26atitle%3DEarly%2520administration%2520of%2520RS%252067333%252C%2520a%2520specific%25205-HT4%2520receptor%2520agonist%252C%2520prevents%2520amyloidogenesis%2520and%2520behavioral%2520deficits%2520in%2520the%25205XFAD%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2013%26volume%3D5%26spage%3D96%26doi%3D10.3389%2Ffnagi.2013.00096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambhampati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraf, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badange, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyala, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojja, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reballi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasti, V.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (SUVN-502): A novel, potent, selective and orally active serotonin 6 (5-HT<sub>6</sub>) receptor antagonist for potential treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1843-1859&author=R.+Nirogiauthor=A.+Shindeauthor=R.+S.+Kambhampatiauthor=A.+R.+Mohammedauthor=S.+K.+Sarafauthor=R.+K.+Badangeauthor=T.+R.+Bandyalaauthor=V.+Bhattaauthor=K.+Bojjaauthor=V.+Reballiauthor=R.+Subramanianauthor=V.+Benadeauthor=R.+C.+Palacharlaauthor=G.+Bhyrapuneniauthor=P.+Jayarajanauthor=V.+Goyalauthor=V.+Jasti&title=Discovery+and+development+of+1-%5B%282-bromophenyl%29sulfonyl%5D-5-methoxy-3-%5B%284-methyl-1-piperazinyl%29methyl%5D-1H-indole+dimesylate+monohydrate+%28SUVN-502%29%3A+A+novel%2C+potent%2C+selective+and+orally+active+serotonin+6+%285-HT6%29+receptor+antagonist+for+potential+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Nirogi, Ramakrishna; Shinde, Anil; Kambhampati, Rama Sastry; Mohammed, Abdul Rasheed; Saraf, Sangram Keshari; Badange, Rajesh kumar; Bandyala, Thrinath Reddy; Bhatta, Venugopalarao; Bojja, Kumar; Reballi, Veena; Subramanian, Ramkumar; Benade, Vijay; Palacharla, Raghava Choudary; Bhyrapuneni, Gopinadh; Jayarajan, Pradeep; Goyal, Vinod; Jasti, Venkat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1843-1859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a novel series of 3-(piperazinylmethyl) indole derivs. as 5-hydroxytryptamine-6 receptor (5-HT6R) antagonists resulted in identification of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (5al, SUVN-502) as a clin. candidate for potential treatment of cognitive disorders.  It has high affinity at human 5-HT6R (Ki = 2.04 nM) and selectivity over 100 target sites which include receptors, enzymes, peptides, growth factors, ion channels, steroids, immunol. factors, second messengers, and prostaglandins.  It has high selectivity over 5-HT2A receptor.  It is orally bioavailable and brain penetrant with robust preclin. efficacy.  The combination of 5al, donepezil, and memantine (triple combination) produces synergistic effects in extracellular levels of acetylcholine in the ventral hippocampus.  Preclin. efficacy in triple combination and high selectivity over 5-HT2A receptors are the differentiating features which culminated in selection of 5al for further development.  The Phase-1 evaluation of safety and pharmacokinetics has been completed, allowing for the initiation of a Phase-2 proof of concept study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_gw476vRgPbVg90H21EOLACvtfcHk0liImBGWzoIffw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D&md5=26e4f0c1c34255ce2c2ef3bbf3c06a85</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01662%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DKambhampati%26aufirst%3DR.%2BS.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DSaraf%26aufirst%3DS.%2BK.%26aulast%3DBadange%26aufirst%3DR.%2BK.%26aulast%3DBandyala%26aufirst%3DT.%2BR.%26aulast%3DBhatta%26aufirst%3DV.%26aulast%3DBojja%26aufirst%3DK.%26aulast%3DReballi%26aufirst%3DV.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DJasti%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520development%2520of%25201-%255B%25282-bromophenyl%2529sulfonyl%255D-5-methoxy-3-%255B%25284-methyl-1-piperazinyl%2529methyl%255D-1H-indole%2520dimesylate%2520monohydrate%2520%2528SUVN-502%2529%253A%2520A%2520novel%252C%2520potent%252C%2520selective%2520and%2520orally%2520active%2520serotonin%25206%2520%25285-HT6%2529%2520receptor%2520antagonist%2520for%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1843%26epage%3D1859%26doi%3D10.1021%2Facs.jmedchem.6b01662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogaraju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagginapalli, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravella, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddana, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of imidazo[1,5-<i>a</i>]pyridine derivatives as 5-HT<sub>4</sub> receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.ejmech.2015.08.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=26363507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=289-301&author=R.+Nirogiauthor=A.+R.+Mohammedauthor=A.+Shindeauthor=N.+Bogarajuauthor=S.+R.+Gagginapalliauthor=S.+R.+Ravellaauthor=L.+Kotaauthor=G.+Bhyrapuneniauthor=N.+R.+Muddanaauthor=V.+Benadeauthor=R.+C.+Palacharlaauthor=P.+Jayarajanauthor=R.+Subramanianauthor=V.+Goyal&title=Synthesis+and+SAR+of+imidazo%5B1%2C5-a%5Dpyridine+derivatives+as+5-HT4+receptor+partial+agonists+for+the+treatment+of+cognitive+disorders+associated+with+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2015.08.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease</span></div><div class="casAuthors">Nirogi, Ramakrishna; Mohammed, Abdul Rasheed; Shinde, Anil K.; Bogaraju, Narsimha; Gagginapalli, Shankar Reddy; Ravella, Srinivasa Rao; Kota, Laxman; Bhyrapuneni, Gopinadh; Muddana, Nageswara Rao; Benade, Vijay; Palacharla, Raghava Chowdary; Jayarajan, Pradeep; Subramanian, Ramkumar; Goyal, Vinod Kumar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">289-301</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disease which has a higher prevalence and incidence in older people.  The need for improved AD therapies is unmet.  The 5-hydroxytryptamine4 receptor (5-HT4R) partial agonists may be of benefit for both the symptomatic and disease-modifying treatment of cognitive disorders assocd. with AD.  Herein, we report the design, synthesis and SAR of imidazo[1,5-a] pyridine derivs. as 5-HT4R partial agonists.  The focused SAR, optimization of ADME properties resulted the discovery of compd. I as potent, selective, brain penetrant 5-HT4 partial agonist as a lead compd. with good ADME properties and efficacy in both symptomatic and disease modifying animal models of cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy8ulfS2opHrVg90H21EOLACvtfcHk0liImBGWzoIffw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzO&md5=5d43819ce00762e923aee113fb2721f4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.051%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DBogaraju%26aufirst%3DN.%26aulast%3DGagginapalli%26aufirst%3DS.%2BR.%26aulast%3DRavella%26aufirst%3DS.%2BR.%26aulast%3DKota%26aufirst%3DL.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DMuddana%26aufirst%3DN.%2BR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DGoyal%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520imidazo%255B1%252C5-a%255Dpyridine%2520derivatives%2520as%25205-HT4%2520receptor%2520partial%2520agonists%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%2520associated%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D289%26epage%3D301%26doi%3D10.1016%2Fj.ejmech.2015.08.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiriveedhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraf, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badange, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R.</span></span> <span> </span><span class="NLM_article-title">Benzamide derivatives and their constrained analogs as histamine H<sub>3</sub> receptor antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.ejmech.2015.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=26731168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFaj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=655-662&author=R.+Nirogiauthor=A.+Shindeauthor=V.+Tiriveedhiauthor=L.+Kotaauthor=S.+K.+Sarafauthor=R.+K.+Badangeauthor=A.+R.+Mohammedauthor=R.+Subramanianauthor=N.+Muddanaauthor=G.+Bhyrapuneniauthor=R.+Abraham&title=Benzamide+derivatives+and+their+constrained+analogs+as+histamine+H3+receptor+antagonists&doi=10.1016%2Fj.ejmech.2015.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists</span></div><div class="casAuthors">Nirogi, Ramakrishna; Shinde, Anil; Tiriveedhi, Vinaykumar; Kota, Laxman; Saraf, Sangram Keshari; Badange, Rajesh Kumar; Mohammed, Abdul Rasheed; Subramanian, Ramkumar; Muddana, Nageshwararao; Bhyrapuneni, Gopinadh; Abraham, Renny</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">655-662</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of substituted [(4-piperidinyl)oxy]benzamides and substituted [(4-piperidinyl)oxy]-3,4-dihydro-2H-isoquinolin-1-one derivs. have been synthesized and tested for their binding affinity towards H3 receptor.  Most of these synthesized compds. have displayed potent binding affinity for H3 receptor when tested in in vitro binding assay.  Preliminary SAR studies, functional activity, pharmacokinetic profile and efficacy profile constitute the subject matter of this communication.  The synthesis of the target compds. was achieved using 4-[(4-piperidinyl)oxy]benzoic acid derivs. as intermediates.  Corresponding amide analogs included 1-isoquinolinone derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGI2izDp8FLVg90H21EOLACvtfcHk0liEbOLmoKRtOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFaj&md5=9d5fe398cfdaab5d6568cebb6aad27fc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DTiriveedhi%26aufirst%3DV.%26aulast%3DKota%26aufirst%3DL.%26aulast%3DSaraf%26aufirst%3DS.%2BK.%26aulast%3DBadange%26aufirst%3DR.%2BK.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DMuddana%26aufirst%3DN.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DAbraham%26aufirst%3DR.%26atitle%3DBenzamide%2520derivatives%2520and%2520their%2520constrained%2520analogs%2520as%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D108%26spage%3D655%26epage%3D662%26doi%3D10.1016%2Fj.ejmech.2015.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suven Life Sciences
Limited</span>.  <i>A study to investigate the
safety, tolerability
and pharmacokinetics of SUVN-D4010 in healthy subjects</i>; NCT02575482; <span class="NLM_publisher-name">ClinicalTrials.gov</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, Oct 14, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Suven+Life+Sciences%0ALimited&title=A+study+to+investigate+the%0Asafety%2C+tolerability%0Aand+pharmacokinetics+of+SUVN-D4010+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DA%2520study%2520to%2520investigate%2520the%250Asafety%252C%2520tolerability%250Aand%2520pharmacokinetics%2520of%2520SUVN-D4010%2520in%2520healthy%2520subjects%26pub%3DClinicalTrials.gov%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21.2"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suven Life Sciences
Limited</span>.  <i>A Study to Investigate the
Effect of Food, Gender, and Age on the Pharmacokinetic Profile of
SUVN-D4010 in Healthy Subjects</i>; NCT03031574; <span class="NLM_publisher-name">ClinicalTrials.gov</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, Jan 25, <span class="NLM_year">2017</span>. Available at <a href="https://clinicaltrials.gov/ct2/results?cond=&amp;term=suvn-D4010&amp;cntry=&amp;state=&amp;city=&amp;dist=" class="extLink">https://clinicaltrials.gov/ct2/results?cond=&term=suvn-D4010&cntry=&state=&city=&dist=</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Suven+Life+Sciences%0ALimited&title=A+Study+to+Investigate+the%0AEffect+of+Food%2C+Gender%2C+and+Age+on+the+Pharmacokinetic+Profile+of%0ASUVN-D4010+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21.2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DA%2520Study%2520to%2520Investigate%2520the%250AEffect%2520of%2520Food%252C%2520Gender%252C%2520and%2520Age%2520on%2520the%2520Pharmacokinetic%2520Profile%2520of%250ASUVN-D4010%2520in%2520Healthy%2520Subjects%26pub%3DClinicalTrials.gov%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soulier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicsic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathé-Allainmat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brémont, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croci, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardamone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aureggi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, M.</span></span> <span> </span><span class="NLM_article-title">New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT<sub>4</sub> receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1021/jm960320m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960320m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVSktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=608-621&author=D.+Yangauthor=J.+L.+Soulierauthor=S.+Sicsicauthor=M.+Math%C3%A9-Allainmatauthor=B.+Br%C3%A9montauthor=T.+Crociauthor=R.+Cardamoneauthor=G.+Aureggiauthor=M.+Langlois&title=New+esters+of+4-amino-5-chloro-2-methoxybenzoic+acid+as+potent+agonists+and+antagonists+for+5-HT4+receptors&doi=10.1021%2Fjm960320m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">New Esters of 4-Amino-5-chloro-2-methoxybenzoic Acid as Potent Agonists and Antagonists for 5-HT4 Receptors</span></div><div class="casAuthors">Yang, Donglai; Soulier, Jean-Louis; Sicsic, Sames; Mathe-Allainmat, Monique; Bremont, Beatrice; Croci, Tiziano; Cardamone, Rosanna; Aureggi, Giulio; Langlois, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">608-621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A no. of benzoates derived from 4-amino-5-chloro-2-methoxybenzoic acid and substituted 1-piperidineethanol were prepd. and found to be potent 5-HT4 receptor agonists in the elec.-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum and the rat esophagus muscle.  Monosubstitution of the piperidine ring with Me, OH, NH-Ac, or CONH2 groups gave compds. equipotent to 2-piperidinoethyl-4-amino-2-methoxybenzoate-HCl (I) (ML 10302), a 5-HT4 receptor agonist previously reported to have nanomolar affinity.  I and 2-(3-(S)-hydroxypiperidino)ethyl-4-amino-2-methoxybenzoate-HCl (II) were as potent as serotonin (5-HT) but had maximal responses which were only 60-80% of that of 5-HT, suggesting a partial agonist profile for these compds.  Binding assays were performed with [3H]GR 113808 in the rat striatum, and several of these compds. were found to have nanomolar affinity for 5-HT4 receptors (I, Ki = 1.07; II, Ki = 1.0 nM).  The introduction of 2 Me groups on the piperidine ring brought about a dramatic change in the pharmacol. profile of 2-[(cis- and trans-3,5-dimethylpiperidinyl)ethyl]-4-amino-5-chloro-2-methoxybenzoate (III-cis isomer).  III (Ki = 0.26 nM) inhibited the relaxant action of 5-HT in the rat esophagus muscle with a pA2 value of 8.6.  The advantage of the ester function was demonstrated by comparing the activity of several such compds. at 5-HT4 receptors with those of the corresponding amide derivs.  This difference was less marked when the basic moiety was sterically constrained as in the quinuclidine and tropane moieties.  Structural analyses of I and III were performed by detg. their X-ray crystal structures and by mol. modeling (SYBYL).  A relatively limited no. of min. energy conformers was found for both compds.  They were characterized by the cis folded conformation of the Et chain and by the orientation of the lone pair of the nitrogen atom pointing out of the mol. as seen in conformationally-constrained benzamides such as zacopride and renzapride.  A hypothetical model for the 5-HT4 receptor with 2 sites for the binding of agonist and antagonist mols. was proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-i-Mdpx5yirVg90H21EOLACvtfcHk0lh41cK_wTmXRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVSktb4%253D&md5=9a560dbfd938b39801cea1109316f80c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm960320m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960320m%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DSoulier%26aufirst%3DJ.%2BL.%26aulast%3DSicsic%26aufirst%3DS.%26aulast%3DMath%25C3%25A9-Allainmat%26aufirst%3DM.%26aulast%3DBr%25C3%25A9mont%26aufirst%3DB.%26aulast%3DCroci%26aufirst%3DT.%26aulast%3DCardamone%26aufirst%3DR.%26aulast%3DAureggi%26aufirst%3DG.%26aulast%3DLanglois%26aufirst%3DM.%26atitle%3DNew%2520esters%2520of%25204-amino-5-chloro-2-methoxybenzoic%2520acid%2520as%2520potent%2520agonists%2520and%2520antagonists%2520for%25205-HT4%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D608%26epage%3D621%26doi%3D10.1021%2Fjm960320m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKinnell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatheree, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquess, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, R. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of TD-8954, a clinical stage 5-HT<sub>4</sub> receptor agonist with gastrointestinal prokinetic properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4210</span>– <span class="NLM_lpage">4215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.bmcl.2013.05.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4210-4215&author=R.+M.+McKinnellauthor=S.+R.+Armstrongauthor=D.+T.+Beattieauthor=P.+R.+Fathereeauthor=D.+D.+Longauthor=D.+G.+Marquessauthor=J.+P.+Shawauthor=R.+G.+Vickery&title=Discovery+of+TD-8954%2C+a+clinical+stage+5-HT4+receptor+agonist+with+gastrointestinal+prokinetic+properties&doi=10.1016%2Fj.bmcl.2013.05.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinnell%26aufirst%3DR.%2BM.%26aulast%3DArmstrong%26aufirst%3DS.%2BR.%26aulast%3DBeattie%26aufirst%3DD.%2BT.%26aulast%3DFatheree%26aufirst%3DP.%2BR.%26aulast%3DLong%26aufirst%3DD.%2BD.%26aulast%3DMarquess%26aufirst%3DD.%2BG.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DVickery%26aufirst%3DR.%2BG.%26atitle%3DDiscovery%2520of%2520TD-8954%252C%2520a%2520clinical%2520stage%25205-HT4%2520receptor%2520agonist%2520with%2520gastrointestinal%2520prokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4210%26epage%3D4215%26doi%3D10.1016%2Fj.bmcl.2013.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Staudinger reactions within density functional theory</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">4299</span>– <span class="NLM_lpage">4308</span>, <span class="refDoi"> DOI: 10.1021/jo049702n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo049702n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVKhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=4299-4308&author=W.+Q.+Tianauthor=Y.+A.+Wang&title=Mechanisms+of+Staudinger+reactions+within+density+functional+theory&doi=10.1021%2Fjo049702n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Staudinger Reactions within Density Functional Theory</span></div><div class="casAuthors">Tian, Wei Quan; Wang, Yan Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4299-4308</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Staudinger reaction of trialkyl- and triphenylphosphines with azides R1N3, affording phosphinimines, was investigated by using d. functional theory.  Geometry optimization of addn. products R3PN:N:NR1 revealed strong preference of cis-adducts as a consequence of addnl. P-Nγ bonding.  The one-step reaction through γ-adduct R3PNR1(:N:N) was ruled out on the basis of high energy barrier γ-TS.  Cis-Adduct is then isomerized to dihydro-1,2,3-triazaphosphete intermediate, which liberates N2 and product phosphinimine.  For R1 = F or Ph, the cyclic intermediate was not localized, and elimination of N2 proceeds directly from the cis-adduct.  The preference of the initial cis-transition state reaction pathway is thoroughly discussed.  The relative stability of the cis- and the trans-intermediates is explored and analyzed with the aid of MOs.  The effects of substituents and solvent effects on the reaction mechanisms of the Staudinger reactions are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUWOnoWXlQ3rVg90H21EOLACvtfcHk0ljYhHe3v_LVag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVKhs7o%253D&md5=e364b77fa012773bff4a4b0a8c2a858b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo049702n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049702n%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DW.%2BQ.%26aulast%3DWang%26aufirst%3DY.%2BA.%26atitle%3DMechanisms%2520of%2520Staudinger%2520reactions%2520within%2520density%2520functional%2520theory%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D4299%26epage%3D4308%26doi%3D10.1021%2Fjo049702n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0ljYhHe3v_LVag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bostrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span></span> <span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1830</span>, <span class="refDoi"> DOI: 10.1021/jm2013248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostromauthor=A.+Hognerauthor=A.+Llinasauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemistry&doi=10.1021%2Fjm2013248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazoles in medicinal chemistry</span></div><div class="casAuthors">Bostrom Jonas; Hogner Anders; Llinas Antonio; Wellner Eric; Plowright Alleyn T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms.  Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities.  The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection.  In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner.  Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers.  The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments).  To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO9RQiG9xFS2Zyxfu64m4ffW6udTcc2eZy72AG_yBZWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D&md5=b934995431ced1be297e6f126262f3cb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostrom%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830%26doi%3D10.1021%2Fjm2013248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bermudez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fake, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joiner, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joiner, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miner, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanger, G. J.</span></span> <span> </span><span class="NLM_article-title">5-Hydroxytryptamine (5-HT<sub>3</sub>) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1924</span>, <span class="refDoi"> DOI: 10.1021/jm00169a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00169a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK3cXksVSmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1924&author=J.+Bermudezauthor=C.+S.+Fakeauthor=G.+F.+Joinerauthor=K.+A.+Joinerauthor=F.+D.+Kingauthor=W.+D.+Minerauthor=G.+J.+Sanger&title=5-Hydroxytryptamine+%285-HT3%29+receptor+antagonists.+1.+Indazole+and+indolizine-3-carboxylic+acid+derivatives&doi=10.1021%2Fjm00169a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine (5-HT3) receptor antagonists.  1.  Indazole and indolizine-3-carboxylic acid derivatives</span></div><div class="casAuthors">Bermudez, Jose; Fake, Charles S.; Joiner, Graham F.; Joiner, Karen A.; King, Frank D.; Miner, Wesley D.; Sanger, Gareth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1924-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Indazolecarboxamides I (X = NH; R = H, Me, Et; R1 = H, F, Cl; n = 2,3), I (X = O, R = H, Me, R1 = H, n = 2), indolizinecarboxamides II (X = N, X1 = C, Z = CH, R2 = H, Me, Et, Ph, n = 2) and the imidazopyridines II (X = C, X1 = Z = N, R2 = Et, n = 2, 3) were prepd. as potent 5-HT3 receptor antagonists devoid of dopamine antagonist and gastric motility stimulatory properties.  Other analogs, e.g., III, with conformationally restricted side chain were also prepd.  Of all the compds. prepd. and tested, I (R = Me, R1 = H, X = NH, n =3) was both potent and selective and was a very effective antiemetic agent against cytotoxic drug-induced emesis both in the ferret and in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs3Xk31qhN4LVg90H21EOLACvtfcHk0lix3tECjQ8o3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksVSmt7s%253D&md5=382cee99c0f2e579545167f500726cd5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00169a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00169a016%26sid%3Dliteratum%253Aachs%26aulast%3DBermudez%26aufirst%3DJ.%26aulast%3DFake%26aufirst%3DC.%2BS.%26aulast%3DJoiner%26aufirst%3DG.%2BF.%26aulast%3DJoiner%26aufirst%3DK.%2BA.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DMiner%26aufirst%3DW.%2BD.%26aulast%3DSanger%26aufirst%3DG.%2BJ.%26atitle%3D5-Hydroxytryptamine%2520%25285-HT3%2529%2520receptor%2520antagonists.%25201.%2520Indazole%2520and%2520indolizine-3-carboxylic%2520acid%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1924%26doi%3D10.1021%2Fjm00169a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Metabolism of a serotonin-4 receptor partial agonist 4-{4-[4-tetrahydrofuran-3-yloxy)-benzo[d]Isoxazol-3-yloxymethyl]-piperidin-1-ylmethyl}-tetrahydropyran-4-ol (TBPT): Identification of an unusual pharmacologically active cyclized oxazolidine metabolite in human</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">3277</span>– <span class="NLM_lpage">3293</span>, <span class="refDoi"> DOI: 10.1002/jps.23542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1002%2Fjps.23542" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=3277-3293&author=A.+Sawant-Basakauthor=K.+J.+Coffmanauthor=G.+S.+Walkerauthor=T.+F.+Ryderauthor=E.+Tsengauthor=E.+Millerauthor=C.+Leeauthor=M.+A.+Vanase-Frawleyauthor=J.+W.+Wongauthor=M.+A.+Brodneyauthor=T.+Rappauthor=R.+S.+Obach&title=Metabolism+of+a+serotonin-4+receptor+partial+agonist+4-%7B4-%5B4-tetrahydrofuran-3-yloxy%29-benzo%5Bd%5DIsoxazol-3-yloxymethyl%5D-piperidin-1-ylmethyl%7D-tetrahydropyran-4-ol+%28TBPT%29%3A+Identification+of+an+unusual+pharmacologically+active+cyclized+oxazolidine+metabolite+in+human&doi=10.1002%2Fjps.23542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjps.23542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23542%26sid%3Dliteratum%253Aachs%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DWong%26aufirst%3DJ.%2BW.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DRapp%26aufirst%3DT.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMetabolism%2520of%2520a%2520serotonin-4%2520receptor%2520partial%2520agonist%25204-%257B4-%255B4-tetrahydrofuran-3-yloxy%2529-benzo%255Bd%255DIsoxazol-3-yloxymethyl%255D-piperidin-1-ylmethyl%257D-tetrahydropyran-4-ol%2520%2528TBPT%2529%253A%2520Identification%2520of%2520an%2520unusual%2520pharmacologically%2520active%2520cyclized%2520oxazolidine%2520metabolite%2520in%2520human%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D3277%26epage%3D3293%26doi%3D10.1002%2Fjps.23542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biala, G.</span></span> <span> </span><span class="NLM_article-title">The novel object recognition memory: neurobiology, test procedure, and its modifications</span>. <i>Cogn. Process</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1007/s10339-011-0430-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1007%2Fs10339-011-0430-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=22160349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A280%3ADC%252BC38zoslWlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=93-110&author=M.+Antunesauthor=G.+Biala&title=The+novel+object+recognition+memory%3A+neurobiology%2C+test+procedure%2C+and+its+modifications&doi=10.1007%2Fs10339-011-0430-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The novel object recognition memory: neurobiology, test procedure, and its modifications</span></div><div class="casAuthors">Antunes M; Biala G</div><div class="citationInfo"><span class="NLM_cas:title">Cognitive processing</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal models of memory have been considered as the subject of many scientific publications at least since the beginning of the twentieth century.  In humans, memory is often accessed through spoken or written language, while in animals, cognitive functions must be accessed through different kind of behaviors in many specific, experimental models of memory and learning.  Among them, the novel object recognition test can be evaluated by the differences in the exploration time of novel and familiar objects.  Its application is not limited to a field of research and enables that various issues can be studied, such as the memory and learning, the preference for novelty, the influence of different brain regions in the process of recognition, and even the study of different drugs and their effects.  This paper describes the novel object recognition paradigms in animals, as a valuable measure of cognition.  The purpose of this work was to review the neurobiology and methodological modifications of the test commonly used in behavioral pharmacology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQocv30hVI3YVf1XRtfYM0dfW6udTcc2eaZBk81er7m6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zoslWlsQ%253D%253D&md5=4f73ed1bafb04056c5aef19b1b86c802</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10339-011-0430-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10339-011-0430-z%26sid%3Dliteratum%253Aachs%26aulast%3DAntunes%26aufirst%3DM.%26aulast%3DBiala%26aufirst%3DG.%26atitle%3DThe%2520novel%2520object%2520recognition%2520memory%253A%2520neurobiology%252C%2520test%2520procedure%252C%2520and%2520its%2520modifications%26jtitle%3DCogn.%2520Process%26date%3D2012%26volume%3D13%26spage%3D93%26epage%3D110%26doi%3D10.1007%2Fs10339-011-0430-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medapati, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmuganathan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandikere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irappanavar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddana, N.</span></span> <span> </span><span class="NLM_article-title">Difference in the norepinephrine levels of experimental and non-experimental rats with age in the object recognition task</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1453</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2012.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.brainres.2012.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=22464882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFeltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1453&publication_year=2012&pages=40-45&author=R.+Nirogiauthor=R.+Abrahamauthor=P.+Jayarajanauthor=R.+B.+Medapatiauthor=D.+Shanmuganathanauthor=V.+Kandikereauthor=S.+Irappanavarauthor=R.+Saralayaauthor=V.+Benadeauthor=G.+Bhyrapuneniauthor=N.+Muddana&title=Difference+in+the+norepinephrine+levels+of+experimental+and+non-experimental+rats+with+age+in+the+object+recognition+task&doi=10.1016%2Fj.brainres.2012.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Difference in the norepinephrine levels of experimental and non-experimental rats with age in the object recognition task</span></div><div class="casAuthors">Nirogi, Ramakrishna; Abraham, Renny; Jayarajan, Pradeep; Medapati, Rajesh Babu; Shanmuganathan, Dhanalakshmi; Kandikere, Vishwottam; Irappanavar, Shantaveer; Saralaya, Ramanatha; Benade, Vijay; Bhyrapuneni, Gopinadh; Muddana, Nageswararao</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1453</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40-45</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present study, we investigated the performance of adult and juvenile rats in the Object Recognition Task (ORT).  While it is well known that the performance of rat in ORT differs with age, the reason for the difference as well as the underlying neurotransmitter that may have led to these differences were investigated.  In the present study, juvenile rats of postnatal day 40-45 (PND 40-45) and adult rats of postnatal day 60+ (PND 60+) were subjected to a two trial ORT.  The juvenile rats did not discriminate between the novel object and the familiar object, while the adult rats discriminated the novel from the familiar object.  On estg. brain concns. of norepinephrine (NE), it was obsd. that the NE level in MTL (medial temporal lobe) of adult exptl. rats was significantly higher than the adult non-exptl. rats.  In juvenile rats, no significant difference was obsd. in the NE levels of exptl. rats in comparison to its non-exptl. counterparts.  Administration of yohimbine (α2A adrenergic receptor antagonist) enhanced the level of NE in juvenile rats and reversed the difference seen with age.  From the present study, we conclude that the deficit in memory seen is likely due to the difference in NE levels with task and this can be reversed by yohimbine which enhance NE levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzGeFKjEr4j7Vg90H21EOLACvtfcHk0ljarJvZeXZL8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFeltb0%253D&md5=8c0fea2283e6a5f57fd74ae28b94aee8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2012.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2012.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DMedapati%26aufirst%3DR.%2BB.%26aulast%3DShanmuganathan%26aufirst%3DD.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DIrappanavar%26aufirst%3DS.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DMuddana%26aufirst%3DN.%26atitle%3DDifference%2520in%2520the%2520norepinephrine%2520levels%2520of%2520experimental%2520and%2520non-experimental%2520rats%2520with%2520age%2520in%2520the%2520object%2520recognition%2520task%26jtitle%3DBrain%2520Res.%26date%3D2012%26volume%3D1453%26spage%3D40%26epage%3D45%26doi%3D10.1016%2Fj.brainres.2012.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Child, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantaloni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondouin, G.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors improve social olfactory memory in the rat</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(96)00169-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2FS0028-3908%2896%2900169-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=681-687&author=S.+Lettyauthor=R.+Childauthor=A.+Dumuisauthor=A.+Pantaloniauthor=J.+Bockaertauthor=G.+Rondouin&title=5-HT4+receptors+improve+social+olfactory+memory+in+the+rat&doi=10.1016%2FS0028-3908%2896%2900169-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2896%2900169-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252896%252900169-4%26sid%3Dliteratum%253Aachs%26aulast%3DLetty%26aufirst%3DS.%26aulast%3DChild%26aufirst%3DR.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DPantaloni%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DRondouin%26aufirst%3DG.%26atitle%3D5-HT4%2520receptors%2520improve%2520social%2520olfactory%2520memory%2520in%2520the%2520rat%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D681%26epage%3D687%26doi%3D10.1016%2FS0028-3908%2896%2900169-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti-Gauthier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumireu-Mourat, B.</span></span> <span> </span><span class="NLM_article-title">BIMU1 increases associative memory in rats by activating 5-HT<sub>4</sub> receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(97)00058-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2FS0028-3908%2897%2900058-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=9225296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK2sXktlSrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=697-706&author=E.+Marchetti-Gauthierauthor=F.+S.+Romanauthor=A.+Dumuisauthor=J.+Bockaertauthor=B.+Soumireu-Mourat&title=BIMU1+increases+associative+memory+in+rats+by+activating+5-HT4+receptors&doi=10.1016%2FS0028-3908%2897%2900058-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">BIMU1 increases associative memory in rats by activating 5-HT4 receptors</span></div><div class="casAuthors">Marchetti-Gauthier, E.; Roman, F. S.; Dumuis, A.; Bockaert, J.; Soumireu-Mourat, B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4/5</span>),
    <span class="NLM_cas:pages">697-706</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Olfactory assocn. learning was used to investigate the involvement of 5-HT4 receptors in learning and long-term memory.  The behavioral role of the 5-HT4 receptors was studied by using BIMU1 (3-ethyl-2,3-dihydro-N-[endo-8-methyl-8-azabicyclo(3.2.1)oct-3-yl]-2-oxo-1H-benzimidazole-1-carboxamide, hydrochloride (Boehringer Ingelheim, Italy)); a mixed 5-HT4 agonist/5-HT3 antagonist, and GR125487 (1-[2-[(Me sulfonyl)-amino]ethyl]-4-piperidinyl-Me 5-fluoro-2-methoxy-1H-indole-3-carboxylate; Glaxo Group Research, Hertfordshire, U.K.), a specific 5-HT4 antagonist.  The i.p. injections of BIMU1 at 1, 5, and 10 mg/kg were followed by an substantial improvement (>15% in percentage of correct responses at the dose of 10 mg/kg) in associative memory.  Difficulty rapidly reversing behavioral responses to previously learned assocn., 1 mo later indicated that the BIMU1 effect at 10 mg/kg was not transient, but correlated to long-term memory.  The effects of BIMU1 are most likely to be mediated by 5-HT4 receptors since they were blocked by GR125487 at 10 mg/kg.  These data suggest that activation of 5-HT4 receptors may modulate cognitive processes like learning and memory.  Also, 5-HT4 receptor agonists could be useful for treating mnesic deficits as displayed in patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzX-RtVuCgcbVg90H21EOLACvtfcHk0lj-zx7X8t2ZWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlSrtLc%253D&md5=c117d4166934db82f0295bc336555a12</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2897%2900058-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252897%252900058-0%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti-Gauthier%26aufirst%3DE.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DSoumireu-Mourat%26aufirst%3DB.%26atitle%3DBIMU1%2520increases%2520associative%2520memory%2520in%2520rats%2520by%2520activating%25205-HT4%2520receptors%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D697%26epage%3D706%26doi%3D10.1016%2FS0028-3908%2897%2900058-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandikere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajjala, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleti, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span> <span> </span><span class="NLM_article-title"><i>In vivo</i> rat striatal 5-HT<sub>4</sub> receptor occupancy using non-radiolabelled SB207145</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1111/jphp.12030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1111%2Fjphp.12030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=23600388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1Wks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=704-712&author=R.+Nirogiauthor=V.+Kandikereauthor=G.+Bhyrapuneniauthor=R.+Saralayaauthor=D.+R.+Ajjalaauthor=R.+R.+Aletiauthor=A.+R.+Mohammed&title=In+vivo+rat+striatal+5-HT4+receptor+occupancy+using+non-radiolabelled+SB207145&doi=10.1111%2Fjphp.12030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In-vivo rat striatal 5-HT4 receptor occupancy using non-radiolabelled SB207145</span></div><div class="casAuthors">Nirogi, Ramakrishna; Kandikere, Vishwottam; Bhyrapuneni, Gopinadh; Saralaya, Ramanatha; Ajjala, Devender Reddy; Aleti, Raghupathi Reddy; Abdul Rasheed, Mohammed</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">704-712</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The objective of the current investigation was to develop a simple, rapid method for detg. in-vivo 5-hydroxytryptamine type 4 receptor (5-HT4R) occupancy in rat brain using non-radiolabeled SB207145 as a tracer for accelerating the drug discovery process.  In-vivo tracer optimization studies for tracer dose, survival intervals and brain distribution profile were carried out in rats.  The tracer was pharmacol. validated using potent well-characterized 5-HT4R ligands.  The brain regional concns. of tracer (SB207145); plasma and brain concns. of 5-HT4R ligands were quantified using high-performance liq. chromatog. coupled with a tandem mass spectrometric detector (LC-MS/MS).  SB207145 showed a higher specific binding in striatum (1.96 ng/g) and lower binding in cerebellum (0.66 ng/g), which is consistent with findings of other published 5-HT4R expression studies.  Pretreatment with potent 5-HT4 ligands dose-dependently reduced striatal SB207145 concn. and the ED to achieve 50% receptor occupancy (ED50) values were 4.8, 2.0, 7.4, 9.9, 3.8 and 0.02 mg/kg for GR113808, piboserod, prucalopride, RS67333, TD8954 and PF04995274, resp.  Results from the mass spectrometry approach to det. 5-HT4R occupancy in rat brain are comparable with those reported using radiolabeled scintillation spectroscopy methods.  In conclusion, the LC-MS/MS characterization permits use of tracer at a preclin. stage in high-throughput fashion as well as characterization of target expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBAD2h_4wjYrVg90H21EOLACvtfcHk0lj-zx7X8t2ZWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1Wks7w%253D&md5=fdd50664c69a42cbdf1501a11582e591</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12030%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DAjjala%26aufirst%3DD.%2BR.%26aulast%3DAleti%26aufirst%3DR.%2BR.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26atitle%3DIn%2520vivo%2520rat%2520striatal%25205-HT4%2520receptor%2520occupancy%2520using%2520non-radiolabelled%2520SB207145%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26spage%3D704%26epage%3D712%26doi%3D10.1111%2Fjphp.12030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span>; <span class="NLM_string-name">Drummond, E.</span>; <span class="NLM_string-name">Zasadny, K.</span>; <span class="NLM_string-name">Skaddan, M.</span>; <span class="NLM_string-name">Brodney, M.</span>; <span class="NLM_string-name">Coffman, K.</span>; <span class="NLM_string-name">Nicholas, T.</span>; <span class="NLM_string-name">Duvvuri, S.</span>; <span class="NLM_string-name">Raunig, D. L.</span>; <span class="NLM_string-name">Leurent, C.</span>; <span class="NLM_string-name">Rowinski, C.</span>; <span class="NLM_string-name">Park, Y.-S.</span>; <span class="NLM_string-name">Ogden, A.</span>; <span class="NLM_string-name">Sawant-Basak, A.</span>; <span class="NLM_string-name">Miller, E. L.</span>; <span class="NLM_string-name">Rapp, T.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Planeta-Wilson, B.</span>; <span class="NLM_string-name">Ropchan, J.</span>; <span class="NLM_string-name">Carson, R.</span>; <span class="NLM_string-name">Morris, E.</span>; <span class="NLM_string-name">Ding, Y.-S.</span>; <span class="NLM_string-name">Katz, E.</span></span> <span> </span><span class="NLM_article-title">Translational receptor occupancy for the 5-HT<sub>4</sub> partial agonist PF-04995274 in rats, non-human primates and healthy volunteers</span>. Presented at the International Conference on Alzheimer’s Disease, Paris, France, July 16–21, <span class="NLM_year">2011</span>; Poster No. 11818.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Grimwood&author=E.+Drummond&author=K.+Zasadny&author=M.+Skaddan&author=M.+Brodney&author=K.+Coffman&author=T.+Nicholas&author=S.+Duvvuri&author=D.+L.+Raunig&author=C.+Leurent&author=C.+Rowinski&author=Y.-S.+Park&author=A.+Ogden&author=A.+Sawant-Basak&author=E.+L.+Miller&author=T.+Rapp&author=Y.+Wang&author=B.+Planeta-Wilson&author=J.+Ropchan&author=R.+Carson&author=E.+Morris&author=Y.-S.+Ding&author=E.+Katz&title=Translational+receptor+occupancy+for+the+5-HT4+partial+agonist+PF-04995274+in+rats%2C+non-human+primates+and+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DTranslational%2520receptor%2520occupancy%2520for%2520the%25205-HT4%2520partial%2520agonist%2520PF-04995274%2520in%2520rats%252C%2520non-human%2520primates%2520and%2520healthy%2520volunteers%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubitski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutzman-Engwall, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horner, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorczyca, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siok, C. J.</span></span> <span> </span><span class="NLM_article-title">The 5-hydroxytryptamine4 receptor agonists, prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.192351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1124%2Fjpet.112.192351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=22408061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlWltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=681-691&author=D.+E.+Johnsonauthor=E.+Drummondauthor=S.+Grimwoodauthor=A.+Sawant-Basakauthor=E.+Millerauthor=E.+Tsengauthor=L.+L.+McDowellauthor=M.+A.+Vanase-Frawleyauthor=K.+E.+Fisherauthor=D.+M.+Rubitskiauthor=K.+J.+Stutzman-Engwallauthor=R.+T.+Nelsonauthor=W.+E.+Hornerauthor=R.+R.+Gorczycaauthor=M.+Hajosauthor=C.+J.+Siok&title=The+5-hydroxytryptamine4+receptor+agonists%2C+prucalopride+and+PRX-03140+increase+acetylcholine+and+histamine+levels+in+the+rat+prefrontal+cortex+and+the+power+of+stimulated+hippocampal+%CE%B8+oscillations&doi=10.1124%2Fjpet.112.192351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations</span></div><div class="casAuthors">Johnson, David E.; Drummond, Elena; Grimwood, Sarah; Sawant-Basak, Aarti; Miller, Emily; Tseng, Elaine; McDowell, Laura L.; Vanase-Frawley, Michelle A.; Fisher, Katherine E.; Rubitski, David M.; Stutzman-Engwall, Kim J.; Nelson, Robin T.; Horner, Weldon E.; Gorczyca, Roxanne R.; Hajos, Mihaly; Siok, Chester J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">681-691</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)4 receptor agonists reportedly stimulate brain acetylcholine (ACh) release, a property that might provide a new pharmacol. approach for treating cognitive deficits assocd. with Alzheimer's disease.  The purpose of this study was to compare the binding affinities, functional activities, and effects on neuropharmacol. responses assocd. with cognition of two highly selective 5-HT4 receptor agonists, prucalopride and 6,7-dihydro-4-hydroxy-7-isopropyl-6-oxo-N-[3-(piperidin-1-yl)propyl]thieno[2,3-b]pyridine-5-carboxamide (PRX-03140).  In vitro, prucalopride and PRX-03140 bound to native rat brain 5-HT4 receptors with Ki values of 30 nM and 110 nM, resp., and increased cAMP prodn. in human embryonic kidney-293 cells expressing recombinant rat 5-HT4 receptors.  In vivo receptor occupancy studies established that prucalopride and PRX-03140 were able to penetrate the brain and bound to 5-HT4 receptors in rat brain, achieving 50% receptor occupancy at free brain exposures of 330 nM and 130 nM, resp.  Rat microdialysis studies revealed that prucalopride maximally increased ACh and histamine levels in the prefrontal cortex at 5 and 10 mg/kg, whereas PRX-03140 significantly increased cortical histamine levels at 50 mg/kg, failing to affect ACh release at doses lower than 150 mg/kg.  In combination studies, donepezil-induced increases in cortical ACh levels were potentiated by prucalopride and PRX-03140.  Electrophysiol. studies in rats demonstrated that both compds. increased the power of brainstem-stimulated hippocampal θ oscillations at 5.6 mg/kg.  These findings show for the first time that the 5-HT4 receptor agonists prucalopride and PRX-03140 can increase cortical ACh and histamine levels, augment donepezil-induced ACh increases, and increase stimulated-hippocampal θ power, all neuropharmacol. parameters consistent with potential pos. effects on cognitive processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYkki5FaX4E7Vg90H21EOLACvtfcHk0lgtl_l1vCGAzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlWltL4%253D&md5=a85101ee05a17788379fad99a454347b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.192351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.192351%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DDrummond%26aufirst%3DE.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DMcDowell%26aufirst%3DL.%2BL.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DRubitski%26aufirst%3DD.%2BM.%26aulast%3DStutzman-Engwall%26aufirst%3DK.%2BJ.%26aulast%3DNelson%26aufirst%3DR.%2BT.%26aulast%3DHorner%26aufirst%3DW.%2BE.%26aulast%3DGorczyca%26aufirst%3DR.%2BR.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DSiok%26aufirst%3DC.%2BJ.%26atitle%3DThe%25205-hydroxytryptamine4%2520receptor%2520agonists%252C%2520prucalopride%2520and%2520PRX-03140%2520increase%2520acetylcholine%2520and%2520histamine%2520levels%2520in%2520the%2520rat%2520prefrontal%2520cortex%2520and%2520the%2520power%2520of%2520stimulated%2520hippocampal%2520%25CE%25B8%2520oscillations%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D681%26epage%3D691%26doi%3D10.1124%2Fjpet.112.192351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span> <span> </span><span class="NLM_article-title">Distinct functional effects of human 5-HT<sub>4</sub> receptor isoforms on beta-amyloid secretion</span>. <i>Neurodegener. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1159/000113691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1159%2F000113691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=18322379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Wht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=163-165&author=S.+J.+Robertauthor=F.+Lezoualc%E2%80%99h&title=Distinct+functional+effects+of+human+5-HT4+receptor+isoforms+on+beta-amyloid+secretion&doi=10.1159%2F000113691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Functional Effects of Human 5-HT4 Receptor Isoforms on β-Amyloid Secretion</span></div><div class="casAuthors">Robert, Sylvain J.; Lezoualc'h, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">163-165</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: The serotonin 5-HT4 receptor is of potential interest for the treatment of Alzheimer's disease because it increases memory and learning and influences amyloid precursor protein (APP) processing.  Several 5-HT4 receptor isoforms have been cloned in humans.  They all belong to the G-protein-coupled receptor superfamily and differ in compn. and length of their amino acid intracellular C-terminal sequence.  At present, it is still unknown whether 5-HT4 receptor isoforms may have distinct effects on APP processing.  Objective: In this study, we investigated the effect of an ultrashort isoform of the human 5-HT4 receptor (2 amino acids after the splicing site), the 5-HT4(d) receptor isoform (h5-HT4(d)), on APP processing in Chinese hamster ovary cells (CHO cells).  Methods: Non-amyloidogenic sol. sAPPα was detd. by immunoblot and β-amyloid peptides (Aβ1-40 and Aβ1-42) were assayed by ELISA in CHO cells stably expressing h5-HT4(d) and transiently transfected with human APP695.  Results: We show here that activation of h5-HT4(d) strongly stimulates the release of sAPPα and concomitantly decreases extracellular Aβ peptides.  These data contrast with our previous findings showing that the h5-HT4(e/g) receptor isoform, which has 20 amino acids after the splicing site, did not influence Aβ secretion.  Conclusion: We conclude that C-terminal tails of 5-HT4 receptor isoforms may influence their functional effect on Aβ secretion and that the pathways regulating either β- or γ-secretase may be differentially controlled by 5-HT4 receptor isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFF1W64EZATLVg90H21EOLACvtfcHk0ljTFXpeqpsGEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Wht7s%253D&md5=c90b7775cd8805e5160a66689b8939ff</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1159%2F000113691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000113691%26sid%3Dliteratum%253Aachs%26aulast%3DRobert%26aufirst%3DS.%2BJ.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26atitle%3DDistinct%2520functional%2520effects%2520of%2520human%25205-HT4%2520receptor%2520isoforms%2520on%2520beta-amyloid%2520secretion%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2008%26volume%3D5%26spage%3D163%26epage%3D165%26doi%3D10.1159%2F000113691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cachard-Chastel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewachter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De- lomenie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devijver, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuven, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicsic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardier, A. M.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1038%2Fsj.bjp.0707178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=17325649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=883-892&author=M.+Cachard-Chastelauthor=F.+Lezoualc%E2%80%99hauthor=I.+Dewachterauthor=C.+De-+lomenieauthor=S.+Croesauthor=S.+Devijverauthor=M.+Langloisauthor=F.+V.+Leuvenauthor=S.+Sicsicauthor=A.+M.+Gardier&title=5-HT4+receptor+agonists+increase+sAPP%CE%B1+levels+in+the+cortex+and+hippocampus+of+male+C57BL%2F6j+mice&doi=10.1038%2Fsj.bjp.0707178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice</span></div><div class="casAuthors">Cachard-Chastel, M.; Lezoualc'h, F.; Dewachter, I.; Delomenie, C.; Croes, S.; Devijver, H.; Langlois, M.; Van Leuven, F.; Sicsic, S.; Gardier, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-892</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A strategy to treat Alzheimer's disease (AD) is to increase the sol. form of amyloid precursor protein (sAPPα), a promnesic protein, in the brain.  Because strong evidence supports beneficial effects of 5-hydroxytryptamine 5-HT4 receptor agonists in memory and learning, we investigated the role of 5-HT4 receptors on APP processing in 8 wk-old male C57BL/6j mice.  Mice were given, s.c., prucalopride or ML 10302 (s.c.), two highly selective 5-HT4 receptor agonists and, up to 240 min later, the hippocampus and cortex were analyzed by Western blot for sAPPα detn.  Prucalopride (5 or 10 mg kg-1) significantly increased sAPPα levels in the hippocampus and cortex, but did not modify the expression level of APP mRNA as detected by quant. RT-PCR.  A selective 5-HT4 receptor antagonist, GR125487 (1 mg kg-1, s.c.) inhibited prucalopride induced- increase in sAPPα levels.  In addn., levels of sAPPα were increased by ML10302 only at 20 mg kg-1 and was limited to the cortex.  Also, prucalopride increased sAPPα levels in the cortex of a transgenic mouse model of AD, expressing the London mutation of APP.  Furthermore, the combined injection of a selective acetylcholinesterase inhibitor, donepezil and prucalopride induced a synergic increase in sAPPα levels in the cortex and hippocampus.  The results demonstrate that the 5-HT4 receptor plays a key role in the non-amyloidogenic pathway of APP metab. in vivo and give support to the beneficial use of 5-HT4 agonists for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgDGVLDs3CMLVg90H21EOLACvtfcHk0ljTFXpeqpsGEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12ntbo%253D&md5=37636a905d062d15019a151f983ecebc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707178%26sid%3Dliteratum%253Aachs%26aulast%3DCachard-Chastel%26aufirst%3DM.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DDe-%2Blomenie%26aufirst%3DC.%26aulast%3DCroes%26aufirst%3DS.%26aulast%3DDevijver%26aufirst%3DS.%26aulast%3DLanglois%26aufirst%3DM.%26aulast%3DLeuven%26aufirst%3DF.%2BV.%26aulast%3DSicsic%26aufirst%3DS.%26aulast%3DGardier%26aufirst%3DA.%2BM.%26atitle%3D5-HT4%2520receptor%2520agonists%2520increase%2520sAPP%25CE%25B1%2520levels%2520in%2520the%2520cortex%2520and%2520hippocampus%2520of%2520male%2520C57BL%252F6j%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D883%26epage%3D892%26doi%3D10.1038%2Fsj.bjp.0707178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of 5-HT<sub>4</sub> receptors inhibits secretion of β-amyloid peptides and increases neuronal survival</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2006.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.expneurol.2006.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=16978609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Krt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2007&pages=274-278&author=S.+S.+Choauthor=Y.+Hu&title=Activation+of+5-HT4+receptors+inhibits+secretion+of+%CE%B2-amyloid+peptides+and+increases+neuronal+survival&doi=10.1016%2Fj.expneurol.2006.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival</span></div><div class="casAuthors">Cho, Seongeun; Hu, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">274-278</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activation of 5-HT4 receptors has been shown to improve memory processes in preclin. cognition models, suggesting potential utility of 5-HT4 agonists for the symptomatic treatment of Alzheimer's disease (AD).  Recent studies have shown that 5-HT4 agonists also increase the secretion of the non-amyloidogenic sol. amyloid precursor protein-alpha (sAPPα).  In the present study, we demonstrated that a selective 5-HT4 partial agonist, RS67333, inhibited the generation of β-amyloid peptide (Aβ) in primary cortical cultures of Tg2576 transgenic mice expressing human APPK670N/M671L.  Furthermore, treatments with RS67333 selectively increased the survival of transgenic neurons in a dose-dependent manner, which was inhibited by 5-HT4 antagonists.  These and previous data collectively suggest that the 5-HT4 receptor may be an effective therapeutic target for AD, providing both symptomatic improvements and neuroprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94iComWBAYLVg90H21EOLACvtfcHk0ljTFXpeqpsGEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Krt73K&md5=0b90d41ab8f752fb01c09cee2df2a429</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2006.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2006.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BS.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DActivation%2520of%25205-HT4%2520receptors%2520inhibits%2520secretion%2520of%2520%25CE%25B2-amyloid%2520peptides%2520and%2520increases%2520neuronal%2520survival%26jtitle%3DExp.%2520Neurol.%26date%3D2007%26volume%3D203%26spage%3D274%26epage%3D278%26doi%3D10.1016%2Fj.expneurol.2006.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, N. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacological evidence for a functional serotonin-2b receptor in a human uterine smooth muscle cell line</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">1254</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.100172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1124%2Fjpet.105.100172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=16517693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1eqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=1254-1261&author=C.+R.+Kellyauthor=N.+A.+Sharif&title=Pharmacological+evidence+for+a+functional+serotonin-2b+receptor+in+a+human+uterine+smooth+muscle+cell+line&doi=10.1124%2Fjpet.105.100172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line</span></div><div class="casAuthors">Kelly, Curtis R.; Sharif, Najam A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1254-1261</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study investigated the serotonin-induced increase in phosphoinositide hydrolysis and mobilization of intracellular Ca2+ ([Ca2+]i) in human uterine smooth muscle cells (HUSMCs) to identify the serotonergic receptor pos. coupled to phospholipase C in these cells.  In phosphoinositide (PI) assays, serotonin (5-HT) and α-methyl-5-HT were potent, full agonists (EC50 = 20 and 4.1 nM, resp.), whereas the phenylethylamine, R-(-)-1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane hydrochloride, was less active (EC50 = 63 nM).  Proposed 5-HT2B-selective agonists, BW-723C86 and (+)-norfenfluramine, exhibited strong agonist potency and efficacy comparable with 5-HT (EC50 = 18 and 33 nM, resp.) and ∼15-fold more potency than (-)-norfenfluramine (EC50 = 500 nM).  5-HT2C receptor agonists m-chlorophenylpiperazine and MK-212 were weak agonists in these cells, with potencies of 110 and 880 nM, resp.  A similar rank order of potency was obsd. in [Ca2+]i mobilization assays (r = 0.9) in the HUSMC and with contraction of rat stomach fundus strips that contain a 5-HT2B receptor (r = 0.9).  Antagonist studies revealed that a 5-HT2B-selective antagonist, RS-127445 (Ki = 0.13 nM), was significantly more effective at inhibiting 5-HT-induced activity than a 5-HT2A antagonist, M-100907 (Ki = 914 nM) and the 5-HT2C antagonists RS-102221 (Ki = 2.5 μM) and SB-242084 (Ki = 42.4 nM) in the HUSMC PI turnover assays.  Taken together, these studies strongly suggest the presence of a functionally active 5-HT2B receptor subtype in HUSMCs.  The physiol. role of this receptor in these cells remains to be defined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWnAOFD_xYkrVg90H21EOLACvtfcHk0liZn1v7n5lPfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1eqtbY%253D&md5=52ea7805fe17184bad2816d80f4fe74a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.100172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.100172%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DC.%2BR.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26atitle%3DPharmacological%2520evidence%2520for%2520a%2520functional%2520serotonin-2b%2520receptor%2520in%2520a%2520human%2520uterine%2520smooth%2520muscle%2520cell%2520line%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D1254%26epage%3D1261%26doi%3D10.1124%2Fjpet.105.100172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="patent1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'patent1'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="patent1_1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span>; <span class="NLM_string-name">Mohammed, A. R.</span>; <span class="NLM_string-name">Yarlgadda, S.</span>; <span class="NLM_string-name">Ravella, S. R.</span>; <span class="NLM_string-name">Shinde, A. K.</span>; <span class="NLM_string-name">Kambhampati, R.</span>; <span class="NLM_string-name">Roayalley, P. K.</span>; <span class="NLM_string-name">Jayarajan, P.</span>; <span class="NLM_string-name">Bhyrapuneni, G.</span>; <span class="NLM_string-name">Patnala, S. M.</span>; <span class="NLM_string-name">Ravula, J.</span>; <span class="NLM_string-name">Jasti, V.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl compounds as 5-HT<sub>4</sub> receptor ligands</span>. Patent <span class="NLM_patent">WO2013042135</span>, March 28, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+Nirogi&author=A.+R.+Mohammed&author=S.+Yarlgadda&author=S.+R.+Ravella&author=A.+K.+Shinde&author=R.+Kambhampati&author=P.+K.+Roayalley&author=P.+Jayarajan&author=G.+Bhyrapuneni&author=S.+M.+Patnala&author=J.+Ravula&author=V.+Jasti&title=Heteroaryl+compounds+as+5-HT4+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=patent1_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26atitle%3DHeteroaryl%2520compounds%2520as%25205-HT4%2520receptor%2520ligands%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="add"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'add'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="add_1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paxinos, G.</span>; <span class="NLM_string-name">Watson, C.</span></span> <i>In the rat brain in stereotaxic coordinates</i>, <span class="NLM_edition">5</span>th ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+Paxinos&author=C.+Watson&title=In+the+rat+brain+in+stereotaxic+coordinates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=add_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPaxinos%26aufirst%3DG.%26btitle%3DIn%2520the%2520rat%2520brain%2520in%2520stereotaxic%2520coordinates%26pub%3DAcademic%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, E.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noiman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastineau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutkowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marantz, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragozzino, M. E.</span></span> <span> </span><span class="NLM_article-title">VRX-03011, a novel 5-HT<sub>4</sub> agonist, enhances memory and hippocampal acetylcholine efflux</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2007.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.neuropharm.2007.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=17692343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFaiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2007&pages=563-573&author=E.%0AG.+Mohlerauthor=S.+Shachamauthor=S.+Noimanauthor=F.+Lezoualc%E2%80%99hauthor=S.+Robertauthor=M.+Gastineauauthor=J.+Rutkowskiauthor=Y.+Marantzauthor=A.+Dumuisauthor=J.+Bockaertauthor=P.+E.+Goldauthor=M.+E.+Ragozzino&title=VRX-03011%2C+a+novel+5-HT4+agonist%2C+enhances+memory+and+hippocampal+acetylcholine+efflux&doi=10.1016%2Fj.neuropharm.2007.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux</span></div><div class="casAuthors">Mohler, Eric G.; Shacham, Sharon; Noiman, Silvia; Lezoualc'h, Frank; Robert, Sylvain; Gastineau, Monique; Rutkowski, Joseph; Marantz, Yael; Dumuis, Aline; Bockaert, Joel; Gold, Paul E.; Ragozzino, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">563-573</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent evidence suggests that 5-hydroxytryptamine (5-HT)4 receptor activity enhances cognition and provides neuroprotection.  Here we report the effects of VRX-03011, a novel partial 5-HT4 agonist, that is both potent (Ki ∼ 30 nM) and highly selective (Ki > 5 μM for all other 5-HT receptors tested).  In sep. expts., rats received VRX-03011 (0.1-10 mg/kg i.p.) 30 min prior to spontaneous alternation testing in a no-delay or a 30-s delay condition.  VRX-03011 (1, 5 and 10 mg/kg, but not 0.1 mg/kg) significantly enhanced delayed spontaneous alternation performance while none of the doses enhanced performance in the no-delay test.  VRX-03011 (1 and 5 mg/kg) concomitantly enhanced hippocampal acetylcholine output and delayed spontaneous alternation scores compared to that of vehicle controls, but had no effect on hippocampal acetylcholine release under a resting condition.  Moreover, suboptimal doses of VRX-03011 and the acetylcholinesterase inhibitor galanthamine combined to enhance memory.  VRX-03011 also regulated amyloid precursor protein (APP) metab. by inducing a concn.-dependent increase in the non-amyloidogenic sol. form of APP (sAPPα) with an EC50 ∼ 1-10 nM.  VRX-03011 had no effect on contractile properties in guinea pig ileum or colon prepns. with an EC50 > 10 μM and did not alter rat intestinal transit at doses up to 10 mg/kg.  These findings suggest that VRX-03011 may represent a novel treatment for Alzheimer's disease that reduces cognitive impairments and provides neuroprotection without gastrointestinal side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgO9nBGMjNbLVg90H21EOLACvtfcHk0liZn1v7n5lPfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFaiu7k%253D&md5=1dd6440e1f54b5577d69f9725e6c2569</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2007.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2007.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DE.%2BG.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DNoiman%26aufirst%3DS.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DGastineau%26aufirst%3DM.%26aulast%3DRutkowski%26aufirst%3DJ.%26aulast%3DMarantz%26aufirst%3DY.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DGold%26aufirst%3DP.%2BE.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3DVRX-03011%252C%2520a%2520novel%25205-HT4%2520agonist%252C%2520enhances%2520memory%2520and%2520hippocampal%2520acetylcholine%2520efflux%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D53%26spage%3D563%26epage%3D573%26doi%3D10.1016%2Fj.neuropharm.2007.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanz, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himes, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallante, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amore, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, K. M.</span></span> <span> </span><span class="NLM_article-title">The γ-Secretase inhibitor <i>N-</i>[<i>N-</i>(3,5-difluorophenacetyl)-l-alanyl]-<i>S</i>-phenylglycine <i>t</i>-butyl ester reduces Aβ levels <i>in vivo</i> in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.048280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1124%2Fjpet.102.048280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=12626636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Sns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=864-871&author=T.+A.+Lanzauthor=C.+S.+Himesauthor=G.+Pallanteauthor=L.+Adamsauthor=S.+Yamazakiauthor=B.+Amoreauthor=K.+M.+Merchant&title=The+%CE%B3-Secretase+inhibitor+N-%5BN-%283%2C5-difluorophenacetyl%29-l-alanyl%5D-S-phenylglycine+t-butyl+ester+reduces+A%CE%B2+levels+in+vivo+in+plasma+and+cerebrospinal+fluid+in+young+%28plaque-free%29+and+aged+%28plaque-bearing%29+Tg2576+mice&doi=10.1124%2Fjpet.102.048280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces Aβ levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice</span></div><div class="casAuthors">Lanz, Thomas A.; Himes, Carol S.; Pallante, Giovanni; Adams, Lisa; Yamazaki, Shinji; Amore, Ben; Merchant, Kalpana M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">864-871</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Acute, s.c. administration of a γ-secretase inhibitor, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-Bu ester (DAPT), to young PDAPP mice dose dependently decreases cortical amyloid-β (Aβ).  The present studies replicated these findings in Tg2576 mice and examd. further whether DAPT would reduce cerebrospinal fluid (CSF) Aβ comparably in young (plaque-free) and aged (plaque-bearing) mice.  In the first study, vehicle or DAPT (10, 30, or 100 mg/kg s.c.) administered to young Tg2576 mice (6 mo old) dose dependently reduced Aβ peptide levels in the cortex as seen previously in the PDAPP mice.  Addnl., a dose-dependent decrease in plasma Aβ levels was evident.  The same dosing regime was applied next to aged mice (17 mo old) to assess Aβ changes in the CSF in addn. to plasma and brains.  DAPT dose dependently reduced Aβ levels in the CSF and plasma, but not in the brain wherein Aβ levels were 400 to 500 times higher than those in young mice, consistent with a large pool of Aβ extd. from amyloid deposits.  In subsequent studies, effects of oral DAPT (100 or 200 mg/kg) were examd. concurrently in young and aged mice.  DAPT reduced Aβ levels in CSF and plasma to a similar extent at both ages.  In contrast, DAPT reduced brain Aβ levels primarily in young mice, with minimal effects in aged mice.  These results demonstrate that Aβ levels in CSF and plasma decrease dose dependently after γ-secretase inhibition, and this response is not affected by amyloid plaque burden.  We conclude that CSF and plasma Aβ may offer a clin. applicable, mechanism-based biomarker for inhibitors of Aβ prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhYEy0KnoA5rVg90H21EOLACvtfcHk0liZn1v7n5lPfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Sns7c%253D&md5=a9a678c814a1b42bbdc43219f2397ac7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.048280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.048280%26sid%3Dliteratum%253Aachs%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DHimes%26aufirst%3DC.%2BS.%26aulast%3DPallante%26aufirst%3DG.%26aulast%3DAdams%26aufirst%3DL.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAmore%26aufirst%3DB.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26atitle%3DThe%2520%25CE%25B3-Secretase%2520inhibitor%2520N-%255BN-%25283%252C5-difluorophenacetyl%2529-l-alanyl%255D-S-phenylglycine%2520t-butyl%2520ester%2520reduces%2520A%25CE%25B2%2520levels%2520in%2520vivo%2520in%2520plasma%2520and%2520cerebrospinal%2520fluid%2520in%2520young%2520%2528plaque-free%2529%2520and%2520aged%2520%2528plaque-bearing%2529%2520Tg2576%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D864%26epage%3D871%26doi%3D10.1124%2Fjpet.102.048280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mouedden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandermeeren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span> <span> </span><span class="NLM_article-title">Reduction of Aβ levels in the Sprague Dawley rat after oral administration of the functional γ-secretase inhibitor, DAPT: A novel non-transgenic model for Aβ production inhibitors</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.2174/138161206775474233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.2174%2F138161206775474233" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=671-676&author=M.+Moueddenauthor=M.+Vandermeerenauthor=T.+Meertauthor=M.+Mercken&title=Reduction+of+A%CE%B2+levels+in+the+Sprague+Dawley+rat+after+oral+administration+of+the+functional+%CE%B3-secretase+inhibitor%2C+DAPT%3A+A+novel+non-transgenic+model+for+A%CE%B2+production+inhibitors&doi=10.2174%2F138161206775474233"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2174%2F138161206775474233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474233%26sid%3Dliteratum%253Aachs%26aulast%3DMouedden%26aufirst%3DM.%26aulast%3DVandermeeren%26aufirst%3DM.%26aulast%3DMeert%26aufirst%3DT.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DReduction%2520of%2520A%25CE%25B2%2520levels%2520in%2520the%2520Sprague%2520Dawley%2520rat%2520after%2520oral%2520administration%2520of%2520the%2520functional%2520%25CE%25B3-secretase%2520inhibitor%252C%2520DAPT%253A%2520A%2520novel%2520non-transgenic%2520model%2520for%2520A%25CE%25B2%2520production%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D671%26epage%3D676%26doi%3D10.2174%2F138161206775474233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jay, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morentin-Gutierrez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span> <span> </span><span class="NLM_article-title"><i>In Vivo</i> Characterization of Aβ(40) changes in brain and cerebrospinal fluid using the novel γ-secretase inhibitor <i>N</i>-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) in the rat</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.100271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1124%2Fjpet.105.100271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=16443723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=786-790&author=J.+D.+Bestauthor=M.+T.+Jayauthor=F.+Otuauthor=I.+Churcherauthor=M.+Reillyauthor=P.+Morentin-Gutierrezauthor=C.+Pattisonauthor=T.+Harrisonauthor=M.+S.+Shearmanauthor=J.+R.+Atack&title=In+Vivo+Characterization+of+A%CE%B2%2840%29+changes+in+brain+and+cerebrospinal+fluid+using+the+novel+%CE%B3-secretase+inhibitor+N-%5Bcis-4-%5B%284-chlorophenyl%29sulfonyl%5D-4-%282%2C5-difluorophenyl%29cyclohexyl%5D-1%2C1%2C1-trifluoromethanesulfonamide+%28MRK-560%29+in+the+rat&doi=10.1124%2Fjpet.105.100271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo characterization of Aβ(40) changes in brain and cerebrospinal fluid using the novel γ-secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]- 1,1,1-trifluoromethanesulfonamide (MRK-560) in the rat</span></div><div class="casAuthors">Best, Jonathan D.; Jay, Mark T.; Otu, Franklin; Churcher, Ian; Reilly, Michael; Morentin-Gutierrez, Pablo; Pattison, Christine; Harrison, Tim; Shearman, Mark S.; Atack, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">786-790</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Plaques in the parenchyma of the brain contg. Aβ peptides are one of the hallmarks of Alzheimer's disease.  These Aβ peptides are produced by the final proteolytic cleavage of the amyloid precursor protein by the intramembraneous aspartyl protease γ-secretase.  Thus, one approach to lowering levels of Aβ has been via the inhibition of the γ-secretase enzyme.  Here, we report a novel, bioavailable γ-secretase inhibitor, MRK-560, that displayed oral pharmacokinetics suitable for once-a-day dosing.  It was able to markedly reduce Aβ in the brain and cerebrospinal fluid (CSF) in the rat, with ED50 values of 6 and 10 mg/kg, resp.  Time-course expts. using MRK-560 demonstrated these redns. in Aβ could be maintained for 24 h, and comparable temporal redns. in rat brain and CSF Aβ(40) further suggested that these two pools of Aβ are related.  This relation between the brain and CSF Aβ was maintained when MRK-560 was dosed once a day for 2 wk, and accordingly, when all the data for the dose-response curve and time courses were correlated, a strong assocn. was obsd. between the brain and CSF Aβ levels.  These results demonstrate that MRK-560 is an orally bioavailable γ-secretase inhibitor with the ability to markedly reduce Aβ peptide in the brain and CSF of the rat and confirm the utility of the rat for assessing the effects of γ-secretase inhibitors on central nervous system Aβ(40) levels in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNWKVBblcKJLVg90H21EOLACvtfcHk0lgfwyS3Ae0Giw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamu7g%253D&md5=8fa446ec4020b77e859e3e92aa03d3cb</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.100271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.100271%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DJ.%2BD.%26aulast%3DJay%26aufirst%3DM.%2BT.%26aulast%3DOtu%26aufirst%3DF.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DMorentin-Gutierrez%26aufirst%3DP.%26aulast%3DPattison%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26atitle%3DIn%2520Vivo%2520Characterization%2520of%2520A%25CE%25B2%252840%2529%2520changes%2520in%2520brain%2520and%2520cerebrospinal%2520fluid%2520using%2520the%2520novel%2520%25CE%25B3-secretase%2520inhibitor%2520N-%255Bcis-4-%255B%25284-chlorophenyl%2529sulfonyl%255D-4-%25282%252C5-difluorophenyl%2529cyclohexyl%255D-1%252C1%252C1-trifluoromethanesulfonamide%2520%2528MRK-560%2529%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D786%26epage%3D790%26doi%3D10.1124%2Fjpet.105.100271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21','cit21.2'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'patent1':['patent1_1'],'add':['add_1'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Karbhari Shinde, Shankar Reddy Gagginapally, Durga Malleshwari Kancharla, Srinivasa Rao Ravella, Narsimha Bogaraju, Vanaja Reddy Middekadi, Ramkumar Subramanian, Raghava Choudary Palacharla, Vijay Benade, Nageswararao Muddana, Renny Abraham, Rajesh Babu Medapati, Jagadeesh Babu Thentu, Venkat Reddy Mekala, Surendra Petlu, Bujji Babu Lingavarapu, Sivasekhar Yarra, Narendra Kagita, Vinod Kumar Goyal, Santosh Kumar Pandey, <span class="NLM_string-name hlFld-ContribAuthor">Venkat Jasti</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00703%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BPreclinical%252BCharacterization%252Bof%252BUsmarapride%252B%252528SUVN-D4010%252529%25253A%252BA%252BPotent%25252C%252BSelective%252B5-HT4%252BReceptor%252BPartial%252BAgonist%252Bfor%252Bthe%252BTreatment%252Bof%252BCognitive%252BDeficits%252BAssociated%252Bwith%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DNirogi%26aufirst%3DRamakrishna%26date%3D2021%26date%3D2021%26date%3D17042021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yu Zhou, Yan Fu, Wanchao Yin, Jian Li, Wei Wang, Fang Bai, Shengtao Xu, Qi Gong, Tao Peng, Yu Hong, Dong Zhang, Dan Zhang, Qiufeng Liu, Yechun Xu, H. Eric Xu, Haiyan Zhang, Hualiang Jiang, <span class="NLM_string-name hlFld-ContribAuthor">Hong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 1844-1855. <a href="https://doi.org/10.1021/acs.jmedchem.0c01863" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01863%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinetics-Driven%252BDrug%252BDesign%252BStrategy%252Bfor%252BNext-Generation%252BAcetylcholinesterase%252BInhibitors%252Bto%252BClinical%252BCandidate%26aulast%3DZhou%26aufirst%3DYu%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D27102020%26date%3D11022021%26volume%3D64%26issue%3D4%26spage%3D1844%26epage%3D1855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siqi  Wang</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Filatov</span>, <span class="hlFld-ContribAuthor ">Stanislav V.  Lozovskiy</span>, <span class="hlFld-ContribAuthor ">Stanislav V.  Shmakov</span>, <span class="hlFld-ContribAuthor ">Olesya V.  Khoroshilova</span>, <span class="hlFld-ContribAuthor ">Anna G.  Larina</span>, <span class="hlFld-ContribAuthor ">Stanislav I.  Selivanov</span>, <span class="hlFld-ContribAuthor ">Vitali M.  Boitsov</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Stepakov</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of Spiro[3-azabicyclo[3.1.0]hexanes] via 1,3-Dipolar Cycloaddition of 1,2-Diphenylcyclopropenes to Ninhydrin-Derived Azomethine Ylides. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2021,</strong> <em>53 </em>
                                    (12)
                                     , 2114-2132. <a href="https://doi.org/10.1055/a-1360-9716" title="DOI URL">https://doi.org/10.1055/a-1360-9716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/a-1360-9716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fa-1360-9716%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DConstruction%252Bof%252BSpiro%25255B3-azabicyclo%25255B3.1.0%25255Dhexanes%25255D%252Bvia%252B1%25252C3-Dipolar%252BCycloaddition%252Bof%252B1%25252C2-Diphenylcyclopropenes%252Bto%252BNinhydrin-Derived%252BAzomethine%252BYlides%26aulast%3DWang%26aufirst%3DSiqi%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D12%26spage%3D2114%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Castro-Alvarez</span>, <span class="hlFld-ContribAuthor ">Emigdio  Chávez-Ángel</span>, <span class="hlFld-ContribAuthor ">Ronald  Nelson</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding the Molecular Basis of 5-HT4 Receptor Partial Agonists through 3D-QSAR Studies. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (7)
                                     , 3602. <a href="https://doi.org/10.3390/ijms22073602" title="DOI URL">https://doi.org/10.3390/ijms22073602</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22073602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22073602%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DUnderstanding%252Bthe%252BMolecular%252BBasis%252Bof%252B5-HT4%252BReceptor%252BPartial%252BAgonists%252Bthrough%252B3D-QSAR%252BStudies%26aulast%3DCastro-Alvarez%26aufirst%3DAlejandro%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D7%26spage%3D3602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaista  Amin</span>, <span class="hlFld-ContribAuthor ">M. Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">A. K.  Najmi</span>, <span class="hlFld-ContribAuthor ">Nadeem  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Asif  Husain</span>, <span class="hlFld-ContribAuthor ">M.  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">A review on synthetic procedures and applications of phosphorus oxychloride (POCl
              3
              ) in the last biennial period (2018–19). </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2021,</strong> <em>196 </em>
                                    (3)
                                     , 211-274. <a href="https://doi.org/10.1080/10426507.2020.1831499" title="DOI URL">https://doi.org/10.1080/10426507.2020.1831499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2020.1831499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2020.1831499%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DA%252Breview%252Bon%252Bsynthetic%252Bprocedures%252Band%252Bapplications%252Bof%252Bphosphorus%252Boxychloride%252B%252528POCl%252B3%252B%252529%252Bin%252Bthe%252Blast%252Bbiennial%252Bperiod%252B%2525282018%2525E2%252580%25259319%252529%26aulast%3DAmin%26aufirst%3DShaista%26date%3D2021%26date%3D2020%26volume%3D196%26issue%3D3%26spage%3D211%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshihide  Usami</span>, <span class="hlFld-ContribAuthor ">Yuya  Tatsui</span>, <span class="hlFld-ContribAuthor ">Kodai  Sumimoto</span>, <span class="hlFld-ContribAuthor ">Ayami  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Nanase  Koito</span>, <span class="hlFld-ContribAuthor ">Hiroki  Yoneyama</span>, <span class="hlFld-ContribAuthor ">Shinya  Harusawa</span>. </span><span class="cited-content_cbyCitation_article-title">3-Trifluoromethanesulfonyloxy-4,7-dihydropyrazolo[1,5-a]pyridine via Ring-Closing Metathesis: Synthesis and Transformation to Withasomnine Homologs. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2021,</strong> <em>103 </em>
                                    (1)
                                     , 284. <a href="https://doi.org/10.3987/COM-20-S(K)13" title="DOI URL">https://doi.org/10.3987/COM-20-S(K)13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-20-S(K)13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-20-S%28K%2913%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3D3-Trifluoromethanesulfonyloxy-4%25252C7-dihydropyrazolo%25255B1%25252C5-a%25255Dpyridine%252Bvia%252BRing-Closing%252BMetathesis%25253A%252BSynthesis%252Band%252BTransformation%252Bto%252BWithasomnine%252BHomologs%26aulast%3DUsami%26aufirst%3DYoshihide%26date%3D2021%26volume%3D103%26issue%3D1%26spage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caroline  Lanthier</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic modulators of the serotonin 5-HT
              4
              receptor: a patent review (2014-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (7)
                                     , 495-508. <a href="https://doi.org/10.1080/13543776.2020.1767587" title="DOI URL">https://doi.org/10.1080/13543776.2020.1767587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1767587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1767587%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTherapeutic%252Bmodulators%252Bof%252Bthe%252Bserotonin%252B5-HT%252B4%252Breceptor%25253A%252Ba%252Bpatent%252Breview%252B%2525282014-present%252529%26aulast%3DLanthier%26aufirst%3DCaroline%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D7%26spage%3D495%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suhas G.  Patil</span>, <span class="hlFld-ContribAuthor ">Jagannath S.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Sagar T.  Sankpal</span>. </span><span class="cited-content_cbyCitation_article-title">Mg
              3
              N
              2
              -assisted one-pot synthesis of 1,3-disubstituted imidazo[1,5-
              a
              ]pyridine. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (20)
                                     , 11808-11815. <a href="https://doi.org/10.1039/C9RA10848C" title="DOI URL">https://doi.org/10.1039/C9RA10848C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA10848C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA10848C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMg%252B3%252BN%252B2%252B-assisted%252Bone-pot%252Bsynthesis%252Bof%252B1%25252C3-disubstituted%252Bimidazo%25255B1%25252C5-%252Ba%252B%25255Dpyridine%26aulast%3DPatil%26aufirst%3DSuhas%2BG.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D20%26spage%3D11808%26epage%3D11815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Congjun  Xu</span>, <span class="hlFld-ContribAuthor ">Yufei  Han</span>, <span class="hlFld-ContribAuthor ">Sicong  Xu</span>, <span class="hlFld-ContribAuthor ">Ruxin  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Yue</span>, <span class="hlFld-ContribAuthor ">Yu  Tian</span>, <span class="hlFld-ContribAuthor ">Xiaofan  Li</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of new Axl kinase inhibitors containing 1,3,4-oxadiazole acetamide moiety as novel linker. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111867. <a href="https://doi.org/10.1016/j.ejmech.2019.111867" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111867%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252BAxl%252Bkinase%252Binhibitors%252Bcontaining%252B1%25252C3%25252C4-oxadiazole%252Bacetamide%252Bmoiety%252Bas%252Bnovel%252Blinker%26aulast%3DXu%26aufirst%3DCongjun%26date%3D2020%26volume%3D186%26spage%3D111867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Iftikhar</span>, <span class="hlFld-ContribAuthor ">Shahnawaz</span>, <span class="hlFld-ContribAuthor ">Muhammad  Saleem</span>, <span class="hlFld-ContribAuthor ">Naheed  Riaz</span>, <span class="hlFld-ContribAuthor ">Aziz‐ur‐Rehman</span>, <span class="hlFld-ContribAuthor ">Ishtiaq  Ahmed</span>, <span class="hlFld-ContribAuthor ">Jameel  Rahman</span>, <span class="hlFld-ContribAuthor ">Muhammad  Ashraf</span>, <span class="hlFld-ContribAuthor ">Muhammad S.  Sharif</span>, <span class="hlFld-ContribAuthor ">Shafi U.  Khan</span>, <span class="hlFld-ContribAuthor ">Thet T.  Htar</span>. </span><span class="cited-content_cbyCitation_article-title">A novel five‐step synthetic route to 1,3,4‐oxadiazole derivatives with potent α‐glucosidase inhibitory potential and their in silico studies. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (12)
                                     , 1900095. <a href="https://doi.org/10.1002/ardp.201900095" title="DOI URL">https://doi.org/10.1002/ardp.201900095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900095%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DA%252Bnovel%252Bfive%2525E2%252580%252590step%252Bsynthetic%252Broute%252Bto%252B1%25252C3%25252C4%2525E2%252580%252590oxadiazole%252Bderivatives%252Bwith%252Bpotent%252B%2525CE%2525B1%2525E2%252580%252590glucosidase%252Binhibitory%252Bpotential%252Band%252Btheir%252Bin%252Bsilico%252Bstudies%26aulast%3DIftikhar%26aufirst%3DMuhammad%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D12%26spage%3D1900095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bérénice  Hatat</span>, <span class="hlFld-ContribAuthor ">Samir  Yahiaoui</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Audrey  Davis</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2019,</strong> <em>11 </em><a href="https://doi.org/10.3389/fnagi.2019.00148" title="DOI URL">https://doi.org/10.3389/fnagi.2019.00148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2019.00148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2019.00148%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DA%252BNovel%252Bin%252Bvivo%252BAnti-amnesic%252BAgent%25252C%252BSpecially%252BDesigned%252Bto%252BExpress%252BBoth%252BAcetylcholinesterase%252B%252528AChE%252529%252BInhibitory%25252C%252BSerotonergic%252BSubtype%252B4%252BReceptor%252B%2525285-HT4R%252529%252BAgonist%252Band%252BSerotonergic%252BSubtype%252B6%252BReceptor%252B%2525285-HT6R%252529%252BInverse%252BAgonist%252BActivities%25252C%252BWith%252Ba%252BPotential%252BInterest%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHatat%26aufirst%3DB%25C3%25A9r%25C3%25A9nice%26date%3D2019%26date%3D2019%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Ángel  García-Pedraza</span>, <span class="hlFld-ContribAuthor ">Mónica  García-Domingo</span>, <span class="hlFld-ContribAuthor ">Miriam  Gómez-Roso</span>, <span class="hlFld-ContribAuthor ">Laura  Ruiz-Remolina</span>, <span class="hlFld-ContribAuthor ">Alicia  Rodríguez-Barbero</span>, <span class="hlFld-ContribAuthor ">María Luisa  Martín</span>, <span class="hlFld-ContribAuthor ">Asunción  Morán</span>. </span><span class="cited-content_cbyCitation_article-title">Hypertension exhibits 5-HT4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature. </span><span class="cited-content_cbyCitation_journal-name">Hypertension Research</span><span> <strong>2019,</strong> <em>42 </em>
                                    (5)
                                     , 618-627. <a href="https://doi.org/10.1038/s41440-019-0217-7" title="DOI URL">https://doi.org/10.1038/s41440-019-0217-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41440-019-0217-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41440-019-0217-7%26sid%3Dliteratum%253Aachs%26jtitle%3DHypertension%2520Research%26atitle%3DHypertension%252Bexhibits%252B5-HT4%252Breceptor%252Bas%252Ba%252Bmodulator%252Bof%252Bsympathetic%252Bneurotransmission%252Bin%252Bthe%252Brat%252Bmesenteric%252Bvasculature%26aulast%3DGarc%25C3%25ADa-Pedraza%26aufirst%3DJos%25C3%25A9%2B%25C3%2581ngel%26date%3D2019%26date%3D2019%26volume%3D42%26issue%3D5%26spage%3D618%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Longjia  Yan</span>, <span class="hlFld-ContribAuthor ">Minggao  Deng</span>, <span class="hlFld-ContribAuthor ">Anchao  Chen</span>, <span class="hlFld-ContribAuthor ">Yongliang  Li</span>, <span class="hlFld-ContribAuthor ">Wanzheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-yun  Du</span>, <span class="hlFld-ContribAuthor ">Chang-zhi  Dong</span>, <span class="hlFld-ContribAuthor ">Bernard  Meunier</span>, <span class="hlFld-ContribAuthor ">Huixiong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-pyrimidin[1,3,4]oxadiazoles and N-pyrimidin[1,3,4]-thiadiazoles from 1,3,4-oxadiazol-2-amines and 1,3,4-thiadiazol-2-amines via Pd-catalyzed heteroarylamination. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (20)
                                     , 1359-1362. <a href="https://doi.org/10.1016/j.tetlet.2019.04.022" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.04.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.04.022%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252BN-pyrimidin%25255B1%25252C3%25252C4%25255Doxadiazoles%252Band%252BN-pyrimidin%25255B1%25252C3%25252C4%25255D-thiadiazoles%252Bfrom%252B1%25252C3%25252C4-oxadiazol-2-amines%252Band%252B1%25252C3%25252C4-thiadiazol-2-amines%252Bvia%252BPd-catalyzed%252Bheteroarylamination%26aulast%3DYan%26aufirst%3DLongjia%26date%3D2019%26volume%3D60%26issue%3D20%26spage%3D1359%26epage%3D1362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh  Kurhade</span>, <span class="hlFld-ContribAuthor ">Markella  Konstantinidou</span>, <span class="hlFld-ContribAuthor ">Fandi  Sutanto</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kurpiewska</span>, <span class="hlFld-ContribAuthor ">Justyna  Kalinowska-Tłuścik</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential Multicomponent Synthesis of 2-(Imidazo[1,5-α]pyridin-1-yl)-1,3,4-Oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (10)
                                     , 2029-2034. <a href="https://doi.org/10.1002/ejoc.201801880" title="DOI URL">https://doi.org/10.1002/ejoc.201801880</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801880%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSequential%252BMulticomponent%252BSynthesis%252Bof%252B2-%252528Imidazo%25255B1%25252C5-%2525CE%2525B1%25255Dpyridin-1-yl%252529-1%25252C3%25252C4-Oxadiazoles%26aulast%3DKurhade%26aufirst%3DSantosh%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D10%26spage%3D2029%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported 5-HT<sub>4</sub>R ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Genesis of ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Heteroaromatic Acid <b>A</b><sub><b>1</b></sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) <i>n</i>-BuLi, isobutyraldehyde, THF, −78 °C, 1 h, 56%. (b) (i) MsCl, Et<sub>3</sub>N, DCM, 0 °C, 90%; (ii) NaN<sub>3</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h, 68%. (c) Ph<sub>3</sub>P, THF, H<sub>2</sub>O, rt, 86%. (d) Ethyl chlorooxoacetate, Et<sub>3</sub>N, DCM, 0 °C, 1 h, 90%. (e) POCl<sub>3</sub>, DCE, reflux, 16 h, 27%. (f) NaOH, EtOH, H<sub>2</sub>O, 95 °C, 75%. (g) Concd HCl.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Heteroaromatic Acid <b>A</b><sub><b>2</b></sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) 1-Chloro-3-methylbutan-2-one, EtOH, 90° C, 16 h, 32%. (b) NaOH, THF, H<sub>2</sub>O, 95 °C, 90%. (c) 1 N HCl.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Heteroaromatic Acid <b>A</b><sub><b>3</b></sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) <i>n</i>-BuLi, THF, isobutyryl chloride, −78 °C, 50%. (b) <i>O</i>-Mesitylenesulfonylhydroxylamine, CHCl<sub>3</sub>, rt, 60%. (c) <i>n</i>-BuLi, dry ice (CO<sub>2</sub> source), −78 °C, 1 N HCl, 50%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the N-Substituted Lithium Isonipecotates<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Cs<sub>2</sub>CO<sub>3</sub>, R–X, AcN, rt or R–CHO, NaBH(OAc)<sub>3</sub>, DCM, 0 °C to rt. (b) LiOH, THF, 0 °C to rt.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Heteroaromatic Hydrazides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Hydrazine hydrate, EtOH, reflux. (b) SOCl<sub>2</sub>, MeOH, 0 °C to rt.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of the Heteroaromatic Carboxamide Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) TBTU, EtiPr<sub>2</sub>N, DCM, 50%. (b) IPA/HCl, 0 °C to rt, 16 h. (c) K<sub>2</sub>CO<sub>3</sub>, R–X, AcN, rt or R–CHO, NaBH(OAc)<sub>3</sub>, DCM, 0 °C to rt.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of the 1,3,4-Oxadiazoles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) POCl<sub>3</sub>, 120 °C, 4–10 h.</p></p></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0021.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Attenuation of long-term memory deficits in NORT by compounds <b>3c</b>, <b>4n</b>, and <b>4o</b>. Data represent exploration-time means ± SEM compared with those of the vehicle group (<i>n</i> = 7–8 per group). **<i>p</i> < 0.01 vs the vehicle group (Student’s paired <i>t</i>-test). Two independent studies were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Attenuation of long-term memory deficits in NORT by compound <b>4o</b> and blockade of its activity by the selective 5-HT<sub>4</sub>R antagonist GR-125487. Data shown are means ± SEM (<i>n</i> = 4 animals).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. 5-HT<sub>4</sub>R occupancy of compounds <b>4n</b> and <b>4o</b>. Data represent means ± SEM of percent changes in acetylcholine levels (<i>n</i> = 5–8 per group). *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 vs the vehicle group (Bonferroni post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Increase in acetylcholine release in the frontal cortex by compound <b>4o</b>. Data represent mean percent increases ± SEM relative to those of the vehicle group (<i>n</i> = 7–8 per group). *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs the vehicle group (Dunnett’s post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/medium/jm-2018-00457j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose-dependent increases in sAPPα levels after subcutaneous (sc) treatments with compound <b>4o</b>. Data represent means ± SD (<i>n</i> = 4−6 per group). *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs the vehicle group (Dunnett’s post-test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-11/acs.jmedchem.8b00457/20180608/images/large/jm-2018-00457j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00457&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerald, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adham, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kao, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laz, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaysse, P. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartig, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branchek, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinshank, R. L.</span></span> <span> </span><span class="NLM_article-title">The 5-HT<sub>4</sub> receptor: Molecular cloning and pharmacological characterization of two splice variants</span>. <i>EMBO Journal</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">2806</span>– <span class="NLM_lpage">2815</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=2806-2815&author=C.+Geraldauthor=N.+Adhamauthor=H.+T.+Kaoauthor=M.+A.+Olsenauthor=T.+M.+Lazauthor=L.+E.+Schechterauthor=J.+A.+Bardauthor=P.+J.+J.+Vaysseauthor=P.+R.+Hartigauthor=T.+A.+Branchekauthor=R.+L.+Weinshank&title=The+5-HT4+receptor%3A+Molecular+cloning+and+pharmacological+characterization+of+two+splice+variants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerald%26aufirst%3DC.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DKao%26aufirst%3DH.%2BT.%26aulast%3DOlsen%26aufirst%3DM.%2BA.%26aulast%3DLaz%26aufirst%3DT.%2BM.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DBard%26aufirst%3DJ.%2BA.%26aulast%3DVaysse%26aufirst%3DP.%2BJ.%2BJ.%26aulast%3DHartig%26aufirst%3DP.%2BR.%26aulast%3DBranchek%26aufirst%3DT.%2BA.%26aulast%3DWeinshank%26aufirst%3DR.%2BL.%26atitle%3DThe%25205-HT4%2520receptor%253A%2520Molecular%2520cloning%2520and%2520pharmacological%2520characterization%2520of%2520two%2520splice%2520variants%26jtitle%3DEMBO%2520Journal%26date%3D1995%26volume%3D14%26spage%3D2806%26epage%3D2815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maillet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span> <span> </span><span class="NLM_article-title">New insights into serotonin 5-HT<sub>4</sub> receptors: A novel therapeutic target for Alzheimer’s disease?</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.2174/1567205043332252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.2174%2F1567205043332252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=15975071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvF2jt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=79-85&author=M.+Mailletauthor=S.+J.+Robertauthor=F.+Lezoualc%E2%80%99h&title=New+insights+into+serotonin+5-HT4+receptors%3A+A+novel+therapeutic+target+for+Alzheimer%E2%80%99s+disease%3F&doi=10.2174%2F1567205043332252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into serotonin 5-HT4 receptors: A novel therapeutic target for Alzheimer's disease?</span></div><div class="casAuthors">Maillet, Marjorie; Robert, Sylvain J.; Lezoualc'h, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">79-85</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin 5-HT4 receptor mediates many physiol. effects in the central nervous system.  The recent mol. identification of 5-HT4 receptors and the development of selective 5-HT4 receptor ligands have led to many important new insights into the signalling pathways and the physiol. roles of these G protein-coupled-receptors in neurons.  With respect to neurodegenerative disorders, it is suggested that 5-HT4 agonists may represent a new avenue for the treatment of Alzheimer's disease.  This mini-review will focus on recent in vitro and in vivo pharmacol. and biochem. studies showing the involvement of 5-HT4 receptors in cognitive processes and the amyloid precursor protein processing.  The potential use of 5-HT4 agonists for the treatment of AD will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEEiivpw5diLVg90H21EOLACvtfcHk0linu4HBDB3sTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvF2jt70%253D&md5=6e42fa1b968fffe34f6ee96ed37bc957</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F1567205043332252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205043332252%26sid%3Dliteratum%253Aachs%26aulast%3DMaillet%26aufirst%3DM.%26aulast%3DRobert%26aufirst%3DS.%2BJ.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26atitle%3DNew%2520insights%2520into%2520serotonin%25205-HT4%2520receptors%253A%2520A%2520novel%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2004%26volume%3D1%26spage%3D79%26epage%3D85%26doi%3D10.2174%2F1567205043332252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, F.</span></span> <span> </span><span class="NLM_article-title">Drugs acting on serotonin receptors for the treatment of functional GI disorders</span>. <i>Dig. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1159/000090309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1159%2F000090309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=16699264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A280%3ADC%252BD283msl2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=59-69&author=M.+Toniniauthor=F.+Pace&title=Drugs+acting+on+serotonin+receptors+for+the+treatment+of+functional+GI+disorders&doi=10.1159%2F000090309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs acting on serotonin receptors for the treatment of functional GI disorders</span></div><div class="casAuthors">Tonini Marcello; Pace Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Digestive diseases (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">59-69</span>
        ISSN:<span class="NLM_cas:issn">0257-2753</span>.
    </div><div class="casAbstract">In the gut, serotonin (5-hydroxytryptamine: 5-HT) exerts a variety of effects on intrinsic enteric neurons, extrinsic afferents, enterocytes and smooth muscle cells, which are related to the expression of multiple 5-HT receptor types and subtypes regulating motility, vascular tone, secretion and perception.  Agonists and antagonists at 5-HT receptors have gained access to the market for the two major variants of the irritable bowel syndrome (IBS), a functional disorder characterized by abdominal pain associated with diarrhea and/or constipation in the absence of any organic abnormality.  Indeed, the 5-HT3 receptor antagonist alosetron is available in the US market for the treatment of women with severe, diarrhea-predominant IBS (D-IBS) refractory to conventional therapy, whereas tegaserod, a partial 5-HT4 receptor agonist, has been approved by the FDA and other regulatory agencies for the treatment of women with constipation-predominant IBS (C-IBS) or functional constipation.  This review is mainly intended to discuss the role of non-neuronal (paracrine) and neuronal 5-HT in the pathophysiology of functional gastrointestinal disorders (FGIDs), such as IBS and functional dyspepsia, and the mechanisms through which drugs acting on 5-HT receptors regulate visceral motility, perception and secretion in these two conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq9uzlmfvkOmx8TEN9K18QfW6udTcc2eYgWQUbeED9Jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283msl2msA%253D%253D&md5=dda3f4f7c10a3e874dbeec3da1d316eb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1159%2F000090309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000090309%26sid%3Dliteratum%253Aachs%26aulast%3DTonini%26aufirst%3DM.%26aulast%3DPace%26aufirst%3DF.%26atitle%3DDrugs%2520acting%2520on%2520serotonin%2520receptors%2520for%2520the%2520treatment%2520of%2520functional%2520GI%2520disorders%26jtitle%3DDig.%2520Dis.%26date%3D2006%26volume%3D24%26spage%3D59%26epage%3D69%26doi%3D10.1159%2F000090309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouras, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camilleri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mckinzie, S.</span></span> <span> </span><span class="NLM_article-title">Selective stimulation of colonic transit by the benzofuran 5-HT<sub>4</sub> agonist prucalopride, in healthy humans</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">682</span>– <span class="NLM_lpage">686</span>, <span class="refDoi"> DOI: 10.1136/gut.44.5.682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1136%2Fgut.44.5.682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10205205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK1MXjtF2ktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1999&pages=682-686&author=E.+P.+Bourasauthor=M.+Camilleriauthor=D.+D.+Burtonauthor=S.+Mckinzie&title=Selective+stimulation+of+colonic+transit+by+the+benzofuran+5-HT4+agonist+prucalopride%2C+in+healthy+humans&doi=10.1136%2Fgut.44.5.682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans</span></div><div class="casAuthors">Bouras, E. P.; Camilleri, M.; Burton, D. D.; McKinzie, S.</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">682-686</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Prucalopride (R093877) is a selective and specific 5HT4 agonist, the first of a new chem. class of benzo-furans, with gastrointestinal prokinetic activities in vitro.  To evaluate the effects of prucalo-pride on gastrointestinal and colonic transit.  A validated scintigraphic technique was used to measure gastrointestinal and colonic transit over 48 h in 50 healthy volunteers.  For seven days, each subject received a daily dose of 0.5, 1, 2, or 4 mg prucalopride, or placebo in a double blind, randomized fashion.  The transit test was performed over the last 48 h.  There were significant accelerations of overall colonic transit at 4, 8, 24, and 48 h (p<0.05) and proximal colonic emptying t1/2 (p<0.05).  The 0.5, 2, and 4 mg doses of prucalopride were almost equally effective and accelerated colonic transit compared with placebo.  Prucalopride did not significantly alter gastric emptying (p>0.5) or small bowel transit (overall p=0.12).  The medication appeared to be well tolerated during the seven day treatment of healthy subjects.  Prucalopride accelerates colonic transit, partly by stimulating proximal colonic emptying, but does not alter gastric or small bowel transit in healthy human subjects.  Prucalopride deserves further study in patients with constipation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0h8xd_-Aq1bVg90H21EOLACvtfcHk0linu4HBDB3sTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtF2ktrg%253D&md5=a2d3dd4271c784729e9fb49d4d6f74ab</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1136%2Fgut.44.5.682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.44.5.682%26sid%3Dliteratum%253Aachs%26aulast%3DBouras%26aufirst%3DE.%2BP.%26aulast%3DCamilleri%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DD.%2BD.%26aulast%3DMckinzie%26aufirst%3DS.%26atitle%3DSelective%2520stimulation%2520of%2520colonic%2520transit%2520by%2520the%2520benzofuran%25205-HT4%2520agonist%2520prucalopride%252C%2520in%2520healthy%2520humans%26jtitle%3DGut%26date%3D1999%26volume%3D44%26spage%3D682%26epage%3D686%26doi%3D10.1136%2Fgut.44.5.682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors, a place in the sun: act two</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2011.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.coph.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=21342787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=87-93&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors%2C+a+place+in+the+sun%3A+act+two&doi=10.1016%2Fj.coph.2011.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors, a place in the sun: act two</span></div><div class="casAuthors">Bockaert, Joel; Claeysen, Sylvie; Compan, Valerie; Dumuis, Aline</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-93</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  5-HT4 receptors control brain physiol. functions such as learning and memory, feeding and mood behavior as well as gastro-intestinal transit. 5-HT4 receptors are one of the 5-HT receptors for which the available drugs and signalling knowledge are the most advanced.  Several therapeutic 5-HT4 receptor drugs have been commercialized.  Therefore, the hope that 5-HT4 receptors could also be the target for brain diseases is reasonable.  Several major devastating illnesses could benefit from 5-HT4 receptors-directed therapy such as Alzheimer's disease, feeding-assocd. diseases such as anorexia and major depressive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe-9UQID9lqbVg90H21EOLACvtfcHk0lg2SewTFhZ4zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXks1Wqs7Y%253D&md5=6f136864149bddba0ec1f0ed3b153968</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%252C%2520a%2520place%2520in%2520the%2520sun%253A%2520act%2520two%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26spage%3D87%26epage%3D93%26doi%3D10.1016%2Fj.coph.2011.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S. J.</span></span> <span> </span><span class="NLM_article-title">The serotonin 5-HT<sub>4</sub> receptor and the amyloid precursor protein processing</span>. <i>Exp. Gerontol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/S0531-5565(02)00157-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2FS0531-5565%2802%2900157-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=12543273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=159-166&author=F.+Lezoualc%E2%80%99hauthor=S.+J.+Robert&title=The+serotonin+5-HT4+receptor+and+the+amyloid+precursor+protein+processing&doi=10.1016%2FS0531-5565%2802%2900157-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin 5-HT4 receptor and the amyloid precursor protein processing</span></div><div class="casAuthors">Lezoualc'h, Frank; Robert, Sylvain J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">159-166</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A large body of evidence supports a major role for the serotonin 5-HT4 receptor in learning and memory and it is suggested that 5-HT4 agonists may be beneficial for memory disorders such as Alzheimer's disease (AD).  The 5-HT4 receptors are members of the G protein-coupled receptor superfamily and are pos. coupled to adenylyl cyclase.  In this communication the authors show that a neuronal isoform of the human 5-HT4 receptor, h5-HT4(g) regulates the metab. of the amyloid precursor protein (APP695).  This process is obsd. in Chinese hamster ovary (CHO) cells stably coexpressing the neuronal h5-HT4(g) receptor isoform as well as the human APP695.  The 5-HT4 agonists strongly stimulate the release of the non-amyloidogenic sol. amyloid precursor protein sAPPα as detected by immunoblot.  Prucalopride was more potent than serotonin (5-HT) with regard to enhanced of sAPPα secretion.  This process was blocked by a selective 5-HT4 antagonist, GR113808.  Furthermore, 5-HT4 ligands enhance sAPPα secretion via cAMP-dependent and PKA-independent signaling pathways indicating there are alternative pathways by which the h5-HT4 receptor via cAMP regulates APP metab.  Because the α-cleavage event may preclude the formation of amyloidogenic peptides, and secreted sAPPα has putative neuroprotective and enhancing-memory properties, our present data suggest the 5-HT4 receptor as a novel target for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobwRXVEkZwfLVg90H21EOLACvtfcHk0lg2SewTFhZ4zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvFWmsw%253D%253D&md5=b4e047f7299a56f139389894c3a3060c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0531-5565%2802%2900157-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0531-5565%252802%252900157-2%26sid%3Dliteratum%253Aachs%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DRobert%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520serotonin%25205-HT4%2520receptor%2520and%2520the%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DExp.%2520Gerontol.%26date%3D2003%26volume%3D38%26spage%3D159%26epage%3D166%26doi%3D10.1016%2FS0531-5565%2802%2900157-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zugaza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmeister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardier, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span> <span> </span><span class="NLM_article-title">The human serotonin 5-HT<sub>4</sub> receptor regulates secretion of non-amyloidogenic precursor protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">44881</span>– <span class="NLM_lpage">44888</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109008200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1074%2Fjbc.M109008200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=11584021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFegurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=44881-44888&author=S.+J.+Robertauthor=J.+L.+Zugazaauthor=R.+Fischmeisterauthor=A.+M.+Gardierauthor=F.+Lezoualc%E2%80%99h&title=The+human+serotonin+5-HT4+receptor+regulates+secretion+of+non-amyloidogenic+precursor+protein&doi=10.1074%2Fjbc.M109008200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein</span></div><div class="casAuthors">Robert, Sylvain J.; Zugaza, Jose L.; Fischmeister, Rodolphe; Gardier, Alain M.; Lezoualc'h, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">44881-44888</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The serotonin 5-HT4 receptor has recently gained a lot of attention for its functional roles in central processes such as memory and cognition.  In this study, we show that activation of the human 5-HT4 (h5-HT4) receptor stimulates the secretion of the non-amyloidogenic sol. form of the amyloid precursor protein (sAPPα).  5-HT enhanced the level of secreted sAPPα in a time- and dose-dependent manner in Chinese hamster ovary cells stably expressing the h5-HT4(e) receptor isoform.  The increase was inhibited by the selective 5-HT4 receptor antagonist, GR 113808.  The 5-HT4 selective agonists, prucalopride and renzapride, also increased secreted sAPPα in IMR32 human neuroblastoma cells.  The stimulatory effect of 5-HT was mimicked by forskolin, a direct activator of adenylyl cyclase, and 8-bromo-cAMP, a membrane-permeant cAMP analog.  On the contrary, inhibition of protein kinase A (PKA) by H 89 potentiated the 5-HT-induced increase in both secreted and cellular sAPPα.  This phenomenon involves a novel PKA-independent stimulatory process that overcomes a PKA-dependent inhibitory one.  Finally, activation of the h5-HT4(e) receptor did not modify extracellular amyloid β-protein in Chinese hamster ovary cells transfected with the human APP695.  Given the neuroprotective and enhancing memory effects of sAPPα, our results may open a new avenue for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZXW1Ib2lqw7Vg90H21EOLACvtfcHk0lg2SewTFhZ4zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFegurk%253D&md5=bf4cbeb9c1c76976cde9ce9579a7ffc5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109008200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109008200%26sid%3Dliteratum%253Aachs%26aulast%3DRobert%26aufirst%3DS.%2BJ.%26aulast%3DZugaza%26aufirst%3DJ.%2BL.%26aulast%3DFischmeister%26aufirst%3DR.%26aulast%3DGardier%26aufirst%3DA.%2BM.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26atitle%3DThe%2520human%2520serotonin%25205-HT4%2520receptor%2520regulates%2520secretion%2520of%2520non-amyloidogenic%2520precursor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D44881%26epage%3D44888%26doi%3D10.1074%2Fjbc.M109008200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Compan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors</span>. <i>Curr. Drug Targets: CNS Neurol. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.2174/1568007043482615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.2174%2F1568007043482615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=14965243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=39-51&author=J.+Bockaertauthor=S.+Claeysenauthor=V.+Companauthor=A.+Dumuis&title=5-HT4+receptors&doi=10.2174%2F1568007043482615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptors</span></div><div class="casAuthors">Bockaert, J.; Claeysen, S.; Compan, V.; Dumuis, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-51</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin 4 receptors (5-HT4Rs) were discovered 15 yr ago.  They are coded by a very complex gene (700Kb, 38 exons) which generates 8 C-terminal variants (a, b, c, d, e, f, g, and n).  Their sequences differ after position L358.  Another variant is characterized by a 14 residue insertion within the extracellular loop 2.  Highly selective potent 5-HT4 receptor antagonists and partial agonists which cross the blood-brain barrier have been synthesized, but a specific full agonist for brain studies is still missing.  Based on physiol. and behavioral expts., 5-HT4Rs may be targets to treat cognitive deficits, abdominal pain, and feeding disorders.  One 5-HT4R-directed drug (SL65.0155) is already in phase II to treat patients suffering from memory deficits or dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemFXFD0xNLrVg90H21EOLACvtfcHk0ljbbSKxg1sW0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrc%253D&md5=b9139c95c9d832dd89b51d45fc3bde96</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1568007043482615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482615%26sid%3Dliteratum%253Aachs%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DCompan%26aufirst%3DV.%26aulast%3DDumuis%26aufirst%3DA.%26atitle%3D5-HT4%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D39%26epage%3D51%26doi%3D10.2174%2F1568007043482615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waizumi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papanikolaou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutzman-Engwall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubitski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span> <span> </span><span class="NLM_article-title">Identification of multiple 5-HT<sub>4</sub> partial agonist clinical candidates for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9240</span>– <span class="NLM_lpage">9254</span>, <span class="refDoi"> DOI: 10.1021/jm300953p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300953p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGhsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9240-9254&author=M.+A.+Brodneyauthor=D.+E.+Johnsonauthor=A.+Sawant-Basakauthor=K.+J.+Coffmanauthor=E.+M.+Drummondauthor=E.+L.+Hudsonauthor=K.+E.+Fisherauthor=H.+Noguchiauthor=N.+Waizumiauthor=L.+L.+McDowellauthor=A.+Papanikolaouauthor=B.+A.+Pettersenauthor=A.+W.+Schmidtauthor=E.+Tsengauthor=K.+Stutzman-Engwallauthor=D.+M.+Rubitskiauthor=M.+A.+Vanase-Frawleyauthor=S.+Grimwood&title=Identification+of+multiple+5-HT4+partial+agonist+clinical+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm300953p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Multiple 5-HT4 Partial Agonist Clinical Candidates for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Brodney, Michael A.; Johnson, David E.; Sawant-Basak, Aarti; Coffman, Karen J.; Drummond, Elena M.; Hudson, Emily L.; Fisher, Katherine E.; Noguchi, Hirohide; Waizumi, Nobuaki; McDowell, Laura L.; Papanikolaou, Alexandros; Pettersen, Betty A.; Schmidt, Anne W.; Tseng, Elaine; Stutzman-Engwall, Kim; Rubitski, David M.; Vanase-Frawley, Michelle A.; Grimwood, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9240-9254</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cognitive impairments obsd. in Alzheimer's disease (AD) are in part a consequence of reduced acetylcholine (ACh) levels resulting from a loss of cholinergic neurons.  Preclinically, serotonin 4 receptor (5-HT4) agonists are reported to modulate cholinergic function and therefore may provide a new mechanistic approach for treating cognitive deficits assocd. with AD.  Herein the authors communicate the design and synthesis of potent, selective, and brain penetrant 5-HT4 agonists.  The overall goal of the medicinal chem. strategy was identification of structurally diverse clin. candidates with varying intrinsic activities.  The exposure-response relationships between binding affinity, intrinsic activity, receptor occupancy, drug exposure, and pharmacodynamic activity in relevant preclin. models of AD were utilized as key selection criteria for advancing compds.  On the basis of their excellent balance of pharmacokinetic attributes and safety, two lead 5-HT4 partial agonist candidates PF-04995274 and PF-03382792 were chosen for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqT9o-N9H9KbVg90H21EOLACvtfcHk0ljbbSKxg1sW0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGhsLzJ&md5=269b3b0ff783eafbaa8f45a90f320a46</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm300953p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300953p%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DDrummond%26aufirst%3DE.%2BM.%26aulast%3DHudson%26aufirst%3DE.%2BL.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DNoguchi%26aufirst%3DH.%26aulast%3DWaizumi%26aufirst%3DN.%26aulast%3DMcDowell%26aufirst%3DL.%2BL.%26aulast%3DPapanikolaou%26aufirst%3DA.%26aulast%3DPettersen%26aufirst%3DB.%2BA.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DStutzman-Engwall%26aufirst%3DK.%26aulast%3DRubitski%26aufirst%3DD.%2BM.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520multiple%25205-HT4%2520partial%2520agonist%2520clinical%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9240%26epage%3D9254%26doi%3D10.1021%2Fjm300953p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptor agonists for the treatment of Alzheimer’s disease</span>. <i>Neurosci. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.4236/nm.2011.22013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.4236%2Fnm.2011.22013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVKht77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=87-92&author=I.+Ahmadauthor=R.+Nirogi&title=5-HT4+receptor+agonists+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.4236%2Fnm.2011.22013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptor agonists for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ahmad, Ishtiyaque; Nirogi, Ramakrishna</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-92</span>CODEN:
                <span class="NLM_cas:coden">NMEEBO</span>;
        ISSN:<span class="NLM_cas:issn">2158-2912</span>.
    
            (<span class="NLM_cas:orgname">Scientific Research Publishing, Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurol. disorder primarily affecting new memory formation as well as retrieval of previously acquired memories.  According to World Health Organization, current global population suffering from cognitive impairment is estd. to 37 million.  The no. is projected to double in next one and half decade.  Half of the population afflicted with dementia is represented by AD patients.  Current therapies, which provide marginal symptomatic relief to AD patients, are effective only in half of the patient population.  In depth understanding of the mol. mechanism of the disease is urgently required to develop more effective therapies.  Therapies in clin. development may either offer symptomatic relief to patients or provide pure disease modifications, thus limiting benefit to patients.  5-HT4 receptor agonists offer an attractive option for the treatment of AD patients.  Activation of 5-HT4 receptor under preclin. conditions is demonstrated to improve neurotransmission and enhance the release of acetylcholine resulting in the memory formation.  In various cell based and animal models, partial 5-HT4 receptor agonists are demonstrated to promote the release of sol. amyloid precursor protein alpha and block the release of amyloid beta peptide offering suitable candidates as disease modification agents.  Remarkably, 5-HT4 receptor agonists are also reported to induce neurogenesis in hippocampus as well as enteric system through the activation of cAMP response element binding protein in rodents.  Taken together, 5-HT4 agonists address all major facets of Alzheimer's disease and may provide therapeutic potential for other neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuyo7_gJ-VqrVg90H21EOLACvtfcHk0ljbbSKxg1sW0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVKht77M&md5=641e27dc6f84024df4874cbf50bb4598</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4236%2Fnm.2011.22013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4236%252Fnm.2011.22013%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DNirogi%26aufirst%3DR.%26atitle%3D5-HT4%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurosci.%2520Med.%26date%3D2011%26volume%3D2%26spage%3D87%26epage%3D92%26doi%3D10.4236%2Fnm.2011.22013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmeister, R.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptor ligands: applications and new prospects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1021/jm020099f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020099f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1ejsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=319-344&author=M.+Langloisauthor=R.+Fischmeister&title=5-HT4+receptor+ligands%3A+applications+and+new+prospects&doi=10.1021%2Fjm020099f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 Receptor Ligands: Applications and New Prospects</span></div><div class="casAuthors">Langlois, Michel; Fischmeister, Rodolphe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-344</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The present paper describes the recent advances made in medicinal chem. and in the mechanisms proposed to explain the physiol. role of 5-HT4 receptors in the different tissues where they are present and the putative clin. applications of the agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0XyIrWuAGRLVg90H21EOLACvtfcHk0ljcm44s20FNOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1ejsg%253D%253D&md5=a812f9e611bcea02f0e819783fa2f1c9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm020099f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020099f%26sid%3Dliteratum%253Aachs%26aulast%3DLanglois%26aufirst%3DM.%26aulast%3DFischmeister%26aufirst%3DR.%26atitle%3D5-HT4%2520receptor%2520ligands%253A%2520applications%2520and%2520new%2520prospects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D319%26epage%3D344%26doi%3D10.1021%2Fjm020099f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Modica, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittala, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salerno, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siracusa, M. A.</span></span> <span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>3</sub> and 5-HT<sub>4</sub> ligands: An update of medicinal chemistry research in the past few years</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">334</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.2174/092986710790192730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.2174%2F092986710790192730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=20015043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=334-362&author=M.+N.+Modicaauthor=V.+Pittalaauthor=G.+Romeoauthor=L.+Salernoauthor=M.+A.+Siracusa&title=Serotonin+5-HT3+and+5-HT4+ligands%3A+An+update+of+medicinal+chemistry+research+in+the+past+few+years&doi=10.2174%2F092986710790192730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years</span></div><div class="casAuthors">Modica, M. N.; Pittala, V.; Romeo, G.; Salerno, L.; Siracusa, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">334-362</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The biogenic amine serotonin (5-hydroxytryptamine, 5-HT) is one of the most studied neurotransmitters in the central nervous system.  It acts through the activation of at least fourteen 5-HT receptor subtypes.  Over the last two decades, high attention was devoted to the 5-HT3 and 5-HT4 receptors due to their colocalization in the gastrointestinal tract and because their ligands are useful in the treatment of intestinal serotonergic system dysfunctions.  The focus of this review is to discuss the literature concerning recent advances on 5-HT3R and 5-HT4R ligands and their structure-activity relationships from a medicinal chem. perspective.  During the last few years, new and significant progresses have been made in the field of novel potent and selective ligands, mixed ligands, agonists, partial agonists, and antagonists, and a no. of patents have been filed.  Furthermore several ligands targeting the 5-HT3R and 5-HT4R have been proposed for novel therapeutic indications such as the treatment of various psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdNfYoWkWpJbVg90H21EOLACvtfcHk0ljcm44s20FNOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSlsr0%253D&md5=7031f777b035675f1c562ec72c054f85</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986710790192730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710790192730%26sid%3Dliteratum%253Aachs%26aulast%3DModica%26aufirst%3DM.%2BN.%26aulast%3DPittala%26aufirst%3DV.%26aulast%3DRomeo%26aufirst%3DG.%26aulast%3DSalerno%26aufirst%3DL.%26aulast%3DSiracusa%26aufirst%3DM.%2BA.%26atitle%3DSerotonin%25205-HT3%2520and%25205-HT4%2520ligands%253A%2520An%2520update%2520of%2520medicinal%2520chemistry%2520research%2520in%2520the%2520past%2520few%2520years%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D334%26epage%3D362%26doi%3D10.2174%2F092986710790192730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castriconi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennuni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabatini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caselli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rienzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menziani, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbraccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappelli, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship studies in serotonin 5-HT<sub>4</sub> receptor ligands based on a benzo[<i>de</i>][2,6]naphthridine scaffold</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.ejmech.2014.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=24871995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=36-46&author=F.+Castriconiauthor=M.+Paolinoauthor=G.+Giulianiauthor=M.+Anziniauthor=G.+Campianiauthor=L.+Mennuniauthor=C.+Sabatiniauthor=M.+Lanzaauthor=G.+Caselliauthor=F.+De+Rienzoauthor=M.+C.+Menzianiauthor=M.+Sbracciaauthor=P.+Molinariauthor=T.+Costaauthor=A.+Cappelli&title=Synthesis+and+structure-activity+relationship+studies+in+serotonin+5-HT4+receptor+ligands+based+on+a+benzo%5Bde%5D%5B2%2C6%5Dnaphthridine+scaffold&doi=10.1016%2Fj.ejmech.2014.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthyridine scaffold</span></div><div class="casAuthors">Castriconi, Federica; Paolino, Marco; Giuliani, Germano; Anzini, Maurizio; Campiani, Giuseppe; Mennuni, Laura; Sabatini, Chiara; Lanza, Marco; Caselli, Gianfranco; De Rienzo, Francesca; Menziani, Maria Cristina; Sbraccia, Maria; Molinari, Paola; Costa, Tommaso; Cappelli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36-46</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A small series of serotonin 5-HT4 receptor ligands has been designed from flexible 2-methoxyquinoline compds. by applying the conformational constraint approach.  2-Methoxyquinoline compds., e.g., I, and the corresponding conformationally constrained analogs, e.g., II, were synthesized and their interactions with the 5-HT4 receptor were examd. by measuring both binding affinity and the ability to promote or inhibit receptor-G protein coupling.  Ester deriv. I and conformationally constrained compd. II were demonstrated to be the most interesting compds. showing a nanomolar 5-HT4R affinity similar to that shown by ref. ligands cisapride (III) and RS-23,597-190 (IV).  The result was rationalized by docking studies in term of high similarity in the binding modalities of flexible I and conformationally constrained II.  The intrinsic efficacy of some selected ligands was detd. by evaluating the receptor-G protein coupling and the results obtained demonstrated that the nature and the position of substituents play a crit. role in the interaction of these ligands with their receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkr3OLUrCRSLVg90H21EOLACvtfcHk0ljcm44s20FNOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqurfF&md5=f638b3b57a0130f99d4bd9095e53ce9e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DCastriconi%26aufirst%3DF.%26aulast%3DPaolino%26aufirst%3DM.%26aulast%3DGiuliani%26aufirst%3DG.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DSabatini%26aufirst%3DC.%26aulast%3DLanza%26aufirst%3DM.%26aulast%3DCaselli%26aufirst%3DG.%26aulast%3DDe%2BRienzo%26aufirst%3DF.%26aulast%3DMenziani%26aufirst%3DM.%2BC.%26aulast%3DSbraccia%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DCappelli%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520studies%2520in%2520serotonin%25205-HT4%2520receptor%2520ligands%2520based%2520on%2520a%2520benzo%255Bde%255D%255B2%252C6%255Dnaphthridine%2520scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D36%26epage%3D46%26doi%3D10.1016%2Fj.ejmech.2014.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">EPIX Pharmaceuticals</span>. Lead product
candidate-PRX-03140. <a href="http://library.corporate-ir.net/library/91/917/91717/items/297502/EPIX-FactSheet-Alz-071708a.pdf" class="extLink">http://library.corporate-ir.net/library/91/917/91717/items/297502/EPIX-FactSheet-Alz-071708a.pdf</a> (accessed April 23, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EPIX+Pharmaceuticals.+Lead+product%0Acandidate-PRX-03140.+http%3A%2F%2Flibrary.corporate-ir.net%2Flibrary%2F91%2F917%2F91717%2Fitems%2F297502%2FEPIX-FactSheet-Alz-071708a.pdf+%28accessed+April+23%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span> </span><span class="NLM_article-title">EPIX Pharmaceuticals Reports Compelling Clinical Results for PRX-03140
in Alzheimer’s Disease; Statistically Significant Improvement
in Cognitive Function Achieved Within Two Weeks</span>.  <i>Business Wire</i>, Dec 18, 2007. Available at <a href="https://www.businesswire.com/news/home/20071218005206/en/EPIX-Pharmaceuticals-Reports-Compelling-Clinical-Results-PRX-03140" class="extLink">https://www.businesswire.com/news/home/20071218005206/en/EPIX-Pharmaceuticals-Reports-Compelling-Clinical-Results-PRX-03140</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EPIX+Pharmaceuticals+Reports+Compelling+Clinical+Results+for+PRX-03140%0Ain+Alzheimer%E2%80%99s+Disease%3B+Statistically+Significant+Improvement%0Ain+Cognitive+Function+Achieved+Within+Two+Weeks.+Business+Wire%2C+Dec+18%2C+2007.+Available+at+https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20071218005206%2Fen%2FEPIX-Pharmaceuticals-Reports-Compelling-Clinical-Results-PRX-03140."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DEPIX%2520Pharmaceuticals%2520Reports%2520Compelling%2520Clinical%2520Results%2520for%2520PRX-03140%250Ain%2520Alzheimer%25E2%2580%2599s%2520Disease%253B%2520Statistically%2520Significant%2520Improvement%250Ain%2520Cognitive%2520Function%2520Achieved%2520Within%2520Two%2520Weeks%26jtitle%3DBusiness%2520Wire" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti-Gauthier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumireu-Mourat, B.</span></span> <span> </span><span class="NLM_article-title">BIMU1 increases associative memory in rats by activating 5-HT<sub>4</sub> receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(97)00058-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2FS0028-3908%2897%2900058-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=9225296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK2sXktlSrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=697-706&author=E.+Marchetti-Gauthierauthor=F.+S.+Romanauthor=A.+Dumuisauthor=J.+Bockaertauthor=B.+Soumireu-Mourat&title=BIMU1+increases+associative+memory+in+rats+by+activating+5-HT4+receptors&doi=10.1016%2FS0028-3908%2897%2900058-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">BIMU1 increases associative memory in rats by activating 5-HT4 receptors</span></div><div class="casAuthors">Marchetti-Gauthier, E.; Roman, F. S.; Dumuis, A.; Bockaert, J.; Soumireu-Mourat, B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4/5</span>),
    <span class="NLM_cas:pages">697-706</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Olfactory assocn. learning was used to investigate the involvement of 5-HT4 receptors in learning and long-term memory.  The behavioral role of the 5-HT4 receptors was studied by using BIMU1 (3-ethyl-2,3-dihydro-N-[endo-8-methyl-8-azabicyclo(3.2.1)oct-3-yl]-2-oxo-1H-benzimidazole-1-carboxamide, hydrochloride (Boehringer Ingelheim, Italy)); a mixed 5-HT4 agonist/5-HT3 antagonist, and GR125487 (1-[2-[(Me sulfonyl)-amino]ethyl]-4-piperidinyl-Me 5-fluoro-2-methoxy-1H-indole-3-carboxylate; Glaxo Group Research, Hertfordshire, U.K.), a specific 5-HT4 antagonist.  The i.p. injections of BIMU1 at 1, 5, and 10 mg/kg were followed by an substantial improvement (>15% in percentage of correct responses at the dose of 10 mg/kg) in associative memory.  Difficulty rapidly reversing behavioral responses to previously learned assocn., 1 mo later indicated that the BIMU1 effect at 10 mg/kg was not transient, but correlated to long-term memory.  The effects of BIMU1 are most likely to be mediated by 5-HT4 receptors since they were blocked by GR125487 at 10 mg/kg.  These data suggest that activation of 5-HT4 receptors may modulate cognitive processes like learning and memory.  Also, 5-HT4 receptor agonists could be useful for treating mnesic deficits as displayed in patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzX-RtVuCgcbVg90H21EOLACvtfcHk0ljJVcOEmyC8CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlSrtLc%253D&md5=c117d4166934db82f0295bc336555a12</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2897%2900058-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252897%252900058-0%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti-Gauthier%26aufirst%3DE.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DSoumireu-Mourat%26aufirst%3DB.%26atitle%3DBIMU1%2520increases%2520associative%2520memory%2520in%2520rats%2520by%2520activating%25205-HT4%2520receptors%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D697%26epage%3D706%26doi%3D10.1016%2FS0028-3908%2897%2900058-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannoni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaven, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bundel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti-Gauthier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valjent, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span> <span> </span><span class="NLM_article-title">Early administration of RS 67333, a specific 5-HT<sub>4</sub> receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">96</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2013.00096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.3389%2Ffnagi.2013.00096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=24399967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslamsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=96&author=P.+Giannoniauthor=F.+Gavenauthor=D.+de+Bundelauthor=K.+Barangerauthor=E.+Marchetti-Gauthierauthor=F.+S.+Romanauthor=E.+Valjentauthor=P.+Marinauthor=J.+Bockaertauthor=S.+Riveraauthor=S.+Claeysen&title=Early+administration+of+RS+67333%2C+a+specific+5-HT4+receptor+agonist%2C+prevents+amyloidogenesis+and+behavioral+deficits+in+the+5XFAD+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.3389%2Ffnagi.2013.00096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Early administration of RS67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease</span></div><div class="casAuthors">Giannoni, Patrizia; Gaven, Florence; Bundel, Dimitride; Baranger, Kevin; Marchetti-Gauthier, Evelyne; Roman, Francois S.; Valjent, Emmanuel; Marin, Philippe; Bockaert, Joeel; Rivera, Santiago; Claeysen, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Dec.</span>),
    <span class="NLM_cas:pages">96/1-96/12</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Amyloid β (Aβ) accumulation is considered the main culprit in the pathogenesis of Alzheimer's disease (AD).  Recent studies suggest that decreasing Aβ prodn. at very early stages of AD could be a promising strategy to slow down disease progression.  Serotonin 5-HT4 receptor activation stimulates α-cleavage of the amyloid precursor protein (APP), leading to the release of the sol. and neurotrophic sAPPα fragment and thus precluding Aβ formation.  Using the 5XFAD mouse model of AD that shows accelerated Aβ deposition, we investigated the effect of chronic treatments (treatment onset at different ages and different durations) with the 5-HT4 receptor agonist RS 67333 during the asymptomatic phase of the disease.  Chronic administration of RS 67333 decreased concomitantly the no. of amyloid plaques and the level of Aβ species.  Redn. of Aβ levels was accompanied by a striking decrease in hippocampal astrogliosis and microgliosis.  RS 67333 also transiently increased sAPPα concn. in the cerebrospinal fiuid and brain.  Moreover, a specific 5-HT4 receptor antagonist (RS 39604) prevented the RS 67333-mediated redn. of the amyloid pathol.  Finally, the novel object recognition test deficits of 5XFAD mice were reversed by chronic treatment with RS 67333.  Collectively, these results strongly highlight this 5-HT4 receptor agonist as a promising disease modifying-agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIgv-fla4yPLVg90H21EOLACvtfcHk0ljJVcOEmyC8CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslamsbzJ&md5=3370afc60266e72919e21e8df93f17b4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2013.00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2013.00096%26sid%3Dliteratum%253Aachs%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3Dde%2BBundel%26aufirst%3DD.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DMarchetti-Gauthier%26aufirst%3DE.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DValjent%26aufirst%3DE.%26aulast%3DMarin%26aufirst%3DP.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DClaeysen%26aufirst%3DS.%26atitle%3DEarly%2520administration%2520of%2520RS%252067333%252C%2520a%2520specific%25205-HT4%2520receptor%2520agonist%252C%2520prevents%2520amyloidogenesis%2520and%2520behavioral%2520deficits%2520in%2520the%25205XFAD%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2013%26volume%3D5%26spage%3D96%26doi%3D10.3389%2Ffnagi.2013.00096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambhampati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraf, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badange, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyala, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojja, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reballi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasti, V.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (SUVN-502): A novel, potent, selective and orally active serotonin 6 (5-HT<sub>6</sub>) receptor antagonist for potential treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1843-1859&author=R.+Nirogiauthor=A.+Shindeauthor=R.+S.+Kambhampatiauthor=A.+R.+Mohammedauthor=S.+K.+Sarafauthor=R.+K.+Badangeauthor=T.+R.+Bandyalaauthor=V.+Bhattaauthor=K.+Bojjaauthor=V.+Reballiauthor=R.+Subramanianauthor=V.+Benadeauthor=R.+C.+Palacharlaauthor=G.+Bhyrapuneniauthor=P.+Jayarajanauthor=V.+Goyalauthor=V.+Jasti&title=Discovery+and+development+of+1-%5B%282-bromophenyl%29sulfonyl%5D-5-methoxy-3-%5B%284-methyl-1-piperazinyl%29methyl%5D-1H-indole+dimesylate+monohydrate+%28SUVN-502%29%3A+A+novel%2C+potent%2C+selective+and+orally+active+serotonin+6+%285-HT6%29+receptor+antagonist+for+potential+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Nirogi, Ramakrishna; Shinde, Anil; Kambhampati, Rama Sastry; Mohammed, Abdul Rasheed; Saraf, Sangram Keshari; Badange, Rajesh kumar; Bandyala, Thrinath Reddy; Bhatta, Venugopalarao; Bojja, Kumar; Reballi, Veena; Subramanian, Ramkumar; Benade, Vijay; Palacharla, Raghava Choudary; Bhyrapuneni, Gopinadh; Jayarajan, Pradeep; Goyal, Vinod; Jasti, Venkat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1843-1859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a novel series of 3-(piperazinylmethyl) indole derivs. as 5-hydroxytryptamine-6 receptor (5-HT6R) antagonists resulted in identification of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (5al, SUVN-502) as a clin. candidate for potential treatment of cognitive disorders.  It has high affinity at human 5-HT6R (Ki = 2.04 nM) and selectivity over 100 target sites which include receptors, enzymes, peptides, growth factors, ion channels, steroids, immunol. factors, second messengers, and prostaglandins.  It has high selectivity over 5-HT2A receptor.  It is orally bioavailable and brain penetrant with robust preclin. efficacy.  The combination of 5al, donepezil, and memantine (triple combination) produces synergistic effects in extracellular levels of acetylcholine in the ventral hippocampus.  Preclin. efficacy in triple combination and high selectivity over 5-HT2A receptors are the differentiating features which culminated in selection of 5al for further development.  The Phase-1 evaluation of safety and pharmacokinetics has been completed, allowing for the initiation of a Phase-2 proof of concept study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_gw476vRgPbVg90H21EOLACvtfcHk0ljJVcOEmyC8CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D&md5=26e4f0c1c34255ce2c2ef3bbf3c06a85</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01662%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DKambhampati%26aufirst%3DR.%2BS.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DSaraf%26aufirst%3DS.%2BK.%26aulast%3DBadange%26aufirst%3DR.%2BK.%26aulast%3DBandyala%26aufirst%3DT.%2BR.%26aulast%3DBhatta%26aufirst%3DV.%26aulast%3DBojja%26aufirst%3DK.%26aulast%3DReballi%26aufirst%3DV.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DJasti%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520development%2520of%25201-%255B%25282-bromophenyl%2529sulfonyl%255D-5-methoxy-3-%255B%25284-methyl-1-piperazinyl%2529methyl%255D-1H-indole%2520dimesylate%2520monohydrate%2520%2528SUVN-502%2529%253A%2520A%2520novel%252C%2520potent%252C%2520selective%2520and%2520orally%2520active%2520serotonin%25206%2520%25285-HT6%2529%2520receptor%2520antagonist%2520for%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1843%26epage%3D1859%26doi%3D10.1021%2Facs.jmedchem.6b01662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogaraju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagginapalli, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravella, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddana, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of imidazo[1,5-<i>a</i>]pyridine derivatives as 5-HT<sub>4</sub> receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.ejmech.2015.08.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=26363507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=289-301&author=R.+Nirogiauthor=A.+R.+Mohammedauthor=A.+Shindeauthor=N.+Bogarajuauthor=S.+R.+Gagginapalliauthor=S.+R.+Ravellaauthor=L.+Kotaauthor=G.+Bhyrapuneniauthor=N.+R.+Muddanaauthor=V.+Benadeauthor=R.+C.+Palacharlaauthor=P.+Jayarajanauthor=R.+Subramanianauthor=V.+Goyal&title=Synthesis+and+SAR+of+imidazo%5B1%2C5-a%5Dpyridine+derivatives+as+5-HT4+receptor+partial+agonists+for+the+treatment+of+cognitive+disorders+associated+with+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2015.08.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease</span></div><div class="casAuthors">Nirogi, Ramakrishna; Mohammed, Abdul Rasheed; Shinde, Anil K.; Bogaraju, Narsimha; Gagginapalli, Shankar Reddy; Ravella, Srinivasa Rao; Kota, Laxman; Bhyrapuneni, Gopinadh; Muddana, Nageswara Rao; Benade, Vijay; Palacharla, Raghava Chowdary; Jayarajan, Pradeep; Subramanian, Ramkumar; Goyal, Vinod Kumar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">289-301</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disease which has a higher prevalence and incidence in older people.  The need for improved AD therapies is unmet.  The 5-hydroxytryptamine4 receptor (5-HT4R) partial agonists may be of benefit for both the symptomatic and disease-modifying treatment of cognitive disorders assocd. with AD.  Herein, we report the design, synthesis and SAR of imidazo[1,5-a] pyridine derivs. as 5-HT4R partial agonists.  The focused SAR, optimization of ADME properties resulted the discovery of compd. I as potent, selective, brain penetrant 5-HT4 partial agonist as a lead compd. with good ADME properties and efficacy in both symptomatic and disease modifying animal models of cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy8ulfS2opHrVg90H21EOLACvtfcHk0liXCjKBNlgrHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2nsrzO&md5=5d43819ce00762e923aee113fb2721f4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.051%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DBogaraju%26aufirst%3DN.%26aulast%3DGagginapalli%26aufirst%3DS.%2BR.%26aulast%3DRavella%26aufirst%3DS.%2BR.%26aulast%3DKota%26aufirst%3DL.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DMuddana%26aufirst%3DN.%2BR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DGoyal%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520imidazo%255B1%252C5-a%255Dpyridine%2520derivatives%2520as%25205-HT4%2520receptor%2520partial%2520agonists%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%2520associated%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D289%26epage%3D301%26doi%3D10.1016%2Fj.ejmech.2015.08.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiriveedhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kota, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraf, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badange, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R.</span></span> <span> </span><span class="NLM_article-title">Benzamide derivatives and their constrained analogs as histamine H<sub>3</sub> receptor antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.ejmech.2015.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=26731168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC28XptFaj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2016&pages=655-662&author=R.+Nirogiauthor=A.+Shindeauthor=V.+Tiriveedhiauthor=L.+Kotaauthor=S.+K.+Sarafauthor=R.+K.+Badangeauthor=A.+R.+Mohammedauthor=R.+Subramanianauthor=N.+Muddanaauthor=G.+Bhyrapuneniauthor=R.+Abraham&title=Benzamide+derivatives+and+their+constrained+analogs+as+histamine+H3+receptor+antagonists&doi=10.1016%2Fj.ejmech.2015.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists</span></div><div class="casAuthors">Nirogi, Ramakrishna; Shinde, Anil; Tiriveedhi, Vinaykumar; Kota, Laxman; Saraf, Sangram Keshari; Badange, Rajesh Kumar; Mohammed, Abdul Rasheed; Subramanian, Ramkumar; Muddana, Nageshwararao; Bhyrapuneni, Gopinadh; Abraham, Renny</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">655-662</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of substituted [(4-piperidinyl)oxy]benzamides and substituted [(4-piperidinyl)oxy]-3,4-dihydro-2H-isoquinolin-1-one derivs. have been synthesized and tested for their binding affinity towards H3 receptor.  Most of these synthesized compds. have displayed potent binding affinity for H3 receptor when tested in in vitro binding assay.  Preliminary SAR studies, functional activity, pharmacokinetic profile and efficacy profile constitute the subject matter of this communication.  The synthesis of the target compds. was achieved using 4-[(4-piperidinyl)oxy]benzoic acid derivs. as intermediates.  Corresponding amide analogs included 1-isoquinolinone derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBGI2izDp8FLVg90H21EOLACvtfcHk0liXCjKBNlgrHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptFaj&md5=9d5fe398cfdaab5d6568cebb6aad27fc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DTiriveedhi%26aufirst%3DV.%26aulast%3DKota%26aufirst%3DL.%26aulast%3DSaraf%26aufirst%3DS.%2BK.%26aulast%3DBadange%26aufirst%3DR.%2BK.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DMuddana%26aufirst%3DN.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DAbraham%26aufirst%3DR.%26atitle%3DBenzamide%2520derivatives%2520and%2520their%2520constrained%2520analogs%2520as%2520histamine%2520H3%2520receptor%2520antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D108%26spage%3D655%26epage%3D662%26doi%3D10.1016%2Fj.ejmech.2015.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suven Life Sciences
Limited</span>.  <i>A study to investigate the
safety, tolerability
and pharmacokinetics of SUVN-D4010 in healthy subjects</i>; NCT02575482; <span class="NLM_publisher-name">ClinicalTrials.gov</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, Oct 14, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Suven+Life+Sciences%0ALimited&title=A+study+to+investigate+the%0Asafety%2C+tolerability%0Aand+pharmacokinetics+of+SUVN-D4010+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DA%2520study%2520to%2520investigate%2520the%250Asafety%252C%2520tolerability%250Aand%2520pharmacokinetics%2520of%2520SUVN-D4010%2520in%2520healthy%2520subjects%26pub%3DClinicalTrials.gov%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21.2"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suven Life Sciences
Limited</span>.  <i>A Study to Investigate the
Effect of Food, Gender, and Age on the Pharmacokinetic Profile of
SUVN-D4010 in Healthy Subjects</i>; NCT03031574; <span class="NLM_publisher-name">ClinicalTrials.gov</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, Jan 25, <span class="NLM_year">2017</span>. Available at <a href="https://clinicaltrials.gov/ct2/results?cond=&amp;term=suvn-D4010&amp;cntry=&amp;state=&amp;city=&amp;dist=" class="extLink">https://clinicaltrials.gov/ct2/results?cond=&term=suvn-D4010&cntry=&state=&city=&dist=</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=Suven+Life+Sciences%0ALimited&title=A+Study+to+Investigate+the%0AEffect+of+Food%2C+Gender%2C+and+Age+on+the+Pharmacokinetic+Profile+of%0ASUVN-D4010+in+Healthy+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21.2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DA%2520Study%2520to%2520Investigate%2520the%250AEffect%2520of%2520Food%252C%2520Gender%252C%2520and%2520Age%2520on%2520the%2520Pharmacokinetic%2520Profile%2520of%250ASUVN-D4010%2520in%2520Healthy%2520Subjects%26pub%3DClinicalTrials.gov%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soulier, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicsic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathé-Allainmat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brémont, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croci, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardamone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aureggi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, M.</span></span> <span> </span><span class="NLM_article-title">New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT<sub>4</sub> receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1021/jm960320m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960320m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVSktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=608-621&author=D.+Yangauthor=J.+L.+Soulierauthor=S.+Sicsicauthor=M.+Math%C3%A9-Allainmatauthor=B.+Br%C3%A9montauthor=T.+Crociauthor=R.+Cardamoneauthor=G.+Aureggiauthor=M.+Langlois&title=New+esters+of+4-amino-5-chloro-2-methoxybenzoic+acid+as+potent+agonists+and+antagonists+for+5-HT4+receptors&doi=10.1021%2Fjm960320m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">New Esters of 4-Amino-5-chloro-2-methoxybenzoic Acid as Potent Agonists and Antagonists for 5-HT4 Receptors</span></div><div class="casAuthors">Yang, Donglai; Soulier, Jean-Louis; Sicsic, Sames; Mathe-Allainmat, Monique; Bremont, Beatrice; Croci, Tiziano; Cardamone, Rosanna; Aureggi, Giulio; Langlois, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">608-621</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A no. of benzoates derived from 4-amino-5-chloro-2-methoxybenzoic acid and substituted 1-piperidineethanol were prepd. and found to be potent 5-HT4 receptor agonists in the elec.-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum and the rat esophagus muscle.  Monosubstitution of the piperidine ring with Me, OH, NH-Ac, or CONH2 groups gave compds. equipotent to 2-piperidinoethyl-4-amino-2-methoxybenzoate-HCl (I) (ML 10302), a 5-HT4 receptor agonist previously reported to have nanomolar affinity.  I and 2-(3-(S)-hydroxypiperidino)ethyl-4-amino-2-methoxybenzoate-HCl (II) were as potent as serotonin (5-HT) but had maximal responses which were only 60-80% of that of 5-HT, suggesting a partial agonist profile for these compds.  Binding assays were performed with [3H]GR 113808 in the rat striatum, and several of these compds. were found to have nanomolar affinity for 5-HT4 receptors (I, Ki = 1.07; II, Ki = 1.0 nM).  The introduction of 2 Me groups on the piperidine ring brought about a dramatic change in the pharmacol. profile of 2-[(cis- and trans-3,5-dimethylpiperidinyl)ethyl]-4-amino-5-chloro-2-methoxybenzoate (III-cis isomer).  III (Ki = 0.26 nM) inhibited the relaxant action of 5-HT in the rat esophagus muscle with a pA2 value of 8.6.  The advantage of the ester function was demonstrated by comparing the activity of several such compds. at 5-HT4 receptors with those of the corresponding amide derivs.  This difference was less marked when the basic moiety was sterically constrained as in the quinuclidine and tropane moieties.  Structural analyses of I and III were performed by detg. their X-ray crystal structures and by mol. modeling (SYBYL).  A relatively limited no. of min. energy conformers was found for both compds.  They were characterized by the cis folded conformation of the Et chain and by the orientation of the lone pair of the nitrogen atom pointing out of the mol. as seen in conformationally-constrained benzamides such as zacopride and renzapride.  A hypothetical model for the 5-HT4 receptor with 2 sites for the binding of agonist and antagonist mols. was proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-i-Mdpx5yirVg90H21EOLACvtfcHk0lgizJ1PFYi6VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVSktb4%253D&md5=9a560dbfd938b39801cea1109316f80c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm960320m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960320m%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DD.%26aulast%3DSoulier%26aufirst%3DJ.%2BL.%26aulast%3DSicsic%26aufirst%3DS.%26aulast%3DMath%25C3%25A9-Allainmat%26aufirst%3DM.%26aulast%3DBr%25C3%25A9mont%26aufirst%3DB.%26aulast%3DCroci%26aufirst%3DT.%26aulast%3DCardamone%26aufirst%3DR.%26aulast%3DAureggi%26aufirst%3DG.%26aulast%3DLanglois%26aufirst%3DM.%26atitle%3DNew%2520esters%2520of%25204-amino-5-chloro-2-methoxybenzoic%2520acid%2520as%2520potent%2520agonists%2520and%2520antagonists%2520for%25205-HT4%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D608%26epage%3D621%26doi%3D10.1021%2Fjm960320m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McKinnell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beattie, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatheree, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquess, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, R. G.</span></span> <span> </span><span class="NLM_article-title">Discovery of TD-8954, a clinical stage 5-HT<sub>4</sub> receptor agonist with gastrointestinal prokinetic properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4210</span>– <span class="NLM_lpage">4215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.bmcl.2013.05.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4210-4215&author=R.+M.+McKinnellauthor=S.+R.+Armstrongauthor=D.+T.+Beattieauthor=P.+R.+Fathereeauthor=D.+D.+Longauthor=D.+G.+Marquessauthor=J.+P.+Shawauthor=R.+G.+Vickery&title=Discovery+of+TD-8954%2C+a+clinical+stage+5-HT4+receptor+agonist+with+gastrointestinal+prokinetic+properties&doi=10.1016%2Fj.bmcl.2013.05.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DMcKinnell%26aufirst%3DR.%2BM.%26aulast%3DArmstrong%26aufirst%3DS.%2BR.%26aulast%3DBeattie%26aufirst%3DD.%2BT.%26aulast%3DFatheree%26aufirst%3DP.%2BR.%26aulast%3DLong%26aufirst%3DD.%2BD.%26aulast%3DMarquess%26aufirst%3DD.%2BG.%26aulast%3DShaw%26aufirst%3DJ.%2BP.%26aulast%3DVickery%26aufirst%3DR.%2BG.%26atitle%3DDiscovery%2520of%2520TD-8954%252C%2520a%2520clinical%2520stage%25205-HT4%2520receptor%2520agonist%2520with%2520gastrointestinal%2520prokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4210%26epage%3D4215%26doi%3D10.1016%2Fj.bmcl.2013.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. A.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Staudinger reactions within density functional theory</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">4299</span>– <span class="NLM_lpage">4308</span>, <span class="refDoi"> DOI: 10.1021/jo049702n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo049702n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVKhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=4299-4308&author=W.+Q.+Tianauthor=Y.+A.+Wang&title=Mechanisms+of+Staudinger+reactions+within+density+functional+theory&doi=10.1021%2Fjo049702n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Staudinger Reactions within Density Functional Theory</span></div><div class="casAuthors">Tian, Wei Quan; Wang, Yan Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4299-4308</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Staudinger reaction of trialkyl- and triphenylphosphines with azides R1N3, affording phosphinimines, was investigated by using d. functional theory.  Geometry optimization of addn. products R3PN:N:NR1 revealed strong preference of cis-adducts as a consequence of addnl. P-Nγ bonding.  The one-step reaction through γ-adduct R3PNR1(:N:N) was ruled out on the basis of high energy barrier γ-TS.  Cis-Adduct is then isomerized to dihydro-1,2,3-triazaphosphete intermediate, which liberates N2 and product phosphinimine.  For R1 = F or Ph, the cyclic intermediate was not localized, and elimination of N2 proceeds directly from the cis-adduct.  The preference of the initial cis-transition state reaction pathway is thoroughly discussed.  The relative stability of the cis- and the trans-intermediates is explored and analyzed with the aid of MOs.  The effects of substituents and solvent effects on the reaction mechanisms of the Staudinger reactions are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUWOnoWXlQ3rVg90H21EOLACvtfcHk0lgizJ1PFYi6VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVKhs7o%253D&md5=e364b77fa012773bff4a4b0a8c2a858b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo049702n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049702n%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DW.%2BQ.%26aulast%3DWang%26aufirst%3DY.%2BA.%26atitle%3DMechanisms%2520of%2520Staudinger%2520reactions%2520within%2520density%2520functional%2520theory%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D4299%26epage%3D4308%26doi%3D10.1021%2Fjo049702n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span> <span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2529</span>, <span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lj6Lv0otFO2FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bostrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowright, A. T.</span></span> <span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1830</span>, <span class="refDoi"> DOI: 10.1021/jm2013248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostromauthor=A.+Hognerauthor=A.+Llinasauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemistry&doi=10.1021%2Fjm2013248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazoles in medicinal chemistry</span></div><div class="casAuthors">Bostrom Jonas; Hogner Anders; Llinas Antonio; Wellner Eric; Plowright Alleyn T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms.  Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities.  The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection.  In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner.  Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers.  The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments).  To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO9RQiG9xFS2Zyxfu64m4ffW6udTcc2eak92eywoPL97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D&md5=b934995431ced1be297e6f126262f3cb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostrom%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830%26doi%3D10.1021%2Fjm2013248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bermudez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fake, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joiner, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joiner, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miner, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanger, G. J.</span></span> <span> </span><span class="NLM_article-title">5-Hydroxytryptamine (5-HT<sub>3</sub>) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1924</span>, <span class="refDoi"> DOI: 10.1021/jm00169a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00169a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK3cXksVSmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1924&author=J.+Bermudezauthor=C.+S.+Fakeauthor=G.+F.+Joinerauthor=K.+A.+Joinerauthor=F.+D.+Kingauthor=W.+D.+Minerauthor=G.+J.+Sanger&title=5-Hydroxytryptamine+%285-HT3%29+receptor+antagonists.+1.+Indazole+and+indolizine-3-carboxylic+acid+derivatives&doi=10.1021%2Fjm00169a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine (5-HT3) receptor antagonists.  1.  Indazole and indolizine-3-carboxylic acid derivatives</span></div><div class="casAuthors">Bermudez, Jose; Fake, Charles S.; Joiner, Graham F.; Joiner, Karen A.; King, Frank D.; Miner, Wesley D.; Sanger, Gareth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1924-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Indazolecarboxamides I (X = NH; R = H, Me, Et; R1 = H, F, Cl; n = 2,3), I (X = O, R = H, Me, R1 = H, n = 2), indolizinecarboxamides II (X = N, X1 = C, Z = CH, R2 = H, Me, Et, Ph, n = 2) and the imidazopyridines II (X = C, X1 = Z = N, R2 = Et, n = 2, 3) were prepd. as potent 5-HT3 receptor antagonists devoid of dopamine antagonist and gastric motility stimulatory properties.  Other analogs, e.g., III, with conformationally restricted side chain were also prepd.  Of all the compds. prepd. and tested, I (R = Me, R1 = H, X = NH, n =3) was both potent and selective and was a very effective antiemetic agent against cytotoxic drug-induced emesis both in the ferret and in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs3Xk31qhN4LVg90H21EOLACvtfcHk0li8Yackr1T7XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXksVSmt7s%253D&md5=382cee99c0f2e579545167f500726cd5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00169a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00169a016%26sid%3Dliteratum%253Aachs%26aulast%3DBermudez%26aufirst%3DJ.%26aulast%3DFake%26aufirst%3DC.%2BS.%26aulast%3DJoiner%26aufirst%3DG.%2BF.%26aulast%3DJoiner%26aufirst%3DK.%2BA.%26aulast%3DKing%26aufirst%3DF.%2BD.%26aulast%3DMiner%26aufirst%3DW.%2BD.%26aulast%3DSanger%26aufirst%3DG.%2BJ.%26atitle%3D5-Hydroxytryptamine%2520%25285-HT3%2529%2520receptor%2520antagonists.%25201.%2520Indazole%2520and%2520indolizine-3-carboxylic%2520acid%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1924%26doi%3D10.1021%2Fjm00169a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapp, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">Metabolism of a serotonin-4 receptor partial agonist 4-{4-[4-tetrahydrofuran-3-yloxy)-benzo[d]Isoxazol-3-yloxymethyl]-piperidin-1-ylmethyl}-tetrahydropyran-4-ol (TBPT): Identification of an unusual pharmacologically active cyclized oxazolidine metabolite in human</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">3277</span>– <span class="NLM_lpage">3293</span>, <span class="refDoi"> DOI: 10.1002/jps.23542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1002%2Fjps.23542" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=3277-3293&author=A.+Sawant-Basakauthor=K.+J.+Coffmanauthor=G.+S.+Walkerauthor=T.+F.+Ryderauthor=E.+Tsengauthor=E.+Millerauthor=C.+Leeauthor=M.+A.+Vanase-Frawleyauthor=J.+W.+Wongauthor=M.+A.+Brodneyauthor=T.+Rappauthor=R.+S.+Obach&title=Metabolism+of+a+serotonin-4+receptor+partial+agonist+4-%7B4-%5B4-tetrahydrofuran-3-yloxy%29-benzo%5Bd%5DIsoxazol-3-yloxymethyl%5D-piperidin-1-ylmethyl%7D-tetrahydropyran-4-ol+%28TBPT%29%3A+Identification+of+an+unusual+pharmacologically+active+cyclized+oxazolidine+metabolite+in+human&doi=10.1002%2Fjps.23542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjps.23542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23542%26sid%3Dliteratum%253Aachs%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DWong%26aufirst%3DJ.%2BW.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DRapp%26aufirst%3DT.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMetabolism%2520of%2520a%2520serotonin-4%2520receptor%2520partial%2520agonist%25204-%257B4-%255B4-tetrahydrofuran-3-yloxy%2529-benzo%255Bd%255DIsoxazol-3-yloxymethyl%255D-piperidin-1-ylmethyl%257D-tetrahydropyran-4-ol%2520%2528TBPT%2529%253A%2520Identification%2520of%2520an%2520unusual%2520pharmacologically%2520active%2520cyclized%2520oxazolidine%2520metabolite%2520in%2520human%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D3277%26epage%3D3293%26doi%3D10.1002%2Fjps.23542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antunes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biala, G.</span></span> <span> </span><span class="NLM_article-title">The novel object recognition memory: neurobiology, test procedure, and its modifications</span>. <i>Cogn. Process</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1007/s10339-011-0430-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1007%2Fs10339-011-0430-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=22160349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A280%3ADC%252BC38zoslWlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=93-110&author=M.+Antunesauthor=G.+Biala&title=The+novel+object+recognition+memory%3A+neurobiology%2C+test+procedure%2C+and+its+modifications&doi=10.1007%2Fs10339-011-0430-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The novel object recognition memory: neurobiology, test procedure, and its modifications</span></div><div class="casAuthors">Antunes M; Biala G</div><div class="citationInfo"><span class="NLM_cas:title">Cognitive processing</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">93-110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal models of memory have been considered as the subject of many scientific publications at least since the beginning of the twentieth century.  In humans, memory is often accessed through spoken or written language, while in animals, cognitive functions must be accessed through different kind of behaviors in many specific, experimental models of memory and learning.  Among them, the novel object recognition test can be evaluated by the differences in the exploration time of novel and familiar objects.  Its application is not limited to a field of research and enables that various issues can be studied, such as the memory and learning, the preference for novelty, the influence of different brain regions in the process of recognition, and even the study of different drugs and their effects.  This paper describes the novel object recognition paradigms in animals, as a valuable measure of cognition.  The purpose of this work was to review the neurobiology and methodological modifications of the test commonly used in behavioral pharmacology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQocv30hVI3YVf1XRtfYM0dfW6udTcc2eYyVWXnOnqcILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zoslWlsQ%253D%253D&md5=4f73ed1bafb04056c5aef19b1b86c802</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs10339-011-0430-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10339-011-0430-z%26sid%3Dliteratum%253Aachs%26aulast%3DAntunes%26aufirst%3DM.%26aulast%3DBiala%26aufirst%3DG.%26atitle%3DThe%2520novel%2520object%2520recognition%2520memory%253A%2520neurobiology%252C%2520test%2520procedure%252C%2520and%2520its%2520modifications%26jtitle%3DCogn.%2520Process%26date%3D2012%26volume%3D13%26spage%3D93%26epage%3D110%26doi%3D10.1007%2Fs10339-011-0430-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medapati, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanmuganathan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandikere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irappanavar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddana, N.</span></span> <span> </span><span class="NLM_article-title">Difference in the norepinephrine levels of experimental and non-experimental rats with age in the object recognition task</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1453</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2012.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.brainres.2012.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=22464882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFeltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1453&publication_year=2012&pages=40-45&author=R.+Nirogiauthor=R.+Abrahamauthor=P.+Jayarajanauthor=R.+B.+Medapatiauthor=D.+Shanmuganathanauthor=V.+Kandikereauthor=S.+Irappanavarauthor=R.+Saralayaauthor=V.+Benadeauthor=G.+Bhyrapuneniauthor=N.+Muddana&title=Difference+in+the+norepinephrine+levels+of+experimental+and+non-experimental+rats+with+age+in+the+object+recognition+task&doi=10.1016%2Fj.brainres.2012.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Difference in the norepinephrine levels of experimental and non-experimental rats with age in the object recognition task</span></div><div class="casAuthors">Nirogi, Ramakrishna; Abraham, Renny; Jayarajan, Pradeep; Medapati, Rajesh Babu; Shanmuganathan, Dhanalakshmi; Kandikere, Vishwottam; Irappanavar, Shantaveer; Saralaya, Ramanatha; Benade, Vijay; Bhyrapuneni, Gopinadh; Muddana, Nageswararao</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1453</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40-45</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present study, we investigated the performance of adult and juvenile rats in the Object Recognition Task (ORT).  While it is well known that the performance of rat in ORT differs with age, the reason for the difference as well as the underlying neurotransmitter that may have led to these differences were investigated.  In the present study, juvenile rats of postnatal day 40-45 (PND 40-45) and adult rats of postnatal day 60+ (PND 60+) were subjected to a two trial ORT.  The juvenile rats did not discriminate between the novel object and the familiar object, while the adult rats discriminated the novel from the familiar object.  On estg. brain concns. of norepinephrine (NE), it was obsd. that the NE level in MTL (medial temporal lobe) of adult exptl. rats was significantly higher than the adult non-exptl. rats.  In juvenile rats, no significant difference was obsd. in the NE levels of exptl. rats in comparison to its non-exptl. counterparts.  Administration of yohimbine (α2A adrenergic receptor antagonist) enhanced the level of NE in juvenile rats and reversed the difference seen with age.  From the present study, we conclude that the deficit in memory seen is likely due to the difference in NE levels with task and this can be reversed by yohimbine which enhance NE levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzGeFKjEr4j7Vg90H21EOLACvtfcHk0lhSASNkECChMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFeltb0%253D&md5=8c0fea2283e6a5f57fd74ae28b94aee8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2012.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2012.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DAbraham%26aufirst%3DR.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DMedapati%26aufirst%3DR.%2BB.%26aulast%3DShanmuganathan%26aufirst%3DD.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DIrappanavar%26aufirst%3DS.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DMuddana%26aufirst%3DN.%26atitle%3DDifference%2520in%2520the%2520norepinephrine%2520levels%2520of%2520experimental%2520and%2520non-experimental%2520rats%2520with%2520age%2520in%2520the%2520object%2520recognition%2520task%26jtitle%3DBrain%2520Res.%26date%3D2012%26volume%3D1453%26spage%3D40%26epage%3D45%26doi%3D10.1016%2Fj.brainres.2012.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Child, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantaloni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondouin, G.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptors improve social olfactory memory in the rat</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(96)00169-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2FS0028-3908%2896%2900169-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=681-687&author=S.+Lettyauthor=R.+Childauthor=A.+Dumuisauthor=A.+Pantaloniauthor=J.+Bockaertauthor=G.+Rondouin&title=5-HT4+receptors+improve+social+olfactory+memory+in+the+rat&doi=10.1016%2FS0028-3908%2896%2900169-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2896%2900169-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252896%252900169-4%26sid%3Dliteratum%253Aachs%26aulast%3DLetty%26aufirst%3DS.%26aulast%3DChild%26aufirst%3DR.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DPantaloni%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DRondouin%26aufirst%3DG.%26atitle%3D5-HT4%2520receptors%2520improve%2520social%2520olfactory%2520memory%2520in%2520the%2520rat%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D681%26epage%3D687%26doi%3D10.1016%2FS0028-3908%2896%2900169-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti-Gauthier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soumireu-Mourat, B.</span></span> <span> </span><span class="NLM_article-title">BIMU1 increases associative memory in rats by activating 5-HT<sub>4</sub> receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(97)00058-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2FS0028-3908%2897%2900058-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=9225296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADyaK2sXktlSrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=697-706&author=E.+Marchetti-Gauthierauthor=F.+S.+Romanauthor=A.+Dumuisauthor=J.+Bockaertauthor=B.+Soumireu-Mourat&title=BIMU1+increases+associative+memory+in+rats+by+activating+5-HT4+receptors&doi=10.1016%2FS0028-3908%2897%2900058-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">BIMU1 increases associative memory in rats by activating 5-HT4 receptors</span></div><div class="casAuthors">Marchetti-Gauthier, E.; Roman, F. S.; Dumuis, A.; Bockaert, J.; Soumireu-Mourat, B.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4/5</span>),
    <span class="NLM_cas:pages">697-706</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Olfactory assocn. learning was used to investigate the involvement of 5-HT4 receptors in learning and long-term memory.  The behavioral role of the 5-HT4 receptors was studied by using BIMU1 (3-ethyl-2,3-dihydro-N-[endo-8-methyl-8-azabicyclo(3.2.1)oct-3-yl]-2-oxo-1H-benzimidazole-1-carboxamide, hydrochloride (Boehringer Ingelheim, Italy)); a mixed 5-HT4 agonist/5-HT3 antagonist, and GR125487 (1-[2-[(Me sulfonyl)-amino]ethyl]-4-piperidinyl-Me 5-fluoro-2-methoxy-1H-indole-3-carboxylate; Glaxo Group Research, Hertfordshire, U.K.), a specific 5-HT4 antagonist.  The i.p. injections of BIMU1 at 1, 5, and 10 mg/kg were followed by an substantial improvement (>15% in percentage of correct responses at the dose of 10 mg/kg) in associative memory.  Difficulty rapidly reversing behavioral responses to previously learned assocn., 1 mo later indicated that the BIMU1 effect at 10 mg/kg was not transient, but correlated to long-term memory.  The effects of BIMU1 are most likely to be mediated by 5-HT4 receptors since they were blocked by GR125487 at 10 mg/kg.  These data suggest that activation of 5-HT4 receptors may modulate cognitive processes like learning and memory.  Also, 5-HT4 receptor agonists could be useful for treating mnesic deficits as displayed in patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzX-RtVuCgcbVg90H21EOLACvtfcHk0lhSASNkECChMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlSrtLc%253D&md5=c117d4166934db82f0295bc336555a12</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2897%2900058-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252897%252900058-0%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti-Gauthier%26aufirst%3DE.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DSoumireu-Mourat%26aufirst%3DB.%26atitle%3DBIMU1%2520increases%2520associative%2520memory%2520in%2520rats%2520by%2520activating%25205-HT4%2520receptors%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D697%26epage%3D706%26doi%3D10.1016%2FS0028-3908%2897%2900058-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandikere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saralaya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajjala, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleti, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span> <span> </span><span class="NLM_article-title"><i>In vivo</i> rat striatal 5-HT<sub>4</sub> receptor occupancy using non-radiolabelled SB207145</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">704</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1111/jphp.12030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1111%2Fjphp.12030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=23600388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1Wks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=704-712&author=R.+Nirogiauthor=V.+Kandikereauthor=G.+Bhyrapuneniauthor=R.+Saralayaauthor=D.+R.+Ajjalaauthor=R.+R.+Aletiauthor=A.+R.+Mohammed&title=In+vivo+rat+striatal+5-HT4+receptor+occupancy+using+non-radiolabelled+SB207145&doi=10.1111%2Fjphp.12030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In-vivo rat striatal 5-HT4 receptor occupancy using non-radiolabelled SB207145</span></div><div class="casAuthors">Nirogi, Ramakrishna; Kandikere, Vishwottam; Bhyrapuneni, Gopinadh; Saralaya, Ramanatha; Ajjala, Devender Reddy; Aleti, Raghupathi Reddy; Abdul Rasheed, Mohammed</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">704-712</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The objective of the current investigation was to develop a simple, rapid method for detg. in-vivo 5-hydroxytryptamine type 4 receptor (5-HT4R) occupancy in rat brain using non-radiolabeled SB207145 as a tracer for accelerating the drug discovery process.  In-vivo tracer optimization studies for tracer dose, survival intervals and brain distribution profile were carried out in rats.  The tracer was pharmacol. validated using potent well-characterized 5-HT4R ligands.  The brain regional concns. of tracer (SB207145); plasma and brain concns. of 5-HT4R ligands were quantified using high-performance liq. chromatog. coupled with a tandem mass spectrometric detector (LC-MS/MS).  SB207145 showed a higher specific binding in striatum (1.96 ng/g) and lower binding in cerebellum (0.66 ng/g), which is consistent with findings of other published 5-HT4R expression studies.  Pretreatment with potent 5-HT4 ligands dose-dependently reduced striatal SB207145 concn. and the ED to achieve 50% receptor occupancy (ED50) values were 4.8, 2.0, 7.4, 9.9, 3.8 and 0.02 mg/kg for GR113808, piboserod, prucalopride, RS67333, TD8954 and PF04995274, resp.  Results from the mass spectrometry approach to det. 5-HT4R occupancy in rat brain are comparable with those reported using radiolabeled scintillation spectroscopy methods.  In conclusion, the LC-MS/MS characterization permits use of tracer at a preclin. stage in high-throughput fashion as well as characterization of target expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBAD2h_4wjYrVg90H21EOLACvtfcHk0lhSASNkECChMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1Wks7w%253D&md5=fdd50664c69a42cbdf1501a11582e591</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12030%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DAjjala%26aufirst%3DD.%2BR.%26aulast%3DAleti%26aufirst%3DR.%2BR.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26atitle%3DIn%2520vivo%2520rat%2520striatal%25205-HT4%2520receptor%2520occupancy%2520using%2520non-radiolabelled%2520SB207145%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26spage%3D704%26epage%3D712%26doi%3D10.1111%2Fjphp.12030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span>; <span class="NLM_string-name">Drummond, E.</span>; <span class="NLM_string-name">Zasadny, K.</span>; <span class="NLM_string-name">Skaddan, M.</span>; <span class="NLM_string-name">Brodney, M.</span>; <span class="NLM_string-name">Coffman, K.</span>; <span class="NLM_string-name">Nicholas, T.</span>; <span class="NLM_string-name">Duvvuri, S.</span>; <span class="NLM_string-name">Raunig, D. L.</span>; <span class="NLM_string-name">Leurent, C.</span>; <span class="NLM_string-name">Rowinski, C.</span>; <span class="NLM_string-name">Park, Y.-S.</span>; <span class="NLM_string-name">Ogden, A.</span>; <span class="NLM_string-name">Sawant-Basak, A.</span>; <span class="NLM_string-name">Miller, E. L.</span>; <span class="NLM_string-name">Rapp, T.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Planeta-Wilson, B.</span>; <span class="NLM_string-name">Ropchan, J.</span>; <span class="NLM_string-name">Carson, R.</span>; <span class="NLM_string-name">Morris, E.</span>; <span class="NLM_string-name">Ding, Y.-S.</span>; <span class="NLM_string-name">Katz, E.</span></span> <span> </span><span class="NLM_article-title">Translational receptor occupancy for the 5-HT<sub>4</sub> partial agonist PF-04995274 in rats, non-human primates and healthy volunteers</span>. Presented at the International Conference on Alzheimer’s Disease, Paris, France, July 16–21, <span class="NLM_year">2011</span>; Poster No. 11818.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=S.+Grimwood&author=E.+Drummond&author=K.+Zasadny&author=M.+Skaddan&author=M.+Brodney&author=K.+Coffman&author=T.+Nicholas&author=S.+Duvvuri&author=D.+L.+Raunig&author=C.+Leurent&author=C.+Rowinski&author=Y.-S.+Park&author=A.+Ogden&author=A.+Sawant-Basak&author=E.+L.+Miller&author=T.+Rapp&author=Y.+Wang&author=B.+Planeta-Wilson&author=J.+Ropchan&author=R.+Carson&author=E.+Morris&author=Y.-S.+Ding&author=E.+Katz&title=Translational+receptor+occupancy+for+the+5-HT4+partial+agonist+PF-04995274+in+rats%2C+non-human+primates+and+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DGrimwood%26aufirst%3DS.%26atitle%3DTranslational%2520receptor%2520occupancy%2520for%2520the%25205-HT4%2520partial%2520agonist%2520PF-04995274%2520in%2520rats%252C%2520non-human%2520primates%2520and%2520healthy%2520volunteers%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubitski, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutzman-Engwall, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horner, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorczyca, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siok, C. J.</span></span> <span> </span><span class="NLM_article-title">The 5-hydroxytryptamine4 receptor agonists, prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1124/jpet.112.192351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1124%2Fjpet.112.192351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=22408061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlWltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=681-691&author=D.+E.+Johnsonauthor=E.+Drummondauthor=S.+Grimwoodauthor=A.+Sawant-Basakauthor=E.+Millerauthor=E.+Tsengauthor=L.+L.+McDowellauthor=M.+A.+Vanase-Frawleyauthor=K.+E.+Fisherauthor=D.+M.+Rubitskiauthor=K.+J.+Stutzman-Engwallauthor=R.+T.+Nelsonauthor=W.+E.+Hornerauthor=R.+R.+Gorczycaauthor=M.+Hajosauthor=C.+J.+Siok&title=The+5-hydroxytryptamine4+receptor+agonists%2C+prucalopride+and+PRX-03140+increase+acetylcholine+and+histamine+levels+in+the+rat+prefrontal+cortex+and+the+power+of+stimulated+hippocampal+%CE%B8+oscillations&doi=10.1124%2Fjpet.112.192351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations</span></div><div class="casAuthors">Johnson, David E.; Drummond, Elena; Grimwood, Sarah; Sawant-Basak, Aarti; Miller, Emily; Tseng, Elaine; McDowell, Laura L.; Vanase-Frawley, Michelle A.; Fisher, Katherine E.; Rubitski, David M.; Stutzman-Engwall, Kim J.; Nelson, Robin T.; Horner, Weldon E.; Gorczyca, Roxanne R.; Hajos, Mihaly; Siok, Chester J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">681-691</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)4 receptor agonists reportedly stimulate brain acetylcholine (ACh) release, a property that might provide a new pharmacol. approach for treating cognitive deficits assocd. with Alzheimer's disease.  The purpose of this study was to compare the binding affinities, functional activities, and effects on neuropharmacol. responses assocd. with cognition of two highly selective 5-HT4 receptor agonists, prucalopride and 6,7-dihydro-4-hydroxy-7-isopropyl-6-oxo-N-[3-(piperidin-1-yl)propyl]thieno[2,3-b]pyridine-5-carboxamide (PRX-03140).  In vitro, prucalopride and PRX-03140 bound to native rat brain 5-HT4 receptors with Ki values of 30 nM and 110 nM, resp., and increased cAMP prodn. in human embryonic kidney-293 cells expressing recombinant rat 5-HT4 receptors.  In vivo receptor occupancy studies established that prucalopride and PRX-03140 were able to penetrate the brain and bound to 5-HT4 receptors in rat brain, achieving 50% receptor occupancy at free brain exposures of 330 nM and 130 nM, resp.  Rat microdialysis studies revealed that prucalopride maximally increased ACh and histamine levels in the prefrontal cortex at 5 and 10 mg/kg, whereas PRX-03140 significantly increased cortical histamine levels at 50 mg/kg, failing to affect ACh release at doses lower than 150 mg/kg.  In combination studies, donepezil-induced increases in cortical ACh levels were potentiated by prucalopride and PRX-03140.  Electrophysiol. studies in rats demonstrated that both compds. increased the power of brainstem-stimulated hippocampal θ oscillations at 5.6 mg/kg.  These findings show for the first time that the 5-HT4 receptor agonists prucalopride and PRX-03140 can increase cortical ACh and histamine levels, augment donepezil-induced ACh increases, and increase stimulated-hippocampal θ power, all neuropharmacol. parameters consistent with potential pos. effects on cognitive processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYkki5FaX4E7Vg90H21EOLACvtfcHk0ljYC3XZvmHbkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlWltL4%253D&md5=a85101ee05a17788379fad99a454347b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.192351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.192351%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DDrummond%26aufirst%3DE.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DMcDowell%26aufirst%3DL.%2BL.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DFisher%26aufirst%3DK.%2BE.%26aulast%3DRubitski%26aufirst%3DD.%2BM.%26aulast%3DStutzman-Engwall%26aufirst%3DK.%2BJ.%26aulast%3DNelson%26aufirst%3DR.%2BT.%26aulast%3DHorner%26aufirst%3DW.%2BE.%26aulast%3DGorczyca%26aufirst%3DR.%2BR.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DSiok%26aufirst%3DC.%2BJ.%26atitle%3DThe%25205-hydroxytryptamine4%2520receptor%2520agonists%252C%2520prucalopride%2520and%2520PRX-03140%2520increase%2520acetylcholine%2520and%2520histamine%2520levels%2520in%2520the%2520rat%2520prefrontal%2520cortex%2520and%2520the%2520power%2520of%2520stimulated%2520hippocampal%2520%25CE%25B8%2520oscillations%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D681%26epage%3D691%26doi%3D10.1124%2Fjpet.112.192351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span> <span> </span><span class="NLM_article-title">Distinct functional effects of human 5-HT<sub>4</sub> receptor isoforms on beta-amyloid secretion</span>. <i>Neurodegener. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1159/000113691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1159%2F000113691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=18322379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Wht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=163-165&author=S.+J.+Robertauthor=F.+Lezoualc%E2%80%99h&title=Distinct+functional+effects+of+human+5-HT4+receptor+isoforms+on+beta-amyloid+secretion&doi=10.1159%2F000113691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct Functional Effects of Human 5-HT4 Receptor Isoforms on β-Amyloid Secretion</span></div><div class="casAuthors">Robert, Sylvain J.; Lezoualc'h, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">163-165</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: The serotonin 5-HT4 receptor is of potential interest for the treatment of Alzheimer's disease because it increases memory and learning and influences amyloid precursor protein (APP) processing.  Several 5-HT4 receptor isoforms have been cloned in humans.  They all belong to the G-protein-coupled receptor superfamily and differ in compn. and length of their amino acid intracellular C-terminal sequence.  At present, it is still unknown whether 5-HT4 receptor isoforms may have distinct effects on APP processing.  Objective: In this study, we investigated the effect of an ultrashort isoform of the human 5-HT4 receptor (2 amino acids after the splicing site), the 5-HT4(d) receptor isoform (h5-HT4(d)), on APP processing in Chinese hamster ovary cells (CHO cells).  Methods: Non-amyloidogenic sol. sAPPα was detd. by immunoblot and β-amyloid peptides (Aβ1-40 and Aβ1-42) were assayed by ELISA in CHO cells stably expressing h5-HT4(d) and transiently transfected with human APP695.  Results: We show here that activation of h5-HT4(d) strongly stimulates the release of sAPPα and concomitantly decreases extracellular Aβ peptides.  These data contrast with our previous findings showing that the h5-HT4(e/g) receptor isoform, which has 20 amino acids after the splicing site, did not influence Aβ secretion.  Conclusion: We conclude that C-terminal tails of 5-HT4 receptor isoforms may influence their functional effect on Aβ secretion and that the pathways regulating either β- or γ-secretase may be differentially controlled by 5-HT4 receptor isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFF1W64EZATLVg90H21EOLACvtfcHk0ljYC3XZvmHbkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Wht7s%253D&md5=c90b7775cd8805e5160a66689b8939ff</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1159%2F000113691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000113691%26sid%3Dliteratum%253Aachs%26aulast%3DRobert%26aufirst%3DS.%2BJ.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26atitle%3DDistinct%2520functional%2520effects%2520of%2520human%25205-HT4%2520receptor%2520isoforms%2520on%2520beta-amyloid%2520secretion%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2008%26volume%3D5%26spage%3D163%26epage%3D165%26doi%3D10.1159%2F000113691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cachard-Chastel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewachter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De- lomenie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devijver, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuven, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sicsic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardier, A. M.</span></span> <span> </span><span class="NLM_article-title">5-HT<sub>4</sub> receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">883</span>– <span class="NLM_lpage">892</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1038%2Fsj.bjp.0707178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=17325649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2007&pages=883-892&author=M.+Cachard-Chastelauthor=F.+Lezoualc%E2%80%99hauthor=I.+Dewachterauthor=C.+De-+lomenieauthor=S.+Croesauthor=S.+Devijverauthor=M.+Langloisauthor=F.+V.+Leuvenauthor=S.+Sicsicauthor=A.+M.+Gardier&title=5-HT4+receptor+agonists+increase+sAPP%CE%B1+levels+in+the+cortex+and+hippocampus+of+male+C57BL%2F6j+mice&doi=10.1038%2Fsj.bjp.0707178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT4 receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice</span></div><div class="casAuthors">Cachard-Chastel, M.; Lezoualc'h, F.; Dewachter, I.; Delomenie, C.; Croes, S.; Devijver, H.; Langlois, M.; Van Leuven, F.; Sicsic, S.; Gardier, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">883-892</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A strategy to treat Alzheimer's disease (AD) is to increase the sol. form of amyloid precursor protein (sAPPα), a promnesic protein, in the brain.  Because strong evidence supports beneficial effects of 5-hydroxytryptamine 5-HT4 receptor agonists in memory and learning, we investigated the role of 5-HT4 receptors on APP processing in 8 wk-old male C57BL/6j mice.  Mice were given, s.c., prucalopride or ML 10302 (s.c.), two highly selective 5-HT4 receptor agonists and, up to 240 min later, the hippocampus and cortex were analyzed by Western blot for sAPPα detn.  Prucalopride (5 or 10 mg kg-1) significantly increased sAPPα levels in the hippocampus and cortex, but did not modify the expression level of APP mRNA as detected by quant. RT-PCR.  A selective 5-HT4 receptor antagonist, GR125487 (1 mg kg-1, s.c.) inhibited prucalopride induced- increase in sAPPα levels.  In addn., levels of sAPPα were increased by ML10302 only at 20 mg kg-1 and was limited to the cortex.  Also, prucalopride increased sAPPα levels in the cortex of a transgenic mouse model of AD, expressing the London mutation of APP.  Furthermore, the combined injection of a selective acetylcholinesterase inhibitor, donepezil and prucalopride induced a synergic increase in sAPPα levels in the cortex and hippocampus.  The results demonstrate that the 5-HT4 receptor plays a key role in the non-amyloidogenic pathway of APP metab. in vivo and give support to the beneficial use of 5-HT4 agonists for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgDGVLDs3CMLVg90H21EOLACvtfcHk0lg6D6l62N4lpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12ntbo%253D&md5=37636a905d062d15019a151f983ecebc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707178%26sid%3Dliteratum%253Aachs%26aulast%3DCachard-Chastel%26aufirst%3DM.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DDe-%2Blomenie%26aufirst%3DC.%26aulast%3DCroes%26aufirst%3DS.%26aulast%3DDevijver%26aufirst%3DS.%26aulast%3DLanglois%26aufirst%3DM.%26aulast%3DLeuven%26aufirst%3DF.%2BV.%26aulast%3DSicsic%26aufirst%3DS.%26aulast%3DGardier%26aufirst%3DA.%2BM.%26atitle%3D5-HT4%2520receptor%2520agonists%2520increase%2520sAPP%25CE%25B1%2520levels%2520in%2520the%2520cortex%2520and%2520hippocampus%2520of%2520male%2520C57BL%252F6j%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D150%26spage%3D883%26epage%3D892%26doi%3D10.1038%2Fsj.bjp.0707178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Activation of 5-HT<sub>4</sub> receptors inhibits secretion of β-amyloid peptides and increases neuronal survival</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">274</span>– <span class="NLM_lpage">278</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2006.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.expneurol.2006.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=16978609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Krt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2007&pages=274-278&author=S.+S.+Choauthor=Y.+Hu&title=Activation+of+5-HT4+receptors+inhibits+secretion+of+%CE%B2-amyloid+peptides+and+increases+neuronal+survival&doi=10.1016%2Fj.expneurol.2006.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of 5-HT4 receptors inhibits secretion of β-amyloid peptides and increases neuronal survival</span></div><div class="casAuthors">Cho, Seongeun; Hu, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">274-278</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Activation of 5-HT4 receptors has been shown to improve memory processes in preclin. cognition models, suggesting potential utility of 5-HT4 agonists for the symptomatic treatment of Alzheimer's disease (AD).  Recent studies have shown that 5-HT4 agonists also increase the secretion of the non-amyloidogenic sol. amyloid precursor protein-alpha (sAPPα).  In the present study, we demonstrated that a selective 5-HT4 partial agonist, RS67333, inhibited the generation of β-amyloid peptide (Aβ) in primary cortical cultures of Tg2576 transgenic mice expressing human APPK670N/M671L.  Furthermore, treatments with RS67333 selectively increased the survival of transgenic neurons in a dose-dependent manner, which was inhibited by 5-HT4 antagonists.  These and previous data collectively suggest that the 5-HT4 receptor may be an effective therapeutic target for AD, providing both symptomatic improvements and neuroprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94iComWBAYLVg90H21EOLACvtfcHk0lg6D6l62N4lpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Krt73K&md5=0b90d41ab8f752fb01c09cee2df2a429</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2006.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2006.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BS.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DActivation%2520of%25205-HT4%2520receptors%2520inhibits%2520secretion%2520of%2520%25CE%25B2-amyloid%2520peptides%2520and%2520increases%2520neuronal%2520survival%26jtitle%3DExp.%2520Neurol.%26date%3D2007%26volume%3D203%26spage%3D274%26epage%3D278%26doi%3D10.1016%2Fj.expneurol.2006.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, N. A.</span></span> <span> </span><span class="NLM_article-title">Pharmacological evidence for a functional serotonin-2b receptor in a human uterine smooth muscle cell line</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">1254</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.100172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1124%2Fjpet.105.100172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=16517693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1eqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=1254-1261&author=C.+R.+Kellyauthor=N.+A.+Sharif&title=Pharmacological+evidence+for+a+functional+serotonin-2b+receptor+in+a+human+uterine+smooth+muscle+cell+line&doi=10.1124%2Fjpet.105.100172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line</span></div><div class="casAuthors">Kelly, Curtis R.; Sharif, Najam A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1254-1261</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study investigated the serotonin-induced increase in phosphoinositide hydrolysis and mobilization of intracellular Ca2+ ([Ca2+]i) in human uterine smooth muscle cells (HUSMCs) to identify the serotonergic receptor pos. coupled to phospholipase C in these cells.  In phosphoinositide (PI) assays, serotonin (5-HT) and α-methyl-5-HT were potent, full agonists (EC50 = 20 and 4.1 nM, resp.), whereas the phenylethylamine, R-(-)-1-(4-iodo-2,5-dimethoxyphenyl)-2-aminopropane hydrochloride, was less active (EC50 = 63 nM).  Proposed 5-HT2B-selective agonists, BW-723C86 and (+)-norfenfluramine, exhibited strong agonist potency and efficacy comparable with 5-HT (EC50 = 18 and 33 nM, resp.) and ∼15-fold more potency than (-)-norfenfluramine (EC50 = 500 nM).  5-HT2C receptor agonists m-chlorophenylpiperazine and MK-212 were weak agonists in these cells, with potencies of 110 and 880 nM, resp.  A similar rank order of potency was obsd. in [Ca2+]i mobilization assays (r = 0.9) in the HUSMC and with contraction of rat stomach fundus strips that contain a 5-HT2B receptor (r = 0.9).  Antagonist studies revealed that a 5-HT2B-selective antagonist, RS-127445 (Ki = 0.13 nM), was significantly more effective at inhibiting 5-HT-induced activity than a 5-HT2A antagonist, M-100907 (Ki = 914 nM) and the 5-HT2C antagonists RS-102221 (Ki = 2.5 μM) and SB-242084 (Ki = 42.4 nM) in the HUSMC PI turnover assays.  Taken together, these studies strongly suggest the presence of a functionally active 5-HT2B receptor subtype in HUSMCs.  The physiol. role of this receptor in these cells remains to be defined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWnAOFD_xYkrVg90H21EOLACvtfcHk0lg6D6l62N4lpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1eqtbY%253D&md5=52ea7805fe17184bad2816d80f4fe74a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.100172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.100172%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DC.%2BR.%26aulast%3DSharif%26aufirst%3DN.%2BA.%26atitle%3DPharmacological%2520evidence%2520for%2520a%2520functional%2520serotonin-2b%2520receptor%2520in%2520a%2520human%2520uterine%2520smooth%2520muscle%2520cell%2520line%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D1254%26epage%3D1261%26doi%3D10.1124%2Fjpet.105.100172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-patent1"><div class="reference"><strong class="refLabel"><a href="#patent1" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-patent1_1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span>; <span class="NLM_string-name">Mohammed, A. R.</span>; <span class="NLM_string-name">Yarlgadda, S.</span>; <span class="NLM_string-name">Ravella, S. R.</span>; <span class="NLM_string-name">Shinde, A. K.</span>; <span class="NLM_string-name">Kambhampati, R.</span>; <span class="NLM_string-name">Roayalley, P. K.</span>; <span class="NLM_string-name">Jayarajan, P.</span>; <span class="NLM_string-name">Bhyrapuneni, G.</span>; <span class="NLM_string-name">Patnala, S. M.</span>; <span class="NLM_string-name">Ravula, J.</span>; <span class="NLM_string-name">Jasti, V.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl compounds as 5-HT<sub>4</sub> receptor ligands</span>. Patent <span class="NLM_patent">WO2013042135</span>, March 28, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+Nirogi&author=A.+R.+Mohammed&author=S.+Yarlgadda&author=S.+R.+Ravella&author=A.+K.+Shinde&author=R.+Kambhampati&author=P.+K.+Roayalley&author=P.+Jayarajan&author=G.+Bhyrapuneni&author=S.+M.+Patnala&author=J.+Ravula&author=V.+Jasti&title=Heteroaryl+compounds+as+5-HT4+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=patent1_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26atitle%3DHeteroaryl%2520compounds%2520as%25205-HT4%2520receptor%2520ligands%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-add"><div class="reference"><strong class="refLabel"><a href="#add" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-add_1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paxinos, G.</span>; <span class="NLM_string-name">Watson, C.</span></span> <i>In the rat brain in stereotaxic coordinates</i>, <span class="NLM_edition">5</span>th ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+Paxinos&author=C.+Watson&title=In+the+rat+brain+in+stereotaxic+coordinates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=add_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DPaxinos%26aufirst%3DG.%26btitle%3DIn%2520the%2520rat%2520brain%2520in%2520stereotaxic%2520coordinates%26pub%3DAcademic%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohler, E.
G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noiman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lezoualc’h, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gastineau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutkowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marantz, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumuis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ragozzino, M. E.</span></span> <span> </span><span class="NLM_article-title">VRX-03011, a novel 5-HT<sub>4</sub> agonist, enhances memory and hippocampal acetylcholine efflux</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2007.06.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1016%2Fj.neuropharm.2007.06.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=17692343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFaiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2007&pages=563-573&author=E.%0AG.+Mohlerauthor=S.+Shachamauthor=S.+Noimanauthor=F.+Lezoualc%E2%80%99hauthor=S.+Robertauthor=M.+Gastineauauthor=J.+Rutkowskiauthor=Y.+Marantzauthor=A.+Dumuisauthor=J.+Bockaertauthor=P.+E.+Goldauthor=M.+E.+Ragozzino&title=VRX-03011%2C+a+novel+5-HT4+agonist%2C+enhances+memory+and+hippocampal+acetylcholine+efflux&doi=10.1016%2Fj.neuropharm.2007.06.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux</span></div><div class="casAuthors">Mohler, Eric G.; Shacham, Sharon; Noiman, Silvia; Lezoualc'h, Frank; Robert, Sylvain; Gastineau, Monique; Rutkowski, Joseph; Marantz, Yael; Dumuis, Aline; Bockaert, Joel; Gold, Paul E.; Ragozzino, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">563-573</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent evidence suggests that 5-hydroxytryptamine (5-HT)4 receptor activity enhances cognition and provides neuroprotection.  Here we report the effects of VRX-03011, a novel partial 5-HT4 agonist, that is both potent (Ki ∼ 30 nM) and highly selective (Ki > 5 μM for all other 5-HT receptors tested).  In sep. expts., rats received VRX-03011 (0.1-10 mg/kg i.p.) 30 min prior to spontaneous alternation testing in a no-delay or a 30-s delay condition.  VRX-03011 (1, 5 and 10 mg/kg, but not 0.1 mg/kg) significantly enhanced delayed spontaneous alternation performance while none of the doses enhanced performance in the no-delay test.  VRX-03011 (1 and 5 mg/kg) concomitantly enhanced hippocampal acetylcholine output and delayed spontaneous alternation scores compared to that of vehicle controls, but had no effect on hippocampal acetylcholine release under a resting condition.  Moreover, suboptimal doses of VRX-03011 and the acetylcholinesterase inhibitor galanthamine combined to enhance memory.  VRX-03011 also regulated amyloid precursor protein (APP) metab. by inducing a concn.-dependent increase in the non-amyloidogenic sol. form of APP (sAPPα) with an EC50 ∼ 1-10 nM.  VRX-03011 had no effect on contractile properties in guinea pig ileum or colon prepns. with an EC50 > 10 μM and did not alter rat intestinal transit at doses up to 10 mg/kg.  These findings suggest that VRX-03011 may represent a novel treatment for Alzheimer's disease that reduces cognitive impairments and provides neuroprotection without gastrointestinal side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgO9nBGMjNbLVg90H21EOLACvtfcHk0lgk9nCmQNS23A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFaiu7k%253D&md5=1dd6440e1f54b5577d69f9725e6c2569</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2007.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2007.06.016%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DE.%2BG.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DNoiman%26aufirst%3DS.%26aulast%3DLezoualc%25E2%2580%2599h%26aufirst%3DF.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DGastineau%26aufirst%3DM.%26aulast%3DRutkowski%26aufirst%3DJ.%26aulast%3DMarantz%26aufirst%3DY.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DGold%26aufirst%3DP.%2BE.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3DVRX-03011%252C%2520a%2520novel%25205-HT4%2520agonist%252C%2520enhances%2520memory%2520and%2520hippocampal%2520acetylcholine%2520efflux%26jtitle%3DNeuropharmacology%26date%3D2007%26volume%3D53%26spage%3D563%26epage%3D573%26doi%3D10.1016%2Fj.neuropharm.2007.06.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanz, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himes, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallante, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amore, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, K. M.</span></span> <span> </span><span class="NLM_article-title">The γ-Secretase inhibitor <i>N-</i>[<i>N-</i>(3,5-difluorophenacetyl)-l-alanyl]-<i>S</i>-phenylglycine <i>t</i>-butyl ester reduces Aβ levels <i>in vivo</i> in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">871</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.048280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1124%2Fjpet.102.048280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=12626636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Sns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=864-871&author=T.+A.+Lanzauthor=C.+S.+Himesauthor=G.+Pallanteauthor=L.+Adamsauthor=S.+Yamazakiauthor=B.+Amoreauthor=K.+M.+Merchant&title=The+%CE%B3-Secretase+inhibitor+N-%5BN-%283%2C5-difluorophenacetyl%29-l-alanyl%5D-S-phenylglycine+t-butyl+ester+reduces+A%CE%B2+levels+in+vivo+in+plasma+and+cerebrospinal+fluid+in+young+%28plaque-free%29+and+aged+%28plaque-bearing%29+Tg2576+mice&doi=10.1124%2Fjpet.102.048280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces Aβ levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice</span></div><div class="casAuthors">Lanz, Thomas A.; Himes, Carol S.; Pallante, Giovanni; Adams, Lisa; Yamazaki, Shinji; Amore, Ben; Merchant, Kalpana M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">864-871</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Acute, s.c. administration of a γ-secretase inhibitor, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-Bu ester (DAPT), to young PDAPP mice dose dependently decreases cortical amyloid-β (Aβ).  The present studies replicated these findings in Tg2576 mice and examd. further whether DAPT would reduce cerebrospinal fluid (CSF) Aβ comparably in young (plaque-free) and aged (plaque-bearing) mice.  In the first study, vehicle or DAPT (10, 30, or 100 mg/kg s.c.) administered to young Tg2576 mice (6 mo old) dose dependently reduced Aβ peptide levels in the cortex as seen previously in the PDAPP mice.  Addnl., a dose-dependent decrease in plasma Aβ levels was evident.  The same dosing regime was applied next to aged mice (17 mo old) to assess Aβ changes in the CSF in addn. to plasma and brains.  DAPT dose dependently reduced Aβ levels in the CSF and plasma, but not in the brain wherein Aβ levels were 400 to 500 times higher than those in young mice, consistent with a large pool of Aβ extd. from amyloid deposits.  In subsequent studies, effects of oral DAPT (100 or 200 mg/kg) were examd. concurrently in young and aged mice.  DAPT reduced Aβ levels in CSF and plasma to a similar extent at both ages.  In contrast, DAPT reduced brain Aβ levels primarily in young mice, with minimal effects in aged mice.  These results demonstrate that Aβ levels in CSF and plasma decrease dose dependently after γ-secretase inhibition, and this response is not affected by amyloid plaque burden.  We conclude that CSF and plasma Aβ may offer a clin. applicable, mechanism-based biomarker for inhibitors of Aβ prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhYEy0KnoA5rVg90H21EOLACvtfcHk0lgk9nCmQNS23A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Sns7c%253D&md5=a9a678c814a1b42bbdc43219f2397ac7</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.048280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.048280%26sid%3Dliteratum%253Aachs%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DHimes%26aufirst%3DC.%2BS.%26aulast%3DPallante%26aufirst%3DG.%26aulast%3DAdams%26aufirst%3DL.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAmore%26aufirst%3DB.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26atitle%3DThe%2520%25CE%25B3-Secretase%2520inhibitor%2520N-%255BN-%25283%252C5-difluorophenacetyl%2529-l-alanyl%255D-S-phenylglycine%2520t-butyl%2520ester%2520reduces%2520A%25CE%25B2%2520levels%2520in%2520vivo%2520in%2520plasma%2520and%2520cerebrospinal%2520fluid%2520in%2520young%2520%2528plaque-free%2529%2520and%2520aged%2520%2528plaque-bearing%2529%2520Tg2576%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D305%26spage%3D864%26epage%3D871%26doi%3D10.1124%2Fjpet.102.048280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mouedden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandermeeren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span> <span> </span><span class="NLM_article-title">Reduction of Aβ levels in the Sprague Dawley rat after oral administration of the functional γ-secretase inhibitor, DAPT: A novel non-transgenic model for Aβ production inhibitors</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.2174/138161206775474233</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.2174%2F138161206775474233" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=671-676&author=M.+Moueddenauthor=M.+Vandermeerenauthor=T.+Meertauthor=M.+Mercken&title=Reduction+of+A%CE%B2+levels+in+the+Sprague+Dawley+rat+after+oral+administration+of+the+functional+%CE%B3-secretase+inhibitor%2C+DAPT%3A+A+novel+non-transgenic+model+for+A%CE%B2+production+inhibitors&doi=10.2174%2F138161206775474233"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2174%2F138161206775474233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474233%26sid%3Dliteratum%253Aachs%26aulast%3DMouedden%26aufirst%3DM.%26aulast%3DVandermeeren%26aufirst%3DM.%26aulast%3DMeert%26aufirst%3DT.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DReduction%2520of%2520A%25CE%25B2%2520levels%2520in%2520the%2520Sprague%2520Dawley%2520rat%2520after%2520oral%2520administration%2520of%2520the%2520functional%2520%25CE%25B3-secretase%2520inhibitor%252C%2520DAPT%253A%2520A%2520novel%2520non-transgenic%2520model%2520for%2520A%25CE%25B2%2520production%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D671%26epage%3D676%26doi%3D10.2174%2F138161206775474233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jay, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churcher, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morentin-Gutierrez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattison, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span> <span> </span><span class="NLM_article-title"><i>In Vivo</i> Characterization of Aβ(40) changes in brain and cerebrospinal fluid using the novel γ-secretase inhibitor <i>N</i>-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) in the rat</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.100271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=10.1124%2Fjpet.105.100271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=16443723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=786-790&author=J.+D.+Bestauthor=M.+T.+Jayauthor=F.+Otuauthor=I.+Churcherauthor=M.+Reillyauthor=P.+Morentin-Gutierrezauthor=C.+Pattisonauthor=T.+Harrisonauthor=M.+S.+Shearmanauthor=J.+R.+Atack&title=In+Vivo+Characterization+of+A%CE%B2%2840%29+changes+in+brain+and+cerebrospinal+fluid+using+the+novel+%CE%B3-secretase+inhibitor+N-%5Bcis-4-%5B%284-chlorophenyl%29sulfonyl%5D-4-%282%2C5-difluorophenyl%29cyclohexyl%5D-1%2C1%2C1-trifluoromethanesulfonamide+%28MRK-560%29+in+the+rat&doi=10.1124%2Fjpet.105.100271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo characterization of Aβ(40) changes in brain and cerebrospinal fluid using the novel γ-secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]- 1,1,1-trifluoromethanesulfonamide (MRK-560) in the rat</span></div><div class="casAuthors">Best, Jonathan D.; Jay, Mark T.; Otu, Franklin; Churcher, Ian; Reilly, Michael; Morentin-Gutierrez, Pablo; Pattison, Christine; Harrison, Tim; Shearman, Mark S.; Atack, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">786-790</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Plaques in the parenchyma of the brain contg. Aβ peptides are one of the hallmarks of Alzheimer's disease.  These Aβ peptides are produced by the final proteolytic cleavage of the amyloid precursor protein by the intramembraneous aspartyl protease γ-secretase.  Thus, one approach to lowering levels of Aβ has been via the inhibition of the γ-secretase enzyme.  Here, we report a novel, bioavailable γ-secretase inhibitor, MRK-560, that displayed oral pharmacokinetics suitable for once-a-day dosing.  It was able to markedly reduce Aβ in the brain and cerebrospinal fluid (CSF) in the rat, with ED50 values of 6 and 10 mg/kg, resp.  Time-course expts. using MRK-560 demonstrated these redns. in Aβ could be maintained for 24 h, and comparable temporal redns. in rat brain and CSF Aβ(40) further suggested that these two pools of Aβ are related.  This relation between the brain and CSF Aβ was maintained when MRK-560 was dosed once a day for 2 wk, and accordingly, when all the data for the dose-response curve and time courses were correlated, a strong assocn. was obsd. between the brain and CSF Aβ levels.  These results demonstrate that MRK-560 is an orally bioavailable γ-secretase inhibitor with the ability to markedly reduce Aβ peptide in the brain and CSF of the rat and confirm the utility of the rat for assessing the effects of γ-secretase inhibitors on central nervous system Aβ(40) levels in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNWKVBblcKJLVg90H21EOLACvtfcHk0lj2vsD0HtPO-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamu7g%253D&md5=8fa446ec4020b77e859e3e92aa03d3cb</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.100271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.100271%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DJ.%2BD.%26aulast%3DJay%26aufirst%3DM.%2BT.%26aulast%3DOtu%26aufirst%3DF.%26aulast%3DChurcher%26aufirst%3DI.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DMorentin-Gutierrez%26aufirst%3DP.%26aulast%3DPattison%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DT.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26atitle%3DIn%2520Vivo%2520Characterization%2520of%2520A%25CE%25B2%252840%2529%2520changes%2520in%2520brain%2520and%2520cerebrospinal%2520fluid%2520using%2520the%2520novel%2520%25CE%25B3-secretase%2520inhibitor%2520N-%255Bcis-4-%255B%25284-chlorophenyl%2529sulfonyl%255D-4-%25282%252C5-difluorophenyl%2529cyclohexyl%255D-1%252C1%252C1-trifluoromethanesulfonamide%2520%2528MRK-560%2529%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D786%26epage%3D790%26doi%3D10.1124%2Fjpet.105.100271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i53"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00457">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_30711"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00457">10.1021/acs.jmedchem.8b00457</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures, characterization data of the final compounds, comparative in vitro affinities of the 5-HT<sub>4</sub>R reference standards, data from the functional assays, protein-binding results, selectivity profile, and elemental analysis (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular-formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_001.pdf">jm8b00457_si_001.pdf (444.06 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00457/suppl_file/jm8b00457_si_002.csv">jm8b00457_si_002.csv (2.42 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-11%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00457%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00457" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990bcf2e822428","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
